data_1i2v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i2v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 1.2 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -130.39 94.24 3.62 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 124.876 1.36 . . . . 0.0 109.303 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.476 HD12 ' CH2' ' A' ' 41' ' ' TRP . 10.5 tt -55.66 163.53 1.33 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 113.678 -1.601 . . . . 0.0 108.166 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.648 HD12 ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -134.85 -43.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.111 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.47 -150.78 12.42 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.4 m -95.88 170.29 9.4 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.504 -0.848 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.1 t -140.19 43.81 1.9 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -119.7 129.92 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.43 74.15 4.98 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.25 58.01 0.04 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-N 113.292 -1.777 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.39 173.91 16.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.532 0.784 . . . . 0.0 109.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.6 t -80.4 172.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.34 30.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.694 1.246 . . . . 0.0 108.754 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' N ' ' C ' ' A' ' 12' ' ' VAL . 30.0 t80 -51.69 138.79 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.5 m -91.75 -75.21 0.48 Allowed 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.647 1.217 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.2 OUTLIER 88.68 -35.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 20' ' ' GLY . 6.1 p-10 -138.96 72.55 1.41 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.512 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.8 t -41.55 -71.46 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -32.55 0.5 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.57 -60.81 5.14 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 tp10 -55.38 -32.78 62.89 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.654 0.74 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.648 ' SG ' HD12 ' A' ' 4' ' ' ILE . 3.0 m -74.72 -43.89 52.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.642 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -30.78 71.6 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.464 1.102 . . . . 0.0 108.242 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.17 -28.41 70.03 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.729 1.268 . . . . 0.0 109.605 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.39 -1.07 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.484 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.65 82.27 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.552 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 19.2 m-85 -79.52 170.86 15.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.95 0.881 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.573 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.7 156.57 20.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.742 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.31 103.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.102 0 O-C-N 125.166 1.541 . . . . 0.0 110.352 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -83.11 -171.23 47.19 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.99 173.92 11.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.547 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 99.5 m -93.93 150.62 20.2 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 125.05 1.469 . . . . 0.0 107.678 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 O-C-N 125.63 1.831 . . . . 0.0 111.022 179.746 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -119.6 150.64 39.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.736 1.273 . . . . 0.0 109.846 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -107.81 155.79 19.85 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CH2' HD12 ' A' ' 3' ' ' LEU . 24.7 m95 -142.98 158.67 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.193 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 82.5 m -94.37 164.5 12.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.808 -1.957 . . . . 0.0 107.551 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -97.55 55.43 1.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.209 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.573 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 12.5 t . . . . . 0 C--N 1.31 -1.152 0 CA-C-O 111.85 -3.928 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 5.2 mmtm -100.98 111.4 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 4' ' ' ILE . 5.2 tt -66.49 163.7 17.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.126 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.58 HD13 ' SG ' ' A' ' 22' ' ' CYS . 21.8 pt -135.09 -41.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.35 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.24 -148.93 9.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -99.43 177.96 5.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.811 -0.695 . . . . 0.0 109.743 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -146.23 49.56 1.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.9 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.85 126.88 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.675 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.88 61.66 1.96 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 125.215 1.572 . . . . 0.0 107.013 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.67 39.51 0.03 OUTLIER Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.35 176.66 11.74 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.265 0.627 . . . . 0.0 109.435 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -80.41 171.4 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m120 42.22 30.09 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.115 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -51.41 135.7 26.83 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 t -123.63 -178.13 3.94 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.802 1.314 . . . . 0.0 108.594 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 t -143.12 -56.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.394 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -101.67 70.2 1.25 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.791 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 4' ' ' ILE . 11.2 t -41.18 -72.85 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -41.0 -32.67 0.25 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.272 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.18 -60.57 5.09 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.554 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 25' ' ' ARG . 5.3 tt0 -58.32 -29.32 65.8 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.58 ' SG ' HD13 ' A' ' 4' ' ' ILE . 7.4 m -77.03 -42.5 38.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.68 -30.1 71.25 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -33.48 74.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.493 HH11 ' CG2' ' A' ' 4' ' ' ILE . 2.0 mtm180 -86.68 -2.27 58.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.155 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.54 14.32 76.32 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.541 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.3 m-85 -77.66 148.93 34.77 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.175 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.568 ' CE ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -47.93 -42.2 26.66 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.508 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.24 -168.79 40.23 Favored Glycine 0 N--CA 1.483 1.799 0 O-C-N 125.165 1.541 . . . . 0.0 110.158 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -162.44 160.72 32.97 Favored Glycine 0 N--CA 1.484 1.876 0 O-C-N 124.67 0.865 . . . . 0.0 111.208 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.31 168.01 28.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.286 -0.957 . . . . 0.0 109.357 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 73.0 m -85.54 151.3 24.04 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.489 2.169 0 O-C-N 125.652 1.845 . . . . 0.0 112.437 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -143.04 132.15 23.09 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -109.41 137.68 46.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -125.33 157.49 36.58 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 125.271 1.607 . . . . 0.0 108.043 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 98.7 m -84.38 161.28 20.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 116.341 -2.143 . . . . 0.0 107.992 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -99.69 57.18 1.0 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.954 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.568 ' HA ' ' CE ' ' A' ' 28' ' ' LYS . 14.2 t . . . . . 0 C--N 1.31 -1.142 0 CA-C-O 112.695 -3.526 . . . . 0.0 109.187 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 4.4 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 9.3 mptt -115.91 102.57 9.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.554 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.496 HD13 ' CZ2' ' A' ' 41' ' ' TRP . 4.8 tt -56.33 162.38 2.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.051 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.626 HD12 ' SG ' ' A' ' 18' ' ' CYS . 2.9 pt -133.98 -45.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.79 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.25 -148.94 10.26 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 125.033 1.458 . . . . 0.0 109.861 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.65 155.83 17.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.139 -1.031 . . . . 0.0 109.279 -179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 43.0 t -124.01 48.77 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.39 118.88 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.571 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 96.04 2.63 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.01 -9.76 5.69 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.451 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.31 176.71 5.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -82.28 168.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 114.178 -1.373 . . . . 0.0 107.987 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 42.31 30.08 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.461 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.7 t80 -53.44 140.62 27.26 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 125.28 1.613 . . . . 0.0 109.633 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' SER . 3.4 m -88.0 -74.28 0.46 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 124.687 1.242 . . . . 0.0 109.733 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 90.06 -38.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -138.19 72.86 1.42 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.626 ' SG ' HD12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -42.57 -72.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -39.08 -32.62 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.16 -60.19 4.6 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' HB ' ' A' ' 4' ' ' ILE . 39.5 tp10 -55.43 -32.17 62.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.137 0.97 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.566 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 m -75.75 -44.89 39.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.105 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.22 -31.56 72.73 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 124.513 1.133 . . . . 0.0 108.202 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.757 1.286 . . . . 0.0 109.948 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' NH1' ' HA ' ' A' ' 4' ' ' ILE . 48.8 mtt180 -93.6 -4.12 51.38 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.158 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.03 79.95 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 m-30 -81.22 162.6 23.5 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.354 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HZ1' ' C ' ' A' ' 44' ' ' THR . 2.3 mppt? -79.71 163.61 24.38 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -32.12 104.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.479 1.737 . . . . 0.0 110.436 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -165.44 39.08 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.837 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -163.95 173.4 12.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 109.585 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 52.6 m -98.56 146.27 25.97 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.287 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.778 0 O-C-N 126.292 2.245 . . . . 0.0 112.033 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -152.55 174.75 13.54 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 123.532 0.52 . . . . 0.0 110.369 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -123.95 147.62 47.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 3' ' ' LEU . 36.8 m95 -145.77 160.59 41.53 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.615 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.9 m -93.26 -175.94 3.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 117.327 -1.749 . . . . 0.0 108.288 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 39.8 mt-10 -142.97 75.78 1.5 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 124.358 1.036 . . . . 0.0 110.53 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.475 ' C ' ' HZ1' ' A' ' 28' ' ' LYS . 1.1 t . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 115.706 -2.092 . . . . 0.0 110.725 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -108.28 103.8 13.05 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.43 HD13 ' CH2' ' A' ' 41' ' ' TRP . 5.3 tt -59.88 163.08 4.84 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.303 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.585 HD11 ' SG ' ' A' ' 18' ' ' CYS . 14.9 pt -135.07 -41.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 125.063 1.477 . . . . 0.0 109.257 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.77 -147.02 9.8 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.131 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.53 -175.3 3.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.797 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 13.7 t -150.17 54.36 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 38' ' ' VAL . 2.6 t -146.73 129.92 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.985 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 67.89 5.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.64 42.69 0.02 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 174.77 12.4 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.98 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.77 1.294 . . . . 0.0 107.655 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m120 42.71 29.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.376 1.047 . . . . 0.0 108.876 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 18.6 t80 -47.43 136.39 9.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.207 1.567 . . . . 0.0 109.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 16' ' ' SER . 37.2 m -96.85 -75.79 0.53 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 124.675 1.234 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' THR . 1.6 t 89.89 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 p-10 -137.35 75.78 1.55 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.133 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -44.5 -59.8 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -33.17 22.76 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.221 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -70.77 -63.93 3.01 Favored Glycine 0 N--CA 1.486 1.973 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.482 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 26.7 tt0 -53.68 -30.77 44.97 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.447 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m -75.92 -43.16 46.45 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.1 -31.31 72.46 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.578 1.174 . . . . 0.0 108.234 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 25' ' ' ARG . 2.3 mt -62.97 -28.27 69.97 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.719 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.77 -2.76 40.38 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.056 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 10.17 80.46 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.526 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.9 m-85 -80.41 167.07 20.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.989 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 166.06 14.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.853 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.1 98.61 0.01 OUTLIER Glycine 0 N--CA 1.485 1.954 0 O-C-N 125.584 1.803 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -73.88 -166.78 13.98 Favored Glycine 0 N--CA 1.48 1.63 0 O-C-N 125.84 1.553 . . . . 0.0 110.324 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.425 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 50.1 p-80 -162.48 171.16 17.52 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.898 -1.151 . . . . 0.0 110.366 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -92.24 150.46 20.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.645 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 8' ' ' VAL . 9.1 p . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -133.15 123.24 25.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.722 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 143.54 27.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.43 ' CH2' HD13 ' A' ' 3' ' ' LEU . 19.1 m95 -130.06 151.85 50.15 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.478 -2.147 . . . . 0.0 109.339 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.526 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 92.2 m -89.75 162.32 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 116.546 -2.061 . . . . 0.0 107.7 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.16 57.25 1.06 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.593 1.187 . . . . 0.0 111.433 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.304 -1.406 1 CA-C-O 111.519 -4.086 . . . . 0.0 110.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -125.93 127.31 45.78 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.439 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 4' ' ' ILE . 1.6 tm? -73.0 163.57 27.98 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.312 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.626 HG22 ' SG ' ' A' ' 22' ' ' CYS . 8.5 pt -136.77 -39.96 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 124.928 1.392 . . . . 0.0 108.684 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.37 -159.18 32.43 Favored Glycine 0 N--CA 1.486 2.022 0 O-C-N 124.799 1.312 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 167.16 11.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.308 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.74 47.29 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 38' ' ' VAL . 69.9 t -119.26 127.43 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.176 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -77.58 70.3 3.94 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.471 -1.241 . . . . 0.0 107.709 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.91 56.9 0.04 OUTLIER Glycine 0 N--CA 1.485 1.954 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.6 173.82 15.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.387 0.698 . . . . 0.0 109.195 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.2 t -80.86 171.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 43.61 28.76 0.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.941 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' N ' ' C ' ' A' ' 12' ' ' VAL . 38.6 t80 -51.99 140.53 20.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.841 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 16' ' ' SER . 4.9 m -89.95 -75.43 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 124.781 1.301 . . . . 0.0 109.792 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER 87.54 -36.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.64 74.23 1.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 123.941 0.776 . . . . 0.0 109.88 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 t -42.7 -72.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.5 -27.79 1.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.317 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.9 -63.05 3.85 Favored Glycine 0 N--CA 1.486 2.003 0 O-C-N 125.137 1.523 . . . . 0.0 109.628 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 11.4 tp10 -51.94 -37.1 51.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -72.34 -42.45 65.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.637 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -30.69 71.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.85 -33.55 75.5 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 124.716 1.26 . . . . 0.0 109.333 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.504 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 1.3 mpt_? -97.87 14.05 28.5 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.89 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 54.91 30.17 52.73 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.636 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 8.5 m-85 -76.85 178.04 7.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.53 -33.44 64.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.359 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 159.68 179.57 34.58 Favored Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.418 1.074 . . . . 0.0 110.555 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.64 156.99 27.79 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.3 p-80 -153.61 157.39 39.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.044 -1.078 . . . . 0.0 109.757 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 95.3 m -78.19 150.11 33.59 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.205 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -145.95 157.9 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.488 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -117.47 150.7 38.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.592 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.417 ' CE2' HD21 ' A' ' 3' ' ' LEU . 40.5 m95 -133.66 168.83 17.98 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 125.063 1.477 . . . . 0.0 108.535 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -100.09 161.5 13.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 55.52 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.42 1.088 . . . . 0.0 109.214 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 42' ' ' CYS . 71.3 p . . . . . 0 C--N 1.302 -1.5 0 CA-C-O 114.641 -2.599 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 10.2 mmtt -97.9 106.01 18.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.28 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.594 HD11 ' CH2' ' A' ' 41' ' ' TRP . 9.1 tt -56.53 162.42 2.21 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.556 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.629 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 10.2 pt -136.85 -41.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.537 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.6 -152.03 12.05 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -93.96 166.61 12.08 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.514 0.773 . . . . 0.0 109.652 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.8 t -136.04 47.16 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.4 127.52 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.13 68.5 3.27 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.39 59.18 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.21 177.07 11.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.575 0.809 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -81.51 170.8 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.643 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.22 29.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.495 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 36.3 t80 -50.91 140.22 15.72 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.77 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.4 m -92.17 -74.28 0.52 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 124.819 1.325 . . . . 0.0 109.437 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.9 OUTLIER 89.08 -37.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -138.29 75.02 1.5 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.816 0.697 . . . . 0.0 109.795 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 4' ' ' ILE . 2.0 t -42.54 -70.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.4 OUTLIER -39.41 -33.74 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.767 0.667 . . . . 0.0 109.568 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.12 -56.89 6.59 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' HG3' ' NH2' ' A' ' 25' ' ' ARG . 1.2 tp10 -55.8 -34.61 65.48 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.567 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.7 m -75.16 -45.21 42.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.38 -31.44 72.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -34.4 74.65 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.426 1.079 . . . . 0.0 109.964 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.536 ' NH2' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -94.23 1.69 55.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.996 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 13.36 82.1 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 124.122 0.889 . . . . 0.0 110.911 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 22.4 m-85 -83.13 168.45 16.84 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.893 0.854 . . . . 0.0 109.928 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.47 162.69 17.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.664 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.45 102.47 0.01 OUTLIER Glycine 0 N--CA 1.484 1.893 0 O-C-N 125.444 1.715 . . . . 0.0 111.355 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.567 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -81.51 -169.48 42.4 Favored Glycine 0 N--CA 1.481 1.643 0 O-C-N 125.488 1.346 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -163.42 177.81 8.59 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.845 -1.178 . . . . 0.0 109.905 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.3 m -99.06 149.83 22.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.155 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -151.11 154.67 37.4 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.971 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -111.36 152.26 27.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.594 ' CH2' HD11 ' A' ' 3' ' ' LEU . 38.6 m95 -144.45 158.65 43.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.737 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.629 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 94.6 m -93.57 -175.83 3.9 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 117.252 -1.779 . . . . 0.0 108.574 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.54 76.12 1.49 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.782 1.277 . . . . 0.0 110.599 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--N 1.297 -1.705 0 CA-C-N 112.604 -2.089 . . . . 0.0 110.256 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -108.69 110.94 22.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 tt -62.49 162.15 10.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.054 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.459 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 16.2 pt -134.08 -43.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 125.137 1.523 . . . . 0.0 109.495 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.428 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 179.85 -148.74 8.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -99.32 170.18 8.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.957 -0.621 . . . . 0.0 110.064 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 8.8 t -136.44 51.34 2.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t -131.64 128.93 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.851 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -78.7 61.39 2.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.68 64.2 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.58 -179.83 5.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 124.419 0.717 . . . . 0.0 109.159 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.68 167.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.644 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.89 29.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.378 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -57.65 134.96 56.64 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.46 177.81 4.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 125.064 1.478 . . . . 0.0 109.89 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.5 t -142.05 -49.04 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.5 p-10 -111.61 72.44 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.414 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' SG ' HD12 ' A' ' 4' ' ' ILE . 5.6 t -40.56 -41.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -50.39 73.01 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.277 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -61.91 -57.41 17.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.13 -33.57 19.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.9 m -76.21 -43.31 42.95 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.61 -30.93 71.97 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.869 1.356 . . . . 0.0 108.278 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.33 -31.73 72.39 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.012 0.911 . . . . 0.0 109.699 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -94.4 -1.0 54.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.785 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.83 6.59 79.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 16.6 m-30 -85.47 164.39 17.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.702 0.763 . . . . 0.0 109.956 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 164.98 15.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.531 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -31.91 97.56 0.01 OUTLIER Glycine 0 N--CA 1.487 2.036 0 O-C-N 125.802 1.939 . . . . 0.0 110.8 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.492 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -77.4 -168.12 29.9 Favored Glycine 0 N--CA 1.48 1.617 0 O-C-N 125.393 1.29 . . . . 0.0 110.209 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -163.1 172.25 15.18 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.069 -1.066 . . . . 0.0 110.08 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 63.8 m -83.74 150.51 25.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.479 1.543 0 O-C-N 125.478 1.736 . . . . 0.0 113.187 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -152.75 128.24 10.0 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.021 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.22 138.65 38.88 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.509 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 72.3 m95 -125.38 152.29 44.99 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.307 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 68.4 m -84.46 163.26 19.57 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 117.457 -1.697 . . . . 0.0 108.613 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -97.13 54.34 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.966 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.485 1.281 1 CA-C-O 111.405 -4.141 . . . . 0.0 111.351 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.443 ' HA ' ' OG1' ' A' ' 44' ' ' THR . 1.6 p30 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -99.79 102.19 13.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.311 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.1 tt -58.6 163.08 3.42 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.577 1.173 . . . . 0.0 108.922 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.517 HD11 ' SG ' ' A' ' 18' ' ' CYS . 17.9 pt -134.65 -42.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 124.693 1.246 . . . . 0.0 109.088 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.75 21.39 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 t -93.77 165.11 12.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.671 -1.265 . . . . 0.0 108.465 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -129.88 37.03 3.99 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.9 t -110.69 124.84 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -79.53 69.34 5.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.54 59.19 0.02 OUTLIER Glycine 0 N--CA 1.486 1.988 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.212 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.39 8.93 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.5 t -80.82 169.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.166 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 42.2 29.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.891 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -60.3 134.7 57.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 125.037 1.461 . . . . 0.0 109.766 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -116.72 170.62 8.45 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 124.817 1.323 . . . . 0.0 108.941 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -141.59 -47.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.678 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -105.15 66.57 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.724 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 4' ' ' ILE . 10.2 t -44.15 -65.01 0.56 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -49.25 -30.35 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.625 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.68 -65.67 2.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.509 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 tt0 -52.76 -31.37 37.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' HG22 ' A' ' 4' ' ' ILE . 16.4 m -77.16 -40.34 45.79 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.23 -29.79 70.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.79 -32.83 74.08 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.057 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.509 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -90.39 1.2 56.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.454 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.14 19.18 79.54 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 16.9 m-85 -76.89 167.33 22.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -64.97 -37.34 87.34 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.511 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.31 -166.71 39.81 Favored Glycine 0 N--CA 1.485 1.905 0 O-C-N 124.79 1.306 . . . . 0.0 110.468 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -163.34 155.68 27.14 Favored Glycine 0 N--CA 1.489 2.198 0 O-C-N 124.866 0.98 . . . . 0.0 111.091 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 55.9 p-80 -163.19 159.27 22.7 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.17 -1.015 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 90.1 m -74.45 149.73 40.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.489 2.193 0 O-C-N 126.287 2.242 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.08 150.79 51.99 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 124.166 0.916 . . . . 0.0 108.988 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.79 147.92 34.67 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.681 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.459 ' CZ2' HD11 ' A' ' 3' ' ' LEU . 38.8 m95 -134.23 158.99 42.31 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.579 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 69.7 m -87.13 172.24 10.09 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 117.133 -1.827 . . . . 0.0 108.12 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.54 58.16 0.85 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 124.016 1.865 . . . . 0.0 110.708 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 1' ' ' ASP . 21.4 p . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 112.061 -3.828 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 10.4 mptt -134.99 126.83 29.33 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.733 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 4' ' ' ILE . 2.2 tm? -84.2 163.6 19.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 125.335 1.647 . . . . 0.0 107.826 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' SG ' ' A' ' 22' ' ' CYS . 3.4 pt -136.66 -40.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.995 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -163.49 37.19 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 124.876 1.36 . . . . 0.0 110.298 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 7' ' ' CYS . 30.8 t -90.31 172.06 9.03 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.263 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' OG ' ' A' ' 6' ' ' SER . 48.2 t -137.77 41.93 2.32 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.007 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.443 HG23 HG23 ' A' ' 38' ' ' VAL . 76.7 t -116.97 124.97 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.439 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 62.84 2.38 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.54 58.74 0.01 OUTLIER Glycine 0 N--CA 1.483 1.79 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.87 -179.84 7.89 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.82 165.74 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.175 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 41.43 30.65 0.14 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.908 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 15' ' ' THR . 2.9 t80 -65.35 134.42 53.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.309 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.564 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.7 m -111.49 177.45 4.65 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 124.633 1.208 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m -142.81 -50.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' GLY . 13.8 p-10 -102.93 68.94 1.02 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' A' ' 17' ' ' ASP . 14.1 t -41.53 -70.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -38.54 -35.96 0.22 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.66 -57.05 8.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 5.5 tp10 -53.9 -35.62 61.83 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 124.532 1.133 . . . . 0.0 108.461 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.601 ' SG ' HD12 ' A' ' 4' ' ' ILE . 3.2 m -75.33 -44.35 45.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.856 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.3 mt -63.76 -30.98 72.01 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.78 -28.82 69.84 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.398 1.061 . . . . 0.0 109.794 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.581 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 14.3 mtm-85 -99.12 6.38 46.51 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.573 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.96 17.57 69.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 15.2 m-30 -83.27 174.47 10.7 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.146 -0.527 . . . . 0.0 109.928 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -87.08 151.98 22.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.39 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.18 104.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 O-C-N 125.632 1.832 . . . . 0.0 110.483 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -87.43 -177.77 48.44 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -164.52 174.98 10.3 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.8 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.6 m -95.14 150.44 20.2 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.048 1.468 . . . . 0.0 107.374 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.214 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.443 HG23 HG23 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -147.58 154.09 40.26 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.95 161.0 15.11 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.272 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.497 ' CE2' HD23 ' A' ' 3' ' ' LEU . 67.8 m95 -148.31 155.5 41.37 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 124.544 1.152 . . . . 0.0 108.483 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.45 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 55.9 m -94.88 164.24 13.0 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.375 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -100.69 59.56 0.95 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.468 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.521 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 13.0 t . . . . . 0 C--N 1.313 -1.02 1 CA-C-O 111.607 -4.044 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -125.49 94.6 4.19 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.651 1.219 . . . . 0.0 108.234 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.471 HD13 ' CZ2' ' A' ' 41' ' ' TRP . 5.9 tt -57.62 163.61 2.4 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.339 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.426 HG22 ' SG ' ' A' ' 42' ' ' CYS . 6.3 pt -134.85 -41.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.408 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.08 -148.42 9.58 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.331 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.79 178.56 5.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.971 -1.114 . . . . 0.0 109.732 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 t -138.77 54.26 1.75 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -138.4 122.63 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 123.808 0.693 . . . . 0.0 109.452 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -77.56 67.49 3.48 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.22 55.89 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.94 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.74 178.45 8.47 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -81.44 170.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 m120 44.16 28.83 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.367 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 19.3 t80 -57.06 135.26 56.32 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.826 1.329 . . . . 0.0 109.802 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 16' ' ' SER . 24.4 m -92.57 -76.89 0.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 125.177 1.548 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' THR . 7.6 t 91.51 -39.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.43 78.24 1.72 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.677 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 1.8 t -48.51 -57.45 6.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 30' ' ' GLY . 2.8 m120 -54.51 -33.23 59.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.12 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.21 -66.92 2.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 42.7 tt0 -47.88 -38.41 16.21 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 56.5 m -74.65 -41.35 60.49 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.691 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.98 -30.07 71.18 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.21 -33.08 74.99 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 124.356 1.035 . . . . 0.0 108.397 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 5.0 mpt_? -94.22 6.14 49.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.952 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.47 75.02 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 10.0 m-85 -77.92 149.31 34.22 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.606 0.827 . . . . 0.0 109.775 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.78 -43.36 8.55 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.864 -1.517 . . . . 0.0 109.028 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.69 -166.97 39.75 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.408 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -161.8 156.0 27.4 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 124.906 1.004 . . . . 0.0 110.626 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.567 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.1 p-80 -156.12 158.98 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.852 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' O ' ' C ' ' A' ' 33' ' ' GLY . 84.1 m -77.78 150.4 34.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.345 0 O-C-N 125.258 1.599 . . . . 0.0 112.21 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -131.1 136.51 48.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 145.35 40.2 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.471 ' CZ2' HD13 ' A' ' 3' ' ' LEU . 34.0 m95 -129.86 156.51 44.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 125.417 1.698 . . . . 0.0 109.185 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 66.2 m -85.75 170.26 12.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 116.59 -2.044 . . . . 0.0 108.079 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 55.53 1.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.173 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 113.079 -3.343 . . . . 0.0 109.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.494 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.445 ' HB2' HG22 ' A' ' 44' ' ' THR . 5.8 tmtt? -117.79 116.34 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.35 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 4' ' ' ILE . 10.6 tt -75.75 162.65 28.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.612 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.637 HD12 ' SG ' ' A' ' 40' ' ' CYS . 8.7 pt -134.37 -43.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 125.026 1.454 . . . . 0.0 108.981 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.72 -161.62 23.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -96.45 155.85 16.59 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.012 0.91 . . . . 0.0 109.922 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 5.2 t -114.17 56.7 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -136.33 116.98 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.295 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -75.41 117.58 17.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -27.25 6.82 Favored Glycine 0 N--CA 1.485 1.959 0 O-C-N 124.638 1.211 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.59 172.84 10.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.441 0.73 . . . . 0.0 109.101 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.7 t -81.23 169.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.69 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 m120 42.34 30.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.698 1.249 . . . . 0.0 108.475 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 6.2 t80 -62.31 143.81 56.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.366 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' SER . 12.4 m -89.47 -73.01 0.53 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 124.465 1.103 . . . . 0.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 15' ' ' THR . 5.3 t 89.41 -37.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 18' ' ' CYS . 19.9 p-10 -139.9 70.35 1.36 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.95 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.6 t -39.53 -65.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -41.58 -48.05 3.94 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -60.45 -68.19 1.79 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' CD ' ' NH2' ' A' ' 25' ' ' ARG . 6.8 tp10 -44.31 -32.85 1.42 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 122.312 1.053 . . . . 0.0 109.385 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' HD11 ' A' ' 4' ' ' ILE . 13.0 m -76.13 -42.56 46.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.474 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' GLY . 25.1 mt -65.12 -30.8 71.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.71 -30.54 71.49 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.327 1.061 . . . . 0.0 109.152 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' NH2' ' CD ' ' A' ' 21' ' ' GLU . 9.0 mtm180 -102.61 7.33 39.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.637 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.87 14.57 68.01 Favored Glycine 0 N--CA 1.491 2.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.213 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 9.9 m-85 -77.41 175.48 9.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.83 0.824 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.31 150.41 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.983 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.15 94.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.858 0 O-C-N 125.867 1.979 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.52 -170.73 28.77 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 124.959 1.035 . . . . 0.0 110.531 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 16.4 p-80 -163.5 172.37 14.55 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.136 -1.032 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 33' ' ' GLY . 69.0 m -81.89 149.95 28.0 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.793 0 O-C-N 125.593 1.808 . . . . 0.0 112.929 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.905 0.86 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -149.48 116.45 5.98 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.664 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.637 ' SG ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.38 133.49 41.92 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 1' ' ' ASP . 67.4 m95 -119.64 156.8 29.73 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.879 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.547 ' SG ' HG23 ' A' ' 4' ' ' ILE . 40.1 m -92.39 174.88 7.06 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.997 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -101.03 61.2 0.95 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 124.999 2.333 . . . . 0.0 111.467 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 31.3 p . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 112.743 -3.503 . . . . 0.0 110.435 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 158.82 16.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.611 1.194 . . . . 0.0 108.08 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.3 tt -99.42 164.5 12.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.693 HD12 ' SG ' ' A' ' 22' ' ' CYS . 44.8 mt -132.56 -43.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 125.366 1.666 . . . . 0.0 109.396 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.81 -147.03 12.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.523 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 53.5 m -96.14 160.42 14.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.808 -0.696 . . . . 0.0 110.236 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.4 t -138.72 27.3 2.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.418 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 69.2 t -93.53 135.08 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -79.13 63.84 3.88 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.732 1.27 . . . . 0.0 107.72 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.56 63.56 0.04 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.19 177.64 11.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.542 0.789 . . . . 0.0 109.294 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.2 t -82.45 168.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.781 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.82 27.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.098 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 5.6 t80 -60.73 134.39 57.03 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.134 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -110.64 167.95 9.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 125.166 1.541 . . . . 0.0 109.831 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.7 m -142.14 -47.43 0.35 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.144 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.34 67.82 0.74 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.924 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 4' ' ' ILE . 5.5 t -50.01 -64.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -33.08 1.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.611 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.38 -55.95 11.29 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 24.2 tt0 -58.97 -30.56 68.01 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.045 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' HD12 ' A' ' 4' ' ' ILE . 1.2 m -78.12 -41.17 35.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.3 -31.41 72.56 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.48 -30.61 71.64 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.761 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HE ' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -92.76 2.53 56.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.119 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.41 20.38 75.28 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 14.1 m-85 -77.04 173.2 12.08 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.652 0.854 . . . . 0.0 110.019 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 4.6 mptt -71.05 -35.24 71.86 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.525 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 165.67 -177.43 40.89 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.3 159.32 29.34 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 21.8 p-80 -163.32 163.13 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.142 -1.029 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' A' ' 33' ' ' GLY . 92.5 m -78.25 151.42 33.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.495 2.578 0 O-C-N 126.471 2.357 . . . . 0.0 111.522 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.6 p . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -134.43 156.31 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -110.84 154.46 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.53 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CD1' ' C ' ' A' ' 40' ' ' CYS . 32.8 m95 -140.35 156.95 46.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.243 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.686 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -87.39 163.62 16.67 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -97.64 53.9 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.316 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 5.0 t . . . . . 0 C--N 1.305 -1.353 1 CA-C-O 111.378 -4.153 . . . . 0.0 111.963 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -154.0 95.55 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 125.948 2.03 . . . . 0.0 108.913 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.446 HD11 ' CH2' ' A' ' 41' ' ' TRP . 9.0 tt -56.04 162.82 1.75 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.087 0.867 . . . . 0.0 109.323 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.501 HD12 ' SG ' ' A' ' 18' ' ' CYS . 31.1 pt -134.41 -41.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.822 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.61 -147.86 10.94 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.735 -1.222 . . . . 0.0 110.45 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 14' ' ' TYR . 4.2 m -86.78 -178.59 6.37 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.414 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.01 49.77 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -148.95 125.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.087 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.83 103.61 5.99 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 -18.78 3.38 Favored Glycine 0 N--CA 1.491 2.334 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.94 171.77 8.56 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.8 t -82.13 169.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.021 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.17 29.0 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.25 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 13.0 t80 -57.64 147.66 26.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.892 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' SER . 15.6 m -96.23 -70.74 0.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.601 1.188 . . . . 0.0 109.355 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 88.65 -36.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.34 86.71 2.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.863 1.316 . . . . 0.0 109.421 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' HD12 ' A' ' 4' ' ' ILE . 2.1 t -66.81 -71.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.183 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -41.97 -32.23 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.126 -0.629 . . . . 0.0 109.557 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -59.37 6.19 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.022 1.451 . . . . 0.0 109.569 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 11.4 tp10 -55.67 -35.75 66.35 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.277 0.56 . . . . 0.0 110.103 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.44 -42.75 58.57 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.91 -30.58 70.98 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.94 -36.43 81.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 124.405 1.066 . . . . 0.0 109.395 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.02 16.04 20.69 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.777 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.81 28.82 53.51 Favored Glycine 0 N--CA 1.49 2.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.745 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 4.4 m-85 -75.94 159.82 30.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.959 0.885 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -57.61 -31.22 66.0 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.855 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 160.43 -173.65 37.03 Favored Glycine 0 N--CA 1.484 1.883 0 O-C-N 124.667 1.229 . . . . 0.0 110.639 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.02 155.8 26.96 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 3.6 p-80 -154.33 166.2 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.948 -1.126 . . . . 0.0 110.158 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 57.5 m -76.96 150.09 35.93 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.477 1.42 0 O-C-N 125.815 1.947 . . . . 0.0 113.133 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.945 0.879 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -151.43 118.1 5.76 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.098 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -98.0 144.71 27.23 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' TRP . 11.2 m95 -127.06 164.96 20.4 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.047 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -96.21 171.42 8.6 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 125.068 1.48 . . . . 0.0 107.195 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' CD ' ' HD1' ' A' ' 31' ' ' HIS . 1.8 tp10 -97.81 54.0 1.13 Allowed 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.896 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 42' ' ' CYS . 31.8 p . . . . . 0 C--N 1.3 -1.554 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.201 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 48.1 mmtt -100.48 104.75 16.16 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.528 HD11 ' CZ2' ' A' ' 41' ' ' TRP . 7.9 tt -59.04 162.19 4.49 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.904 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.612 HD11 ' SG ' ' A' ' 18' ' ' CYS . 20.8 pt -134.49 -43.09 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 125.027 1.454 . . . . 0.0 109.123 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 -148.09 10.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.1 t -97.29 164.49 12.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.66 1.219 . . . . 0.0 108.863 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -127.77 50.09 2.07 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.284 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 11' ' ' ALA . 33.1 t -130.02 122.09 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.817 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.5 92.53 2.37 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 -6.91 5.71 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . . . -96.41 178.97 5.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.0 t -81.65 168.8 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.972 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 p30 40.0 31.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 125.386 1.679 . . . . 0.0 108.315 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.6 t80 -55.45 137.34 48.5 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 125.327 1.642 . . . . 0.0 109.522 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' SER . 17.7 m -86.59 -73.76 0.45 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.552 1.157 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.6 OUTLIER 89.39 -36.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -137.75 73.77 1.45 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.612 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -46.85 -62.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -27.71 5.99 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.313 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.53 -67.43 1.72 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 34.0 tt0 -49.19 -31.83 9.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.426 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.2 m -75.86 -43.59 44.87 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 124.286 0.991 . . . . 0.0 108.338 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.89 -31.1 72.16 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.497 1.123 . . . . 0.0 108.05 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.08 -31.27 72.37 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.696 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -91.05 -3.34 57.27 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.533 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.22 12.09 76.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 23.6 m-85 -81.52 163.87 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.583 0.814 . . . . 0.0 110.038 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' GLY . 3.4 mppt? -86.71 169.14 12.92 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.292 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -31.18 99.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 O-C-N 125.647 1.842 . . . . 0.0 110.932 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.41 -165.96 33.6 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.587 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 32.6 p-80 -164.19 171.98 14.27 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.282 -0.959 . . . . 0.0 109.938 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 20.7 m -101.52 147.44 26.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.481 1.697 0 O-C-N 125.664 1.853 . . . . 0.0 112.615 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -153.22 174.38 14.34 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 123.563 0.539 . . . . 0.0 110.242 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -122.53 147.3 46.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 124.782 1.301 . . . . 0.0 107.997 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.528 ' CZ2' HD11 ' A' ' 3' ' ' LEU . 51.0 m95 -146.72 160.45 42.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.263 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 93.0 m -94.21 -173.01 2.96 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 117.224 -1.79 . . . . 0.0 108.673 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.587 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 5.5 mt-10 -143.88 76.42 1.51 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.072 0.939 . . . . 0.0 110.272 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 115.952 -1.975 . . . . 0.0 109.969 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.426 ' HA ' ' OG1' ' A' ' 44' ' ' THR . 3.1 m-20 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -120.9 109.97 15.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.476 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -71.74 163.33 28.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.832 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.651 HD13 ' SG ' ' A' ' 22' ' ' CYS . 4.9 pt -136.53 -41.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 125.17 1.544 . . . . 0.0 108.74 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -163.06 24.99 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -93.52 163.48 13.55 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.354 -0.923 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -123.06 54.49 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.83 121.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.34 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -77.6 71.12 4.06 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.95 59.35 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.8 179.71 8.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.5 t -79.24 170.72 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.5 30.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.61 1.194 . . . . 0.0 109.511 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 25.0 t80 -52.99 135.16 37.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.642 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 16' ' ' SER . 50.6 m -92.29 -74.58 0.51 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.485 1.116 . . . . 0.0 109.695 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 15' ' ' THR . 3.6 t 90.21 -39.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.4 p-10 -136.84 73.93 1.47 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.245 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 6.7 t -43.91 -57.96 3.02 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.54 -36.03 61.36 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -67.01 -70.19 1.18 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 46.3 tp10 -45.64 -34.01 3.22 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.412 1.101 . . . . 0.0 110.206 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 4' ' ' ILE . 4.2 m -73.23 -43.59 60.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.697 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.34 -30.99 72.02 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.986 1.429 . . . . 0.0 109.166 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.68 7.73 45.76 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.187 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.72 19.62 69.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.547 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 15.4 m-30 -84.29 172.0 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.913 -0.643 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.541 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.03 149.43 25.58 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.43 99.46 0.01 OUTLIER Glycine 0 N--CA 1.486 2.021 0 O-C-N 125.744 1.903 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.55 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.42 -174.7 35.78 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 10.9 p-80 -163.94 174.43 11.45 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.19 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' O ' ' C ' ' A' ' 33' ' ' GLY . 99.3 m -90.94 152.58 20.66 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.492 2.414 0 O-C-N 126.058 2.099 . . . . 0.0 111.595 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -125.93 136.29 52.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.233 0.958 . . . . 0.0 109.805 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.6 140.47 38.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CE2' HD11 ' A' ' 3' ' ' LEU . 51.1 m95 -129.66 162.67 27.81 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.04 -1.437 . . . . 0.0 107.851 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.547 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 80.9 m -95.21 172.25 8.23 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 117.269 -1.772 . . . . 0.0 108.382 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -101.16 61.23 0.94 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 124.754 2.216 . . . . 0.0 112.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.541 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 36.4 p . . . . . 0 C--N 1.305 -1.364 0 CA-C-O 112.489 -3.624 . . . . 0.0 111.252 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.525 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -110.67 98.18 7.41 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.967 -1.469 . . . . 0.0 109.089 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.576 HD11 ' CZ2' ' A' ' 41' ' ' TRP . 8.1 tt -56.16 161.47 2.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.077 0.861 . . . . 0.0 109.062 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.507 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 19.8 pt -136.26 -41.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 124.823 1.327 . . . . 0.0 109.396 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.26 -148.59 9.62 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 124.86 1.35 . . . . 0.0 110.156 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -94.42 -172.45 2.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.777 -0.711 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' VAL . 24.5 t -152.89 34.91 0.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 38' ' ' VAL . 2.0 t -126.97 127.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -78.73 62.15 3.18 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 44.47 0.02 OUTLIER Glycine 0 N--CA 1.487 2.055 0 CA-C-N 114.253 -1.34 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.23 179.06 9.09 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -78.2 167.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.634 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.47 29.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.988 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -52.1 135.77 30.86 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 124.902 1.376 . . . . 0.0 110.173 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.513 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.5 t -120.65 175.58 5.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 125.125 1.516 . . . . 0.0 108.931 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.7 -50.5 0.41 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.126 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' CYS . 7.7 p-10 -109.12 69.26 0.7 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.434 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 4' ' ' ILE . 7.6 t -38.26 -58.58 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -45.63 -50.28 13.49 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.311 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -61.61 -65.06 3.47 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.538 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 6.1 tp10 -41.19 -37.1 0.85 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 124.376 1.071 . . . . 0.0 108.627 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.5 m -75.56 -43.9 46.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.517 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 22.2 mt -62.75 -30.29 71.33 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.09 -32.84 74.55 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.261 0.975 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 18.6 mtm-85 -92.18 3.79 54.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.843 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 12.89 83.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.528 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 21.8 m-85 -89.89 170.04 10.72 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.994 0.902 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 43' ' ' GLU . 34.3 mtpt -84.64 154.86 22.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.446 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -34.98 96.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 O-C-N 125.341 1.65 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.622 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -69.45 -170.83 7.6 Favored Glycine 0 N--CA 1.48 1.607 0 O-C-N 125.386 1.286 . . . . 0.0 110.893 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -161.94 171.46 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.578 -1.311 . . . . 0.0 110.455 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' C ' ' A' ' 33' ' ' GLY . 87.0 m -92.04 151.45 20.45 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.492 2.415 0 O-C-N 125.667 1.855 . . . . 0.0 112.509 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 7' ' ' CYS . 2.5 p . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.94 137.63 54.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 124.156 0.91 . . . . 0.0 109.507 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -107.36 147.28 30.53 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 3' ' ' LEU . 65.2 m95 -137.06 152.49 50.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 84.2 m -86.45 -171.59 3.62 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.051 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -142.73 74.46 1.45 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 59.7 p . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 112.973 -3.394 . . . . 0.0 109.573 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' CZ ' ' A' ' 27' ' ' TYR . 3.6 tmtm? -97.73 107.18 19.62 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.424 HD11 ' CH2' ' A' ' 41' ' ' TRP . 5.7 tt -64.32 162.69 14.36 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.077 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.548 HD13 ' SG ' ' A' ' 18' ' ' CYS . 18.3 pt -135.73 -39.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.117 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.33 -148.1 8.96 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -104.34 167.37 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.185 -1.008 . . . . 0.0 109.765 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 56.1 m -134.62 43.87 2.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.94 123.79 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 124.779 1.299 . . . . 0.0 109.08 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 73.57 4.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.08 52.08 0.02 OUTLIER Glycine 0 N--CA 1.488 2.102 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.152 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.67 176.57 10.82 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -80.47 170.64 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 42.49 30.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.37 134.28 56.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.999 1.437 . . . . 0.0 109.965 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 6' ' ' SER . 2.8 m -120.46 173.84 6.91 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 124.807 1.317 . . . . 0.0 109.107 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.0 t -142.36 -50.04 0.37 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.919 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -102.58 66.42 0.96 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.057 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.6 t -43.15 -71.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.452 HD21 ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -43.64 -28.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.075 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.48 -60.78 4.51 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 1.1 tt0 -56.26 -31.49 63.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.498 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 10.9 m -77.1 -41.91 40.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.452 ' CD1' HD21 ' A' ' 19' ' ' ASN . 17.6 mt -64.08 -29.45 70.59 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.78 -30.41 71.06 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 124.308 1.005 . . . . 0.0 109.309 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -86.94 0.85 54.38 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.613 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.79 14.93 76.67 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.321 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 18.9 m-85 -79.24 140.7 37.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -43.39 -50.21 6.87 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.334 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.04 169.3 40.83 Favored Glycine 0 N--CA 1.481 1.662 0 O-C-N 125.213 1.571 . . . . 0.0 110.445 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -148.51 154.17 25.68 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 1.2 p-80 -149.85 160.6 43.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 21.0 m -85.06 146.54 27.11 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.484 1.842 0 O-C-N 126.133 2.145 . . . . 0.0 111.95 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' ND2' ' OG ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -153.34 175.67 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -121.3 144.94 48.36 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.424 ' CH2' HD11 ' A' ' 3' ' ' LEU . 50.1 m95 -146.95 158.03 43.8 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.508 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 89.7 m -88.33 -174.9 4.81 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 117.837 -1.545 . . . . 0.0 108.11 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.598 ' CD ' ' HD1' ' A' ' 31' ' ' HIS 0.271 44.6 tt0 -141.72 73.66 1.42 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 124.083 0.864 . . . . 0.0 110.364 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.467 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 45.3 p . . . . . 0 C--N 1.295 -1.783 0 O-C-N 125.24 1.587 . . . . 0.0 111.675 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 9.0 p-10 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 11.9 tptt -134.18 100.51 4.73 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.241 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 4' ' ' ILE . 8.8 tt -59.45 161.56 5.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' A' ' 18' ' ' CYS . 9.0 pt -135.82 -42.58 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.727 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.58 -148.39 9.04 Favored Glycine 0 N--CA 1.482 1.703 0 O-C-N 124.987 1.429 . . . . 0.0 109.983 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 25.1 t -102.61 171.57 7.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.318 -1.353 . . . . 0.0 108.639 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 44.4 t -144.32 40.99 1.35 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.659 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.268 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.58 68.08 3.6 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.95 50.17 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.23 178.41 10.21 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -84.61 168.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.31 29.5 0.23 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.837 1.336 . . . . 0.0 108.225 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE1' ' O ' ' A' ' 15' ' ' THR . 18.6 t80 -57.85 134.24 56.12 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.893 1.37 . . . . 0.0 110.073 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.0 t -117.73 -179.76 3.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.741 1.276 . . . . 0.0 109.15 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 -49.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.682 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 18' ' ' CYS . 10.5 p-10 -105.24 66.15 0.74 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.096 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.1 t -37.77 -71.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 59.9 t30 -37.19 -42.85 0.47 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.618 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -64.78 -55.03 24.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' HG2' ' NH2' ' A' ' 25' ' ' ARG . 18.0 tt0 -56.79 -29.94 63.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 4' ' ' ILE . 1.9 m -76.08 -45.45 33.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.11 -32.29 71.97 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.78 -34.75 76.42 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.802 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.54 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 4.4 mtm180 -89.5 -0.42 57.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.309 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.85 12.6 79.53 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 18.2 m-30 -83.98 164.69 19.18 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.251 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -87.92 172.38 9.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.369 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -27.89 106.2 0.01 OUTLIER Glycine 0 N--CA 1.485 1.961 0 O-C-N 125.964 2.04 . . . . 0.0 110.834 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.2 -170.17 33.44 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 6.6 p-80 -166.08 176.83 7.4 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 60.4 m -100.68 147.38 26.07 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.768 0 O-C-N 126.126 2.141 . . . . 0.0 112.046 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 8.7 m-80 -155.36 176.38 12.66 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.97 147.81 44.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 122.351 1.072 . . . . 0.0 108.319 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.474 ' CZ2' HD13 ' A' ' 3' ' ' LEU . 52.2 m95 -146.16 162.02 38.92 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.399 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.2 m -94.61 -173.51 3.04 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 117.038 -1.865 . . . . 0.0 108.868 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 11.5 tt0 -142.68 75.79 1.5 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.959 0.787 . . . . 0.0 109.944 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 115.057 -2.402 . . . . 0.0 110.439 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 1.2 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -130.39 94.24 3.62 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 124.876 1.36 . . . . 0.0 109.303 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.476 HD12 ' CH2' ' A' ' 41' ' ' TRP . 10.5 tt -55.66 163.53 1.33 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 113.678 -1.601 . . . . 0.0 108.166 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.648 HD12 ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -134.85 -43.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.111 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.47 -150.78 12.42 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.4 m -95.88 170.29 9.4 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.504 -0.848 . . . . 0.0 109.858 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.1 t -140.19 43.81 1.9 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -119.7 129.92 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.43 74.15 4.98 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.25 58.01 0.04 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-N 113.292 -1.777 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.39 173.91 16.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.532 0.784 . . . . 0.0 109.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.6 t -80.4 172.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.34 30.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.694 1.246 . . . . 0.0 108.754 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' N ' ' C ' ' A' ' 12' ' ' VAL . 30.0 t80 -51.69 138.79 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.5 m -91.75 -75.21 0.48 Allowed 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.647 1.217 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.2 OUTLIER 88.68 -35.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 20' ' ' GLY . 6.1 p-10 -138.96 72.55 1.41 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.512 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.8 t -41.55 -71.46 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -32.55 0.5 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.57 -60.81 5.14 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 tp10 -55.38 -32.78 62.89 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.654 0.74 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.648 ' SG ' HD12 ' A' ' 4' ' ' ILE . 3.0 m -74.72 -43.89 52.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.642 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -30.78 71.6 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.464 1.102 . . . . 0.0 108.242 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.17 -28.41 70.03 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.729 1.268 . . . . 0.0 109.605 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.39 -1.07 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.484 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.65 82.27 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.552 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 19.2 m-85 -79.52 170.86 15.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.95 0.881 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.573 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.7 156.57 20.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.742 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.31 103.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.102 0 O-C-N 125.166 1.541 . . . . 0.0 110.352 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -83.11 -171.23 47.19 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.99 173.92 11.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.547 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 99.5 m -93.93 150.62 20.2 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 125.05 1.469 . . . . 0.0 107.678 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -36.95 140.32 0.31 Allowed Glycine 0 N--CA 1.483 1.821 0 O-C-N 125.63 1.831 . . . . 0.0 111.022 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -81.6 -48.88 11.2 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.323 -0.939 . . . . 0.0 109.149 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.29 36.1 4.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.913 0.758 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.78 49.39 0.09 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.245 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -48.4 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.329 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' ALA . 3.0 p -170.25 -40.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -119.6 150.64 39.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.736 1.273 . . . . 0.0 109.846 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -107.81 155.79 19.85 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CH2' HD12 ' A' ' 3' ' ' LEU . 24.7 m95 -142.98 158.67 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.193 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 82.5 m -94.37 164.5 12.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.808 -1.957 . . . . 0.0 107.551 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -97.55 55.43 1.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.209 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.573 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 12.5 t . . . . . 0 C--N 1.31 -1.152 0 CA-C-O 111.85 -3.928 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 5.2 mmtm -100.98 111.4 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 4' ' ' ILE . 5.2 tt -66.49 163.7 17.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.126 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.58 HD13 ' SG ' ' A' ' 22' ' ' CYS . 21.8 pt -135.09 -41.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.35 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.24 -148.93 9.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -99.43 177.96 5.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.811 -0.695 . . . . 0.0 109.743 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -146.23 49.56 1.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.9 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -144.85 126.88 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.675 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.88 61.66 1.96 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 125.215 1.572 . . . . 0.0 107.013 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.67 39.51 0.03 OUTLIER Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.35 176.66 11.74 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.265 0.627 . . . . 0.0 109.435 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -80.41 171.4 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.8 m120 42.22 30.09 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.115 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -51.41 135.7 26.83 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 t -123.63 -178.13 3.94 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.802 1.314 . . . . 0.0 108.594 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.7 t -143.12 -56.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.394 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -101.67 70.2 1.25 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.791 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 4' ' ' ILE . 11.2 t -41.18 -72.85 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -41.0 -32.67 0.25 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.272 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.18 -60.57 5.09 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.554 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 25' ' ' ARG . 5.3 tt0 -58.32 -29.32 65.8 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.58 ' SG ' HD13 ' A' ' 4' ' ' ILE . 7.4 m -77.03 -42.5 38.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.68 -30.1 71.25 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -33.48 74.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.493 HH11 ' CG2' ' A' ' 4' ' ' ILE . 2.0 mtm180 -86.68 -2.27 58.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.155 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.54 14.32 76.32 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.541 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.3 m-85 -77.66 148.93 34.77 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.175 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.568 ' CE ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -47.93 -42.2 26.66 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.508 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.24 -168.79 40.23 Favored Glycine 0 N--CA 1.483 1.799 0 O-C-N 125.165 1.541 . . . . 0.0 110.158 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -162.44 160.72 32.97 Favored Glycine 0 N--CA 1.484 1.876 0 O-C-N 124.67 0.865 . . . . 0.0 111.208 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.31 168.01 28.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.286 -0.957 . . . . 0.0 109.357 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 73.0 m -85.54 151.3 24.04 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -26.37 -83.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 O-C-N 125.652 1.845 . . . . 0.0 112.437 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -145.17 -51.31 0.26 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 125.091 1.112 . . . . 0.0 109.329 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.412 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.6 t80 -169.74 81.35 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.27 0.981 . . . . 0.0 110.328 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 82.51 35.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.582 1.176 . . . . 0.0 109.464 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 41.4 t30 -61.97 -31.33 71.67 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.782 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 86.29 7.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.64 1.213 . . . . 0.0 107.806 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' HB2' ' ND2' ' A' ' 37' ' ' ASN . 9.6 m120 -143.04 132.15 23.09 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -109.41 137.68 46.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -125.33 157.49 36.58 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 125.271 1.607 . . . . 0.0 108.043 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 98.7 m -84.38 161.28 20.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 116.341 -2.143 . . . . 0.0 107.992 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -99.69 57.18 1.0 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.954 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.568 ' HA ' ' CE ' ' A' ' 28' ' ' LYS . 14.2 t . . . . . 0 C--N 1.31 -1.142 0 CA-C-O 112.695 -3.526 . . . . 0.0 109.187 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 4.4 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 9.3 mptt -115.91 102.57 9.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.554 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.496 HD13 ' CZ2' ' A' ' 41' ' ' TRP . 4.8 tt -56.33 162.38 2.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.051 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.626 HD12 ' SG ' ' A' ' 18' ' ' CYS . 2.9 pt -133.98 -45.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.79 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.25 -148.94 10.26 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 125.033 1.458 . . . . 0.0 109.861 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.65 155.83 17.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.139 -1.031 . . . . 0.0 109.279 -179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 43.0 t -124.01 48.77 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.39 118.88 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.571 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 96.04 2.63 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.01 -9.76 5.69 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.451 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.31 176.71 5.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -82.28 168.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 114.178 -1.373 . . . . 0.0 107.987 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 42.31 30.08 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.461 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.7 t80 -53.44 140.62 27.26 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 125.28 1.613 . . . . 0.0 109.633 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' SER . 3.4 m -88.0 -74.28 0.46 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 124.687 1.242 . . . . 0.0 109.733 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 90.06 -38.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -138.19 72.86 1.42 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.626 ' SG ' HD12 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -42.57 -72.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -39.08 -32.62 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.16 -60.19 4.6 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' CG ' ' HB ' ' A' ' 4' ' ' ILE . 39.5 tp10 -55.43 -32.17 62.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.137 0.97 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.566 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 m -75.75 -44.89 39.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.105 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.22 -31.56 72.73 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 124.513 1.133 . . . . 0.0 108.202 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.757 1.286 . . . . 0.0 109.948 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' NH1' ' HA ' ' A' ' 4' ' ' ILE . 48.8 mtt180 -93.6 -4.12 51.38 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.158 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.03 79.95 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 m-30 -81.22 162.6 23.5 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.354 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' HZ1' ' C ' ' A' ' 44' ' ' THR . 2.3 mppt? -79.71 163.61 24.38 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -32.12 104.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.479 1.737 . . . . 0.0 110.436 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -165.44 39.08 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.837 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -163.95 173.4 12.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 109.585 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 52.6 m -98.56 146.27 25.97 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.287 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . 21.82 -124.05 0.01 OUTLIER Glycine 0 N--CA 1.483 1.778 0 O-C-N 126.292 2.245 . . . . 0.0 112.033 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.9 t -159.91 -44.53 0.05 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 125.274 1.22 . . . . 0.0 108.869 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -172.39 85.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.502 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 84.39 53.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.866 1.354 . . . . 0.0 109.173 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.573 ' CG ' ' H ' ' A' ' 38' ' ' VAL . 11.4 t-20 -106.47 -154.09 0.51 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.099 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 16.9 m -164.45 31.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -152.55 174.75 13.54 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 123.532 0.52 . . . . 0.0 110.369 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -123.95 147.62 47.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 3' ' ' LEU . 36.8 m95 -145.77 160.59 41.53 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.615 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.9 m -93.26 -175.94 3.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 117.327 -1.749 . . . . 0.0 108.288 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 39.8 mt-10 -142.97 75.78 1.5 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 124.358 1.036 . . . . 0.0 110.53 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.475 ' C ' ' HZ1' ' A' ' 28' ' ' LYS . 1.1 t . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 115.706 -2.092 . . . . 0.0 110.725 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -108.28 103.8 13.05 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.43 HD13 ' CH2' ' A' ' 41' ' ' TRP . 5.3 tt -59.88 163.08 4.84 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.303 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.585 HD11 ' SG ' ' A' ' 18' ' ' CYS . 14.9 pt -135.07 -41.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 125.063 1.477 . . . . 0.0 109.257 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.77 -147.02 9.8 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.131 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.53 -175.3 3.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.797 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 13.7 t -150.17 54.36 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' A' ' 38' ' ' VAL . 2.6 t -146.73 129.92 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.985 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 67.89 5.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.64 42.69 0.02 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 174.77 12.4 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.98 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.77 1.294 . . . . 0.0 107.655 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m120 42.71 29.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.376 1.047 . . . . 0.0 108.876 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 18.6 t80 -47.43 136.39 9.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.207 1.567 . . . . 0.0 109.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 16' ' ' SER . 37.2 m -96.85 -75.79 0.53 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 124.675 1.234 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' THR . 1.6 t 89.89 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 p-10 -137.35 75.78 1.55 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.133 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -44.5 -59.8 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -33.17 22.76 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.221 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -70.77 -63.93 3.01 Favored Glycine 0 N--CA 1.486 1.973 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.482 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 26.7 tt0 -53.68 -30.77 44.97 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.447 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m -75.92 -43.16 46.45 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.1 -31.31 72.46 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.578 1.174 . . . . 0.0 108.234 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 25' ' ' ARG . 2.3 mt -62.97 -28.27 69.97 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.719 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.77 -2.76 40.38 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.056 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 10.17 80.46 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.526 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.9 m-85 -80.41 167.07 20.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.989 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 166.06 14.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.853 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.1 98.61 0.01 OUTLIER Glycine 0 N--CA 1.485 1.954 0 O-C-N 125.584 1.803 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -73.88 -166.78 13.98 Favored Glycine 0 N--CA 1.48 1.63 0 O-C-N 125.84 1.553 . . . . 0.0 110.324 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.425 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 50.1 p-80 -162.48 171.16 17.52 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.898 -1.151 . . . . 0.0 110.366 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -92.24 150.46 20.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 37' ' ' ASN . . . -39.07 -81.31 0.02 OUTLIER Glycine 0 N--CA 1.472 1.096 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.645 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -160.94 -74.29 0.06 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.735 0.779 . . . . 0.0 109.79 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -129.77 -89.29 0.49 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 113.779 -1.555 . . . . 0.0 111.495 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.35 1.28 29.48 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 123.852 0.72 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.542 ' CG ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 t-20 -45.71 -42.03 11.27 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.863 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 8' ' ' VAL . 9.1 p 46.16 24.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 125.075 1.484 . . . . 0.0 108.792 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 37' ' ' ASN . 3.4 m-20 -133.15 123.24 25.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.722 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 143.54 27.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.43 ' CH2' HD13 ' A' ' 3' ' ' LEU . 19.1 m95 -130.06 151.85 50.15 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.478 -2.147 . . . . 0.0 109.339 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.526 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 92.2 m -89.75 162.32 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 116.546 -2.061 . . . . 0.0 107.7 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.16 57.25 1.06 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.593 1.187 . . . . 0.0 111.433 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.304 -1.406 1 CA-C-O 111.519 -4.086 . . . . 0.0 110.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -125.93 127.31 45.78 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.439 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 4' ' ' ILE . 1.6 tm? -73.0 163.57 27.98 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.312 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.626 HG22 ' SG ' ' A' ' 22' ' ' CYS . 8.5 pt -136.77 -39.96 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 124.928 1.392 . . . . 0.0 108.684 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.37 -159.18 32.43 Favored Glycine 0 N--CA 1.486 2.022 0 O-C-N 124.799 1.312 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 167.16 11.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.308 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.74 47.29 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 38' ' ' VAL . 69.9 t -119.26 127.43 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.176 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -77.58 70.3 3.94 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.471 -1.241 . . . . 0.0 107.709 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.91 56.9 0.04 OUTLIER Glycine 0 N--CA 1.485 1.954 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.6 173.82 15.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.387 0.698 . . . . 0.0 109.195 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.41 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.2 t -80.86 171.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 43.61 28.76 0.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.941 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' N ' ' C ' ' A' ' 12' ' ' VAL . 38.6 t80 -51.99 140.53 20.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.841 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 16' ' ' SER . 4.9 m -89.95 -75.43 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 124.781 1.301 . . . . 0.0 109.792 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER 87.54 -36.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.64 74.23 1.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 123.941 0.776 . . . . 0.0 109.88 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 t -42.7 -72.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.5 -27.79 1.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.317 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.9 -63.05 3.85 Favored Glycine 0 N--CA 1.486 2.003 0 O-C-N 125.137 1.523 . . . . 0.0 109.628 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 11.4 tp10 -51.94 -37.1 51.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 4' ' ' ILE . 1.4 m -72.34 -42.45 65.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.637 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -30.69 71.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.85 -33.55 75.5 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 124.716 1.26 . . . . 0.0 109.333 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.504 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 1.3 mpt_? -97.87 14.05 28.5 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.89 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 54.91 30.17 52.73 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.636 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 8.5 m-85 -76.85 178.04 7.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.53 -33.44 64.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.359 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 159.68 179.57 34.58 Favored Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.418 1.074 . . . . 0.0 110.555 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.64 156.99 27.79 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.3 p-80 -153.61 157.39 39.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.044 -1.078 . . . . 0.0 109.757 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 95.3 m -78.19 150.11 33.59 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.52 154.33 3.41 Favored Glycine 0 N--CA 1.483 1.821 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.205 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.2 t -96.42 -68.04 0.82 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.758 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -97.33 21.69 9.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.638 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.97 53.55 0.1 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.608 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' CB ' ' A' ' 38' ' ' VAL . 18.5 p30 -62.08 -154.53 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.441 1.088 . . . . 0.0 108.231 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' CB ' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER 88.77 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -145.95 157.9 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.488 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -117.47 150.7 38.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.592 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.417 ' CE2' HD21 ' A' ' 3' ' ' LEU . 40.5 m95 -133.66 168.83 17.98 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 125.063 1.477 . . . . 0.0 108.535 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -100.09 161.5 13.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 55.52 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.42 1.088 . . . . 0.0 109.214 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 42' ' ' CYS . 71.3 p . . . . . 0 C--N 1.302 -1.5 0 CA-C-O 114.641 -2.599 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.428 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 10.2 mmtt -97.9 106.01 18.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.28 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.594 HD11 ' CH2' ' A' ' 41' ' ' TRP . 9.1 tt -56.53 162.42 2.21 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.556 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.629 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 10.2 pt -136.85 -41.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.537 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.6 -152.03 12.05 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -93.96 166.61 12.08 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.514 0.773 . . . . 0.0 109.652 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.8 t -136.04 47.16 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.4 127.52 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.13 68.5 3.27 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.39 59.18 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.21 177.07 11.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.575 0.809 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -81.51 170.8 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.643 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.22 29.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.495 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 36.3 t80 -50.91 140.22 15.72 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.77 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.4 m -92.17 -74.28 0.52 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 124.819 1.325 . . . . 0.0 109.437 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.9 OUTLIER 89.08 -37.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -138.29 75.02 1.5 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.816 0.697 . . . . 0.0 109.795 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' SG ' HD12 ' A' ' 4' ' ' ILE . 2.0 t -42.54 -70.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.4 OUTLIER -39.41 -33.74 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.767 0.667 . . . . 0.0 109.568 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.12 -56.89 6.59 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' HG3' ' NH2' ' A' ' 25' ' ' ARG . 1.2 tp10 -55.8 -34.61 65.48 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.567 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.7 m -75.16 -45.21 42.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.38 -31.44 72.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -34.4 74.65 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.426 1.079 . . . . 0.0 109.964 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.536 ' NH2' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -94.23 1.69 55.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.996 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 13.36 82.1 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 124.122 0.889 . . . . 0.0 110.911 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 22.4 m-85 -83.13 168.45 16.84 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.893 0.854 . . . . 0.0 109.928 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.47 162.69 17.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.664 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.45 102.47 0.01 OUTLIER Glycine 0 N--CA 1.484 1.893 0 O-C-N 125.444 1.715 . . . . 0.0 111.355 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.567 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -81.51 -169.48 42.4 Favored Glycine 0 N--CA 1.481 1.643 0 O-C-N 125.488 1.346 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -163.42 177.81 8.59 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.845 -1.178 . . . . 0.0 109.905 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.3 m -99.06 149.83 22.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.83 145.05 11.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.155 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.3 t -91.86 -65.27 1.02 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 125.041 1.083 . . . . 0.0 109.048 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -95.38 21.09 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.61 53.61 0.11 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' VAL . 8.8 t-20 -60.48 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 125.085 1.491 . . . . 0.0 108.152 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 37' ' ' ASN . 2.6 m 75.9 -1.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -151.11 154.67 37.4 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.971 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -111.36 152.26 27.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.594 ' CH2' HD11 ' A' ' 3' ' ' LEU . 38.6 m95 -144.45 158.65 43.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.737 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.629 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 94.6 m -93.57 -175.83 3.9 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 117.252 -1.779 . . . . 0.0 108.574 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.54 76.12 1.49 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.782 1.277 . . . . 0.0 110.599 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--N 1.297 -1.705 0 CA-C-N 112.604 -2.089 . . . . 0.0 110.256 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -108.69 110.94 22.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.509 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 tt -62.49 162.15 10.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.054 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.459 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 16.2 pt -134.08 -43.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 125.137 1.523 . . . . 0.0 109.495 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 179.85 -148.74 8.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -99.32 170.18 8.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.957 -0.621 . . . . 0.0 110.064 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 8.8 t -136.44 51.34 2.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 t -131.64 128.93 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.851 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -78.7 61.39 2.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.68 64.2 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.58 -179.83 5.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 124.419 0.717 . . . . 0.0 109.159 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.68 167.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.644 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.89 29.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.378 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -57.65 134.96 56.64 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.46 177.81 4.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 125.064 1.478 . . . . 0.0 109.89 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.5 t -142.05 -49.04 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.5 p-10 -111.61 72.44 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.414 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' SG ' HD12 ' A' ' 4' ' ' ILE . 5.6 t -40.56 -41.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -50.39 73.01 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.277 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -61.91 -57.41 17.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.13 -33.57 19.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.9 m -76.21 -43.31 42.95 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.61 -30.93 71.97 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.869 1.356 . . . . 0.0 108.278 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.33 -31.73 72.39 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.012 0.911 . . . . 0.0 109.699 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -94.4 -1.0 54.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.785 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.83 6.59 79.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 16.6 m-30 -85.47 164.39 17.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.702 0.763 . . . . 0.0 109.956 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 164.98 15.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.531 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -31.91 97.56 0.01 OUTLIER Glycine 0 N--CA 1.487 2.036 0 O-C-N 125.802 1.939 . . . . 0.0 110.8 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.492 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -77.4 -168.12 29.9 Favored Glycine 0 N--CA 1.48 1.617 0 O-C-N 125.393 1.29 . . . . 0.0 110.209 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -163.1 172.25 15.18 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.069 -1.066 . . . . 0.0 110.08 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 63.8 m -83.74 150.51 25.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -29.0 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.543 0 O-C-N 125.478 1.736 . . . . 0.0 113.187 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.3 p -148.18 -56.49 0.22 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.096 0.951 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 10.0 t80 -172.49 85.31 0.07 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.84 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 88.27 32.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.904 1.378 . . . . 0.0 109.089 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 39' ' ' ASN . 52.7 t30 -79.98 -7.25 58.7 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.57 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m 42.98 29.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 124.578 1.174 . . . . 0.0 109.982 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB2' ' ND2' ' A' ' 37' ' ' ASN . 60.9 m-80 -152.75 128.24 10.0 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.021 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.22 138.65 38.88 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.509 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 72.3 m95 -125.38 152.29 44.99 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.307 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 68.4 m -84.46 163.26 19.57 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 117.457 -1.697 . . . . 0.0 108.613 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -97.13 54.34 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.966 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.485 1.281 1 CA-C-O 111.405 -4.141 . . . . 0.0 111.351 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.443 ' HA ' ' OG1' ' A' ' 44' ' ' THR . 1.6 p30 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -99.79 102.19 13.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.311 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.1 tt -58.6 163.08 3.42 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.577 1.173 . . . . 0.0 108.922 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.517 HD11 ' SG ' ' A' ' 18' ' ' CYS . 17.9 pt -134.65 -42.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 124.693 1.246 . . . . 0.0 109.088 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.75 21.39 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 t -93.77 165.11 12.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.671 -1.265 . . . . 0.0 108.465 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -129.88 37.03 3.99 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.9 t -110.69 124.84 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -79.53 69.34 5.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.54 59.19 0.02 OUTLIER Glycine 0 N--CA 1.486 1.988 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.212 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.39 8.93 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.5 t -80.82 169.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.166 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 42.2 29.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.891 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -60.3 134.7 57.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 125.037 1.461 . . . . 0.0 109.766 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -116.72 170.62 8.45 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 124.817 1.323 . . . . 0.0 108.941 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -141.59 -47.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.678 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -105.15 66.57 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.724 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 4' ' ' ILE . 10.2 t -44.15 -65.01 0.56 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -49.25 -30.35 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.625 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.68 -65.67 2.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.509 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 tt0 -52.76 -31.37 37.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' SG ' HG22 ' A' ' 4' ' ' ILE . 16.4 m -77.16 -40.34 45.79 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.23 -29.79 70.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.79 -32.83 74.08 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.057 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.509 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -90.39 1.2 56.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.454 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.14 19.18 79.54 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 16.9 m-85 -76.89 167.33 22.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -64.97 -37.34 87.34 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.511 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.31 -166.71 39.81 Favored Glycine 0 N--CA 1.485 1.905 0 O-C-N 124.79 1.306 . . . . 0.0 110.468 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -163.34 155.68 27.14 Favored Glycine 0 N--CA 1.489 2.198 0 O-C-N 124.866 0.98 . . . . 0.0 111.091 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 55.9 p-80 -163.19 159.27 22.7 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.17 -1.015 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 90.1 m -74.45 149.73 40.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -22.33 -92.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 O-C-N 126.287 2.242 . . . . 0.0 112.473 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.9 t -178.2 -64.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.844 0.967 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -122.75 58.18 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 123.961 0.788 . . . . 0.0 109.776 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -164.44 -40.9 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 43.98 62.94 1.77 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.753 -1.567 . . . . 0.0 107.903 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p -122.83 -43.46 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.914 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.08 150.79 51.99 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 124.166 0.916 . . . . 0.0 108.988 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.79 147.92 34.67 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.681 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.459 ' CZ2' HD11 ' A' ' 3' ' ' LEU . 38.8 m95 -134.23 158.99 42.31 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.579 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 69.7 m -87.13 172.24 10.09 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 117.133 -1.827 . . . . 0.0 108.12 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.54 58.16 0.85 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 124.016 1.865 . . . . 0.0 110.708 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 1' ' ' ASP . 21.4 p . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 112.061 -3.828 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 10.4 mptt -134.99 126.83 29.33 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.733 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 4' ' ' ILE . 2.2 tm? -84.2 163.6 19.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 125.335 1.647 . . . . 0.0 107.826 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.601 HD12 ' SG ' ' A' ' 22' ' ' CYS . 3.4 pt -136.66 -40.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.995 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -163.49 37.19 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 124.876 1.36 . . . . 0.0 110.298 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 7' ' ' CYS . 30.8 t -90.31 172.06 9.03 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.263 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' OG ' ' A' ' 6' ' ' SER . 48.2 t -137.77 41.93 2.32 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.007 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.443 HG23 HG23 ' A' ' 38' ' ' VAL . 76.7 t -116.97 124.97 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.439 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 62.84 2.38 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.54 58.74 0.01 OUTLIER Glycine 0 N--CA 1.483 1.79 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.87 -179.84 7.89 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.82 165.74 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.175 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 41.43 30.65 0.14 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.908 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 15' ' ' THR . 2.9 t80 -65.35 134.42 53.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.309 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.564 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.7 m -111.49 177.45 4.65 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 124.633 1.208 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m -142.81 -50.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' GLY . 13.8 p-10 -102.93 68.94 1.02 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' A' ' 17' ' ' ASP . 14.1 t -41.53 -70.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -38.54 -35.96 0.22 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.66 -57.05 8.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 5.5 tp10 -53.9 -35.62 61.83 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 124.532 1.133 . . . . 0.0 108.461 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.601 ' SG ' HD12 ' A' ' 4' ' ' ILE . 3.2 m -75.33 -44.35 45.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.856 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.3 mt -63.76 -30.98 72.01 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.78 -28.82 69.84 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.398 1.061 . . . . 0.0 109.794 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.581 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 14.3 mtm-85 -99.12 6.38 46.51 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.573 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.96 17.57 69.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 15.2 m-30 -83.27 174.47 10.7 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.146 -0.527 . . . . 0.0 109.928 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -87.08 151.98 22.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.39 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.18 104.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 O-C-N 125.632 1.832 . . . . 0.0 110.483 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -87.43 -177.77 48.44 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -164.52 174.98 10.3 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.8 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.6 m -95.14 150.44 20.2 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.048 1.468 . . . . 0.0 107.374 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.18 147.52 2.58 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 p -92.87 -69.29 0.75 Allowed 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.27 0.629 . . . . 0.0 109.319 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -95.0 17.51 13.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.056 0.847 . . . . 0.0 110.094 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.52 53.79 0.11 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.724 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' VAL . 10.4 t-20 -60.87 -155.57 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER 88.37 -14.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -147.58 154.09 40.26 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.95 161.0 15.11 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.272 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.497 ' CE2' HD23 ' A' ' 3' ' ' LEU . 67.8 m95 -148.31 155.5 41.37 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 124.544 1.152 . . . . 0.0 108.483 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.45 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 55.9 m -94.88 164.24 13.0 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.375 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -100.69 59.56 0.95 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.468 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.521 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 13.0 t . . . . . 0 C--N 1.313 -1.02 1 CA-C-O 111.607 -4.044 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -125.49 94.6 4.19 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.651 1.219 . . . . 0.0 108.234 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.471 HD13 ' CZ2' ' A' ' 41' ' ' TRP . 5.9 tt -57.62 163.61 2.4 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.339 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.426 HG22 ' SG ' ' A' ' 42' ' ' CYS . 6.3 pt -134.85 -41.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.408 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.08 -148.42 9.58 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.331 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.79 178.56 5.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.971 -1.114 . . . . 0.0 109.732 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 t -138.77 54.26 1.75 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -138.4 122.63 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 123.808 0.693 . . . . 0.0 109.452 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -77.56 67.49 3.48 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.22 55.89 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.94 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.74 178.45 8.47 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -81.44 170.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 m120 44.16 28.83 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.367 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 19.3 t80 -57.06 135.26 56.32 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.826 1.329 . . . . 0.0 109.802 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 16' ' ' SER . 24.4 m -92.57 -76.89 0.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 125.177 1.548 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' THR . 7.6 t 91.51 -39.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.43 78.24 1.72 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.677 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 1.8 t -48.51 -57.45 6.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 30' ' ' GLY . 2.8 m120 -54.51 -33.23 59.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.12 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.21 -66.92 2.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 42.7 tt0 -47.88 -38.41 16.21 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 56.5 m -74.65 -41.35 60.49 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.691 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.98 -30.07 71.18 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.21 -33.08 74.99 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 124.356 1.035 . . . . 0.0 108.397 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 5.0 mpt_? -94.22 6.14 49.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.952 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.47 75.02 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 10.0 m-85 -77.92 149.31 34.22 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.606 0.827 . . . . 0.0 109.775 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.78 -43.36 8.55 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.864 -1.517 . . . . 0.0 109.028 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.69 -166.97 39.75 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.408 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -161.8 156.0 27.4 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 124.906 1.004 . . . . 0.0 110.626 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.567 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.1 p-80 -156.12 158.98 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.852 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' O ' ' C ' ' A' ' 33' ' ' GLY . 84.1 m -77.78 150.4 34.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -27.14 -51.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.258 1.599 . . . . 0.0 112.21 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -165.05 -51.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 124.898 0.999 . . . . 0.0 109.528 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -169.77 80.82 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.516 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 82.12 32.85 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.728 1.267 . . . . 0.0 109.072 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -57.53 -18.71 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.581 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 87.49 -11.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.234 1.584 . . . . 0.0 107.941 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -131.1 136.51 48.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 145.35 40.2 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.471 ' CZ2' HD13 ' A' ' 3' ' ' LEU . 34.0 m95 -129.86 156.51 44.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 125.417 1.698 . . . . 0.0 109.185 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 66.2 m -85.75 170.26 12.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 116.59 -2.044 . . . . 0.0 108.079 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 55.53 1.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.173 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 1' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 113.079 -3.343 . . . . 0.0 109.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.494 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.445 ' HB2' HG22 ' A' ' 44' ' ' THR . 5.8 tmtt? -117.79 116.34 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.35 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 4' ' ' ILE . 10.6 tt -75.75 162.65 28.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.612 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.637 HD12 ' SG ' ' A' ' 40' ' ' CYS . 8.7 pt -134.37 -43.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 125.026 1.454 . . . . 0.0 108.981 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.72 -161.62 23.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -96.45 155.85 16.59 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.012 0.91 . . . . 0.0 109.922 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 5.2 t -114.17 56.7 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -136.33 116.98 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.295 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -75.41 117.58 17.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -27.25 6.82 Favored Glycine 0 N--CA 1.485 1.959 0 O-C-N 124.638 1.211 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.59 172.84 10.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.441 0.73 . . . . 0.0 109.101 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.7 t -81.23 169.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.69 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 m120 42.34 30.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.698 1.249 . . . . 0.0 108.475 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 6.2 t80 -62.31 143.81 56.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.366 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' SER . 12.4 m -89.47 -73.01 0.53 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 124.465 1.103 . . . . 0.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 15' ' ' THR . 5.3 t 89.41 -37.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 18' ' ' CYS . 19.9 p-10 -139.9 70.35 1.36 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.95 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.6 t -39.53 -65.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -41.58 -48.05 3.94 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -60.45 -68.19 1.79 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' CD ' ' NH2' ' A' ' 25' ' ' ARG . 6.8 tp10 -44.31 -32.85 1.42 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 122.312 1.053 . . . . 0.0 109.385 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' HD11 ' A' ' 4' ' ' ILE . 13.0 m -76.13 -42.56 46.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.474 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' GLY . 25.1 mt -65.12 -30.8 71.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.71 -30.54 71.49 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.327 1.061 . . . . 0.0 109.152 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' NH2' ' CD ' ' A' ' 21' ' ' GLU . 9.0 mtm180 -102.61 7.33 39.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.637 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.87 14.57 68.01 Favored Glycine 0 N--CA 1.491 2.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.213 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 9.9 m-85 -77.41 175.48 9.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.83 0.824 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.31 150.41 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.983 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.15 94.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.858 0 O-C-N 125.867 1.979 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.52 -170.73 28.77 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 124.959 1.035 . . . . 0.0 110.531 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 16.4 p-80 -163.5 172.37 14.55 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.136 -1.032 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 33' ' ' GLY . 69.0 m -81.89 149.95 28.0 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -26.71 -88.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.793 0 O-C-N 125.593 1.808 . . . . 0.0 112.929 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.9 t -153.91 -52.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.757 0.916 . . . . 0.0 109.686 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 24.9 t80 -172.72 85.52 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.287 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 35' ' ' PHE . . . 85.07 29.19 0.05 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.728 1.268 . . . . 0.0 109.165 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 17.2 t-20 -79.12 -12.9 60.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.469 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 m 44.6 34.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 124.572 1.17 . . . . 0.0 110.161 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 70.6 m-80 -149.48 116.45 5.98 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.637 ' SG ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.38 133.49 41.92 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 1' ' ' ASP . 67.4 m95 -119.64 156.8 29.73 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.879 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.547 ' SG ' HG23 ' A' ' 4' ' ' ILE . 40.1 m -92.39 174.88 7.06 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.997 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -101.03 61.2 0.95 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 124.999 2.333 . . . . 0.0 111.467 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 31.3 p . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 112.743 -3.503 . . . . 0.0 110.435 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 158.82 16.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.611 1.194 . . . . 0.0 108.08 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.3 tt -99.42 164.5 12.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.693 HD12 ' SG ' ' A' ' 22' ' ' CYS . 44.8 mt -132.56 -43.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 125.366 1.666 . . . . 0.0 109.396 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.81 -147.03 12.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.523 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 53.5 m -96.14 160.42 14.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.808 -0.696 . . . . 0.0 110.236 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.805 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 35.4 t -138.72 27.3 2.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 69.2 t -93.53 135.08 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -79.13 63.84 3.88 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.732 1.27 . . . . 0.0 107.72 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.56 63.56 0.04 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.19 177.64 11.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.542 0.789 . . . . 0.0 109.294 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.2 t -82.45 168.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.781 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.82 27.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.098 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 5.6 t80 -60.73 134.39 57.03 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.134 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -110.64 167.95 9.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 125.166 1.541 . . . . 0.0 109.831 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.7 m -142.14 -47.43 0.35 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.144 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.34 67.82 0.74 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.924 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 4' ' ' ILE . 5.5 t -50.01 -64.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -33.08 1.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.611 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.38 -55.95 11.29 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 24.2 tt0 -58.97 -30.56 68.01 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.045 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' HD12 ' A' ' 4' ' ' ILE . 1.2 m -78.12 -41.17 35.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.3 -31.41 72.56 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.48 -30.61 71.64 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.761 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HE ' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -92.76 2.53 56.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.119 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.41 20.38 75.28 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 14.1 m-85 -77.04 173.2 12.08 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.652 0.854 . . . . 0.0 110.019 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 4.6 mptt -71.05 -35.24 71.86 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.525 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 165.67 -177.43 40.89 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.3 159.32 29.34 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 21.8 p-80 -163.32 163.13 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.142 -1.029 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' A' ' 33' ' ' GLY . 92.5 m -78.25 151.42 33.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -19.8 -96.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.578 0 O-C-N 126.471 2.357 . . . . 0.0 111.522 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -176.54 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.657 0.857 . . . . 0.0 109.717 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -118.94 38.16 3.89 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.091 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.17 48.41 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.566 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.805 ' ND2' ' SG ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -38.05 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 36' ' ' ALA . 3.6 p -144.65 -43.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -134.43 156.31 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -110.84 154.46 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.53 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CD1' ' C ' ' A' ' 40' ' ' CYS . 32.8 m95 -140.35 156.95 46.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.243 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.686 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -87.39 163.62 16.67 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -97.64 53.9 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.316 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 5.0 t . . . . . 0 C--N 1.305 -1.353 1 CA-C-O 111.378 -4.153 . . . . 0.0 111.963 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -154.0 95.55 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 125.948 2.03 . . . . 0.0 108.913 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.446 HD11 ' CH2' ' A' ' 41' ' ' TRP . 9.0 tt -56.04 162.82 1.75 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.087 0.867 . . . . 0.0 109.323 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.501 HD12 ' SG ' ' A' ' 18' ' ' CYS . 31.1 pt -134.41 -41.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.822 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.61 -147.86 10.94 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.735 -1.222 . . . . 0.0 110.45 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 14' ' ' TYR . 4.2 m -86.78 -178.59 6.37 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.414 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.01 49.77 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 t -148.95 125.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.087 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.83 103.61 5.99 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 -18.78 3.38 Favored Glycine 0 N--CA 1.491 2.334 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.94 171.77 8.56 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.8 t -82.13 169.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.021 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.17 29.0 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.25 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 13.0 t80 -57.64 147.66 26.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.892 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' SER . 15.6 m -96.23 -70.74 0.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.601 1.188 . . . . 0.0 109.355 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 88.65 -36.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.34 86.71 2.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.863 1.316 . . . . 0.0 109.421 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' HD12 ' A' ' 4' ' ' ILE . 2.1 t -66.81 -71.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.183 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -41.97 -32.23 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.126 -0.629 . . . . 0.0 109.557 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -59.37 6.19 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.022 1.451 . . . . 0.0 109.569 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 11.4 tp10 -55.67 -35.75 66.35 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.277 0.56 . . . . 0.0 110.103 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.44 -42.75 58.57 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.91 -30.58 70.98 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.94 -36.43 81.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 124.405 1.066 . . . . 0.0 109.395 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.02 16.04 20.69 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.777 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.81 28.82 53.51 Favored Glycine 0 N--CA 1.49 2.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.745 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 4.4 m-85 -75.94 159.82 30.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.959 0.885 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -57.61 -31.22 66.0 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.855 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 160.43 -173.65 37.03 Favored Glycine 0 N--CA 1.484 1.883 0 O-C-N 124.667 1.229 . . . . 0.0 110.639 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.02 155.8 26.96 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 3.6 p-80 -154.33 166.2 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.948 -1.126 . . . . 0.0 110.158 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 57.5 m -76.96 150.09 35.93 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 37' ' ' ASN . . . -27.43 -88.37 0.01 OUTLIER Glycine 0 N--CA 1.477 1.42 0 O-C-N 125.815 1.947 . . . . 0.0 113.133 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -148.32 -57.07 0.22 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.617 1.199 . . . . 0.0 111.449 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 10.0 t80 -172.68 85.82 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.716 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 35' ' ' PHE . . . 87.83 33.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.951 1.407 . . . . 0.0 109.052 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.445 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 5.6 t-20 -82.84 -11.96 57.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.239 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m 42.47 34.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.05 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -151.43 118.1 5.76 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.098 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -98.0 144.71 27.23 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' TRP . 11.2 m95 -127.06 164.96 20.4 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.047 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -96.21 171.42 8.6 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 125.068 1.48 . . . . 0.0 107.195 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' CD ' ' HD1' ' A' ' 31' ' ' HIS . 1.8 tp10 -97.81 54.0 1.13 Allowed 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.896 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.445 HG23 ' HB3' ' A' ' 42' ' ' CYS . 31.8 p . . . . . 0 C--N 1.3 -1.554 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.201 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 48.1 mmtt -100.48 104.75 16.16 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.528 HD11 ' CZ2' ' A' ' 41' ' ' TRP . 7.9 tt -59.04 162.19 4.49 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.904 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.612 HD11 ' SG ' ' A' ' 18' ' ' CYS . 20.8 pt -134.49 -43.09 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 125.027 1.454 . . . . 0.0 109.123 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 -148.09 10.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.1 t -97.29 164.49 12.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.66 1.219 . . . . 0.0 108.863 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -127.77 50.09 2.07 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.284 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 11' ' ' ALA . 33.1 t -130.02 122.09 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.817 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.5 92.53 2.37 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 -6.91 5.71 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . . . -96.41 178.97 5.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.0 t -81.65 168.8 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.972 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 p30 40.0 31.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 125.386 1.679 . . . . 0.0 108.315 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.6 t80 -55.45 137.34 48.5 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 125.327 1.642 . . . . 0.0 109.522 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' SER . 17.7 m -86.59 -73.76 0.45 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.552 1.157 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.6 OUTLIER 89.39 -36.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -137.75 73.77 1.45 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.612 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -46.85 -62.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -27.71 5.99 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.313 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.53 -67.43 1.72 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 34.0 tt0 -49.19 -31.83 9.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.426 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.2 m -75.86 -43.59 44.87 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 124.286 0.991 . . . . 0.0 108.338 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.89 -31.1 72.16 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.497 1.123 . . . . 0.0 108.05 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.08 -31.27 72.37 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.696 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -91.05 -3.34 57.27 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.533 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.22 12.09 76.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 23.6 m-85 -81.52 163.87 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.583 0.814 . . . . 0.0 110.038 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' GLY . 3.4 mppt? -86.71 169.14 12.92 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.292 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -31.18 99.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 O-C-N 125.647 1.842 . . . . 0.0 110.932 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.41 -165.96 33.6 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.587 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 32.6 p-80 -164.19 171.98 14.27 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.282 -0.959 . . . . 0.0 109.938 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 20.7 m -101.52 147.44 26.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . 21.44 -124.16 0.01 OUTLIER Glycine 0 N--CA 1.481 1.697 0 O-C-N 125.664 1.853 . . . . 0.0 112.615 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -158.53 -45.06 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.179 1.164 . . . . 0.0 109.218 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -172.04 85.46 0.07 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.456 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 84.19 53.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.794 1.309 . . . . 0.0 109.289 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 38' ' ' VAL . 57.6 t30 -106.9 -154.02 0.51 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 113.492 -1.685 . . . . 0.0 107.971 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 8.1 m -165.9 35.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 123.914 0.759 . . . . 0.0 108.991 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -153.22 174.38 14.34 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 123.563 0.539 . . . . 0.0 110.242 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -122.53 147.3 46.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 124.782 1.301 . . . . 0.0 107.997 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.528 ' CZ2' HD11 ' A' ' 3' ' ' LEU . 51.0 m95 -146.72 160.45 42.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.263 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 93.0 m -94.21 -173.01 2.96 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 117.224 -1.79 . . . . 0.0 108.673 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.587 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 5.5 mt-10 -143.88 76.42 1.51 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.072 0.939 . . . . 0.0 110.272 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 115.952 -1.975 . . . . 0.0 109.969 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.426 ' HA ' ' OG1' ' A' ' 44' ' ' THR . 3.1 m-20 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -120.9 109.97 15.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.476 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.47 HD21 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -71.74 163.33 28.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.832 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.651 HD13 ' SG ' ' A' ' 22' ' ' CYS . 4.9 pt -136.53 -41.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 125.17 1.544 . . . . 0.0 108.74 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -163.06 24.99 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -93.52 163.48 13.55 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.354 -0.923 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -123.06 54.49 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.83 121.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.34 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.41 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -77.6 71.12 4.06 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.95 59.35 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.8 179.71 8.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.5 t -79.24 170.72 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 40.5 30.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.61 1.194 . . . . 0.0 109.511 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 25.0 t80 -52.99 135.16 37.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.642 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 16' ' ' SER . 50.6 m -92.29 -74.58 0.51 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.485 1.116 . . . . 0.0 109.695 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 15' ' ' THR . 3.6 t 90.21 -39.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.4 p-10 -136.84 73.93 1.47 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.245 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 6.7 t -43.91 -57.96 3.02 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.54 -36.03 61.36 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -67.01 -70.19 1.18 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 46.3 tp10 -45.64 -34.01 3.22 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.412 1.101 . . . . 0.0 110.206 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.651 ' SG ' HD13 ' A' ' 4' ' ' ILE . 4.2 m -73.23 -43.59 60.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.697 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.34 -30.99 72.02 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.986 1.429 . . . . 0.0 109.166 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.68 7.73 45.76 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.187 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.72 19.62 69.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.547 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 15.4 m-30 -84.29 172.0 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.913 -0.643 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.541 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.03 149.43 25.58 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.43 99.46 0.01 OUTLIER Glycine 0 N--CA 1.486 2.021 0 O-C-N 125.744 1.903 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.55 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.42 -174.7 35.78 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 10.9 p-80 -163.94 174.43 11.45 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.19 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' O ' ' C ' ' A' ' 33' ' ' GLY . 99.3 m -90.94 152.58 20.66 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -19.51 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 O-C-N 126.058 2.099 . . . . 0.0 111.595 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -166.7 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 O-C-N 124.556 0.798 . . . . 0.0 108.972 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -125.54 39.61 3.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.856 0.722 . . . . 0.0 109.811 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.86 56.13 0.11 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -37.98 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.226 0.954 . . . . 0.0 109.755 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 36' ' ' ALA . 15.3 m -136.55 -48.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.496 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -125.93 136.29 52.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.233 0.958 . . . . 0.0 109.805 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.6 140.47 38.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' CE2' HD11 ' A' ' 3' ' ' LEU . 51.1 m95 -129.66 162.67 27.81 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.04 -1.437 . . . . 0.0 107.851 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.547 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 80.9 m -95.21 172.25 8.23 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 117.269 -1.772 . . . . 0.0 108.382 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -101.16 61.23 0.94 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 124.754 2.216 . . . . 0.0 112.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.541 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 36.4 p . . . . . 0 C--N 1.305 -1.364 0 CA-C-O 112.489 -3.624 . . . . 0.0 111.252 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.525 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -110.67 98.18 7.41 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.967 -1.469 . . . . 0.0 109.089 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.576 HD11 ' CZ2' ' A' ' 41' ' ' TRP . 8.1 tt -56.16 161.47 2.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.077 0.861 . . . . 0.0 109.062 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.507 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 19.8 pt -136.26 -41.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 124.823 1.327 . . . . 0.0 109.396 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.26 -148.59 9.62 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 124.86 1.35 . . . . 0.0 110.156 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.7 m -94.42 -172.45 2.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.777 -0.711 . . . . 0.0 109.812 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' VAL . 24.5 t -152.89 34.91 0.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 38' ' ' VAL . 2.0 t -126.97 127.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -78.73 62.15 3.18 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 44.47 0.02 OUTLIER Glycine 0 N--CA 1.487 2.055 0 CA-C-N 114.253 -1.34 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.23 179.06 9.09 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -78.2 167.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.634 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.47 29.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.988 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -52.1 135.77 30.86 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 124.902 1.376 . . . . 0.0 110.173 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.513 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.5 t -120.65 175.58 5.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 125.125 1.516 . . . . 0.0 108.931 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.7 -50.5 0.41 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.126 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' CYS . 7.7 p-10 -109.12 69.26 0.7 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.434 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' HD12 ' A' ' 4' ' ' ILE . 7.6 t -38.26 -58.58 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -45.63 -50.28 13.49 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.311 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -61.61 -65.06 3.47 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.538 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 6.1 tp10 -41.19 -37.1 0.85 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 124.376 1.071 . . . . 0.0 108.627 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.5 m -75.56 -43.9 46.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.517 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 22.2 mt -62.75 -30.29 71.33 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.09 -32.84 74.55 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.261 0.975 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 18.6 mtm-85 -92.18 3.79 54.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.843 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 12.89 83.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 21.8 m-85 -89.89 170.04 10.72 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.994 0.902 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 43' ' ' GLU . 34.3 mtpt -84.64 154.86 22.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.446 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -34.98 96.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 O-C-N 125.341 1.65 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.622 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -69.45 -170.83 7.6 Favored Glycine 0 N--CA 1.48 1.607 0 O-C-N 125.386 1.286 . . . . 0.0 110.893 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -161.94 171.46 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.578 -1.311 . . . . 0.0 110.455 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' C ' ' A' ' 33' ' ' GLY . 87.0 m -92.04 151.45 20.45 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -20.7 -92.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.415 0 O-C-N 125.667 1.855 . . . . 0.0 112.509 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 p -176.07 -70.3 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 124.949 1.029 . . . . 0.0 110.13 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -119.23 39.21 3.63 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.364 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.61 49.89 0.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.191 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -40.82 95.3 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 36' ' ' ALA . 2.5 p -152.28 -45.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 124.777 1.298 . . . . 0.0 109.241 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -120.94 137.63 54.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 124.156 0.91 . . . . 0.0 109.507 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -107.36 147.28 30.53 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CZ2' HD11 ' A' ' 3' ' ' LEU . 65.2 m95 -137.06 152.49 50.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 84.2 m -86.45 -171.59 3.62 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.051 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -142.73 74.46 1.45 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 59.7 p . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 112.973 -3.394 . . . . 0.0 109.573 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG3' ' CZ ' ' A' ' 27' ' ' TYR . 3.6 tmtm? -97.73 107.18 19.62 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD11 ' CH2' ' A' ' 41' ' ' TRP . 5.7 tt -64.32 162.69 14.36 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.077 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.548 HD13 ' SG ' ' A' ' 18' ' ' CYS . 18.3 pt -135.73 -39.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.117 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.33 -148.1 8.96 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -104.34 167.37 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.185 -1.008 . . . . 0.0 109.765 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 56.1 m -134.62 43.87 2.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.94 123.79 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 124.779 1.299 . . . . 0.0 109.08 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 73.57 4.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.08 52.08 0.02 OUTLIER Glycine 0 N--CA 1.488 2.102 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.152 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.67 176.57 10.82 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 t -80.47 170.64 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 42.49 30.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.569 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.37 134.28 56.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.999 1.437 . . . . 0.0 109.965 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 6' ' ' SER . 2.8 m -120.46 173.84 6.91 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 124.807 1.317 . . . . 0.0 109.107 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.0 t -142.36 -50.04 0.37 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.919 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -102.58 66.42 0.96 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.057 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.6 t -43.15 -71.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.452 HD21 ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -43.64 -28.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.075 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.48 -60.78 4.51 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 1.1 tt0 -56.26 -31.49 63.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.498 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 10.9 m -77.1 -41.91 40.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.452 ' CD1' HD21 ' A' ' 19' ' ' ASN . 17.6 mt -64.08 -29.45 70.59 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.8 mt -65.78 -30.41 71.06 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 124.308 1.005 . . . . 0.0 109.309 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -86.94 0.85 54.38 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.613 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.79 14.93 76.67 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.321 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 18.9 m-85 -79.24 140.7 37.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -43.39 -50.21 6.87 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.334 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.04 169.3 40.83 Favored Glycine 0 N--CA 1.481 1.662 0 O-C-N 125.213 1.571 . . . . 0.0 110.445 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -148.51 154.17 25.68 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 1.2 p-80 -149.85 160.6 43.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 21.0 m -85.06 146.54 27.11 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . 21.73 -126.25 0.01 OUTLIER Glycine 0 N--CA 1.484 1.842 0 O-C-N 126.133 2.145 . . . . 0.0 111.95 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -156.07 -45.2 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 125.081 1.106 . . . . 0.0 108.92 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.405 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.5 t80 -172.35 85.53 0.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.24 52.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.863 1.352 . . . . 0.0 109.219 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.527 ' CG ' ' H ' ' A' ' 38' ' ' VAL . 9.9 t-20 -105.53 -152.71 0.47 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.806 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.527 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 13.5 m -165.55 33.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' ND2' ' OG ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -153.34 175.67 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -121.3 144.94 48.36 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.424 ' CH2' HD11 ' A' ' 3' ' ' LEU . 50.1 m95 -146.95 158.03 43.8 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.508 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 89.7 m -88.33 -174.9 4.81 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 117.837 -1.545 . . . . 0.0 108.11 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.598 ' CD ' ' HD1' ' A' ' 31' ' ' HIS 0.271 44.6 tt0 -141.72 73.66 1.42 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 124.083 0.864 . . . . 0.0 110.364 -178.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.467 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 45.3 p . . . . . 0 C--N 1.295 -1.783 0 O-C-N 125.24 1.587 . . . . 0.0 111.675 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 9.0 p-10 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 11.9 tptt -134.18 100.51 4.73 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.241 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 4' ' ' ILE . 8.8 tt -59.45 161.56 5.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' A' ' 18' ' ' CYS . 9.0 pt -135.82 -42.58 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.727 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.58 -148.39 9.04 Favored Glycine 0 N--CA 1.482 1.703 0 O-C-N 124.987 1.429 . . . . 0.0 109.983 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 25.1 t -102.61 171.57 7.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.318 -1.353 . . . . 0.0 108.639 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 44.4 t -144.32 40.99 1.35 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.659 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.268 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.58 68.08 3.6 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.95 50.17 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.23 178.41 10.21 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -84.61 168.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.31 29.5 0.23 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.837 1.336 . . . . 0.0 108.225 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE1' ' O ' ' A' ' 15' ' ' THR . 18.6 t80 -57.85 134.24 56.12 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.893 1.37 . . . . 0.0 110.073 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.0 t -117.73 -179.76 3.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.741 1.276 . . . . 0.0 109.15 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.05 -49.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.682 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 18' ' ' CYS . 10.5 p-10 -105.24 66.15 0.74 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.096 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.1 t -37.77 -71.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 59.9 t30 -37.19 -42.85 0.47 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.618 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -64.78 -55.03 24.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' HG2' ' NH2' ' A' ' 25' ' ' ARG . 18.0 tt0 -56.79 -29.94 63.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 4' ' ' ILE . 1.9 m -76.08 -45.45 33.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.11 -32.29 71.97 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.78 -34.75 76.42 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.802 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.54 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 4.4 mtm180 -89.5 -0.42 57.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.309 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.85 12.6 79.53 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.578 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 18.2 m-30 -83.98 164.69 19.18 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.251 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -87.92 172.38 9.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.369 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -27.89 106.2 0.01 OUTLIER Glycine 0 N--CA 1.485 1.961 0 O-C-N 125.964 2.04 . . . . 0.0 110.834 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.2 -170.17 33.44 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 6.6 p-80 -166.08 176.83 7.4 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 60.4 m -100.68 147.38 26.07 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . 22.06 -125.87 0.01 OUTLIER Glycine 0 N--CA 1.483 1.768 0 O-C-N 126.126 2.141 . . . . 0.0 112.046 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t -155.59 -45.64 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 125.239 1.199 . . . . 0.0 108.901 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -171.99 85.47 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.389 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 85.24 52.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.817 1.323 . . . . 0.0 109.327 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.577 ' CG ' ' H ' ' A' ' 38' ' ' VAL . 16.8 t-20 -105.29 -152.57 0.47 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.899 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.577 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -166.52 34.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 123.85 0.719 . . . . 0.0 109.491 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 8.7 m-80 -155.36 176.38 12.66 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.97 147.81 44.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 122.351 1.072 . . . . 0.0 108.319 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.474 ' CZ2' HD13 ' A' ' 3' ' ' LEU . 52.2 m95 -146.16 162.02 38.92 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.399 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.2 m -94.61 -173.51 3.04 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 117.038 -1.865 . . . . 0.0 108.868 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 11.5 tt0 -142.68 75.79 1.5 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.959 0.787 . . . . 0.0 109.944 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 115.057 -2.402 . . . . 0.0 110.439 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 9.7 mptt -130.39 94.24 3.62 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 124.876 1.36 . . . . 0.0 109.303 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -55.66 163.53 1.33 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 113.678 -1.601 . . . . 0.0 108.166 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.686 HD13 ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -134.85 -43.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.111 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.47 -150.78 12.42 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 38.4 m -95.88 170.29 9.4 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.504 -0.848 . . . . 0.0 109.858 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.1 t -140.19 43.81 1.9 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 97.8 t -119.7 129.92 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.43 74.15 4.98 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.25 58.01 0.04 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-N 113.292 -1.777 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.39 173.91 16.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.532 0.784 . . . . 0.0 109.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.4 172.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 41.34 30.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.694 1.246 . . . . 0.0 108.754 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' N ' ' C ' ' A' ' 12' ' ' VAL . 30.0 t80 -51.69 138.79 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.5 m -91.75 -75.21 0.48 Allowed 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.647 1.217 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.2 OUTLIER 88.68 -35.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 20' ' ' GLY . 6.1 p-10 -138.96 72.55 1.41 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.8 t -41.55 -71.46 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -42.23 -32.55 0.5 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.307 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.57 -60.81 5.14 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 tp10 -55.38 -32.78 62.89 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.654 0.74 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.0 m -74.72 -43.89 52.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.642 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -30.78 71.6 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.464 1.102 . . . . 0.0 108.242 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.17 -28.41 70.03 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.729 1.268 . . . . 0.0 109.605 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.39 -1.07 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.484 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.65 82.27 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.552 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 19.2 m-85 -79.52 170.86 15.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.95 0.881 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.626 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.7 156.57 20.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.742 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.31 103.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.102 0 O-C-N 125.166 1.541 . . . . 0.0 110.352 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -83.11 -171.23 47.19 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.99 173.92 11.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.547 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 99.5 m -93.93 150.62 20.2 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 125.05 1.469 . . . . 0.0 107.678 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 O-C-N 125.63 1.831 . . . . 0.0 111.022 179.746 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.0 p . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 38.1 m-20 -119.6 150.64 39.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.736 1.273 . . . . 0.0 109.846 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -107.81 155.79 19.85 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD12 ' A' ' 3' ' ' LEU . 24.7 m95 -142.98 158.67 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.193 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 82.5 m -94.37 164.5 12.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.808 -1.957 . . . . 0.0 107.551 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -97.55 55.43 1.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.209 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.626 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 12.5 t . . . . . 0 C--N 1.31 -1.152 0 CA-C-O 111.85 -3.928 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 5.2 mmtm -100.98 111.4 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 4' ' ' ILE . 5.2 tt -66.49 163.7 17.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.126 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.579 HD13 ' SG ' ' A' ' 22' ' ' CYS . 21.8 pt -135.09 -41.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.35 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.24 -148.93 9.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -99.43 177.96 5.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.811 -0.695 . . . . 0.0 109.743 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -146.23 49.56 1.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.9 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 38' ' ' VAL . 3.9 t -144.85 126.88 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.675 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.88 61.66 1.96 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 125.215 1.572 . . . . 0.0 107.013 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.67 39.51 0.03 OUTLIER Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.35 176.66 11.74 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.265 0.627 . . . . 0.0 109.435 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.41 171.4 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 12' ' ' VAL . 13.8 m120 42.22 30.09 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.115 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -51.41 135.7 26.83 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 16' ' ' SER . 1.1 t -123.63 -178.13 3.94 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.802 1.314 . . . . 0.0 108.594 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 15' ' ' THR . 38.7 t -143.12 -56.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.394 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -101.67 70.2 1.25 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.791 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 11.2 t -41.18 -72.85 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -41.0 -32.67 0.25 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.272 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.18 -60.57 5.09 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.554 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 25' ' ' ARG . 5.3 tt0 -58.32 -29.32 65.8 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 4' ' ' ILE . 7.4 m -77.03 -42.5 38.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.68 -30.1 71.25 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -33.48 74.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.553 HH11 HG22 ' A' ' 4' ' ' ILE . 2.0 mtm180 -86.68 -2.27 58.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.155 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.54 14.32 76.32 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.548 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.3 m-85 -77.66 148.93 34.77 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.175 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -47.93 -42.2 26.66 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.508 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.24 -168.79 40.23 Favored Glycine 0 N--CA 1.483 1.799 0 O-C-N 125.165 1.541 . . . . 0.0 110.158 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.44 160.72 32.97 Favored Glycine 0 N--CA 1.484 1.876 0 O-C-N 124.67 0.865 . . . . 0.0 111.208 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.31 168.01 28.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.286 -0.957 . . . . 0.0 109.357 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 73.0 m -85.54 151.3 24.04 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.489 2.169 0 O-C-N 125.652 1.845 . . . . 0.0 112.437 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.409 HG23 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -143.04 132.15 23.09 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -109.41 137.68 46.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -125.33 157.49 36.58 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 125.271 1.607 . . . . 0.0 108.043 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 98.7 m -84.38 161.28 20.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 116.341 -2.143 . . . . 0.0 107.992 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -99.69 57.18 1.0 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.954 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.656 ' HA ' ' CE ' ' A' ' 28' ' ' LYS . 14.2 t . . . . . 0 C--N 1.31 -1.142 0 CA-C-O 112.695 -3.526 . . . . 0.0 109.187 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 9.3 mptt -115.91 102.57 9.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.554 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 4.8 tt -56.33 162.38 2.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.051 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.645 HD11 ' SG ' ' A' ' 18' ' ' CYS . 2.9 pt -133.98 -45.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.79 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.25 -148.94 10.26 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 125.033 1.458 . . . . 0.0 109.861 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.65 155.83 17.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.139 -1.031 . . . . 0.0 109.279 -179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 43.0 t -124.01 48.77 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 59.7 t -125.39 118.88 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.571 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 96.04 2.63 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.01 -9.76 5.69 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.451 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -96.31 176.71 5.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -82.28 168.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 114.178 -1.373 . . . . 0.0 107.987 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 42.31 30.08 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.461 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.7 t80 -53.44 140.62 27.26 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 125.28 1.613 . . . . 0.0 109.633 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' SER . 3.4 m -88.0 -74.28 0.46 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 124.687 1.242 . . . . 0.0 109.733 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 90.06 -38.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -138.19 72.86 1.42 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -42.57 -72.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -39.08 -32.62 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.16 -60.19 4.6 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 4' ' ' ILE . 39.5 tp10 -55.43 -32.17 62.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.137 0.97 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.9 m -75.75 -44.89 39.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.105 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.22 -31.56 72.73 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 124.513 1.133 . . . . 0.0 108.202 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.757 1.286 . . . . 0.0 109.948 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.602 ' NH1' ' HA ' ' A' ' 4' ' ' ILE . 48.8 mtt180 -93.6 -4.12 51.38 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.158 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.03 79.95 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 m-30 -81.22 162.6 23.5 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.354 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' NZ ' ' OG1' ' A' ' 44' ' ' THR . 2.3 mppt? -79.71 163.61 24.38 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -32.12 104.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.479 1.737 . . . . 0.0 110.436 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -165.44 39.08 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.837 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -163.95 173.4 12.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 109.585 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 52.6 m -98.56 146.27 25.97 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.287 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.778 0 O-C-N 126.292 2.245 . . . . 0.0 112.033 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -152.55 174.75 13.54 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 123.532 0.52 . . . . 0.0 110.369 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -123.95 147.62 47.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 36.8 m95 -145.77 160.59 41.53 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.615 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.9 m -93.26 -175.94 3.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 117.327 -1.749 . . . . 0.0 108.288 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 39.8 mt-10 -142.97 75.78 1.5 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 124.358 1.036 . . . . 0.0 110.53 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' NZ ' ' A' ' 28' ' ' LYS . 1.1 t . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 115.706 -2.092 . . . . 0.0 110.725 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -108.28 103.8 13.05 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.3 tt -59.88 163.08 4.84 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.303 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.571 HD11 ' SG ' ' A' ' 18' ' ' CYS . 14.9 pt -135.07 -41.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 125.063 1.477 . . . . 0.0 109.257 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.77 -147.02 9.8 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.131 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.53 -175.3 3.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.797 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 13.7 t -150.17 54.36 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 ' CG2' HG23 ' A' ' 38' ' ' VAL . 2.6 t -146.73 129.92 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.985 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 67.89 5.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.64 42.69 0.02 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 174.77 12.4 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 13' ' ' ASN . 2.4 t -79.98 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.77 1.294 . . . . 0.0 107.655 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.416 ' H ' HG12 ' A' ' 12' ' ' VAL . 4.4 m120 42.71 29.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.376 1.047 . . . . 0.0 108.876 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 18.6 t80 -47.43 136.39 9.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.207 1.567 . . . . 0.0 109.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 16' ' ' SER . 37.2 m -96.85 -75.79 0.53 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 124.675 1.234 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' THR . 1.6 t 89.89 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 p-10 -137.35 75.78 1.55 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.133 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.571 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -44.5 -59.8 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 13.6 t-20 -50.86 -33.17 22.76 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.221 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -70.77 -63.93 3.01 Favored Glycine 0 N--CA 1.486 1.973 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.482 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 26.7 tt0 -53.68 -30.77 44.97 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m -75.92 -43.16 46.45 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.1 -31.31 72.46 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.578 1.174 . . . . 0.0 108.234 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 25' ' ' ARG . 2.3 mt -62.97 -28.27 69.97 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.719 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.77 -2.76 40.38 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.056 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 10.17 80.46 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.53 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.9 m-85 -80.41 167.07 20.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.989 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.24 166.06 14.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.853 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -33.1 98.61 0.01 OUTLIER Glycine 0 N--CA 1.485 1.954 0 O-C-N 125.584 1.803 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -73.88 -166.78 13.98 Favored Glycine 0 N--CA 1.48 1.63 0 O-C-N 125.84 1.553 . . . . 0.0 110.324 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.425 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 50.1 p-80 -162.48 171.16 17.52 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.898 -1.151 . . . . 0.0 110.366 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -92.24 150.46 20.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.645 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 8' ' ' VAL . 9.1 p . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -133.15 123.24 25.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.722 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 143.54 27.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 19.1 m95 -130.06 151.85 50.15 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.478 -2.147 . . . . 0.0 109.339 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 92.2 m -89.75 162.32 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 116.546 -2.061 . . . . 0.0 107.7 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.16 57.25 1.06 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.593 1.187 . . . . 0.0 111.433 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.454 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 3.2 t . . . . . 0 C--N 1.304 -1.406 1 CA-C-O 111.519 -4.086 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -125.93 127.31 45.78 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.439 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 4' ' ' ILE . 1.6 tm? -73.0 163.57 27.98 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.312 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.601 HG21 ' SG ' ' A' ' 22' ' ' CYS . 8.5 pt -136.77 -39.96 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 124.928 1.392 . . . . 0.0 108.684 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.37 -159.18 32.43 Favored Glycine 0 N--CA 1.486 2.022 0 O-C-N 124.799 1.312 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 167.16 11.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.308 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.74 47.29 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.565 HG21 HG22 ' A' ' 38' ' ' VAL . 69.9 t -119.26 127.43 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.176 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -77.58 70.3 3.94 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.471 -1.241 . . . . 0.0 107.709 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.91 56.9 0.04 OUTLIER Glycine 0 N--CA 1.485 1.954 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.6 173.82 15.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.387 0.698 . . . . 0.0 109.195 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.2 t -80.86 171.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.42 ' H ' HG12 ' A' ' 12' ' ' VAL . 50.9 m-20 43.61 28.76 0.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.941 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' N ' ' C ' ' A' ' 12' ' ' VAL . 38.6 t80 -51.99 140.53 20.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.841 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' SER . 4.9 m -89.95 -75.43 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 124.781 1.301 . . . . 0.0 109.792 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER 87.54 -36.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.64 74.23 1.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 123.941 0.776 . . . . 0.0 109.88 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 t -42.7 -72.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.5 -27.79 1.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.317 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.9 -63.05 3.85 Favored Glycine 0 N--CA 1.486 2.003 0 O-C-N 125.137 1.523 . . . . 0.0 109.628 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 11.4 tp10 -51.94 -37.1 51.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.4 m -72.34 -42.45 65.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.637 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -30.69 71.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.85 -33.55 75.5 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 124.716 1.26 . . . . 0.0 109.333 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 1.3 mpt_? -97.87 14.05 28.5 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.89 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 54.91 30.17 52.73 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.636 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 8.5 m-85 -76.85 178.04 7.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.53 -33.44 64.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.359 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 159.68 179.57 34.58 Favored Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.418 1.074 . . . . 0.0 110.555 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.64 156.99 27.79 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.3 p-80 -153.61 157.39 39.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.044 -1.078 . . . . 0.0 109.757 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 95.3 m -78.19 150.11 33.59 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.205 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -145.95 157.9 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.488 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -117.47 150.7 38.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.592 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CE2' HD23 ' A' ' 3' ' ' LEU . 40.5 m95 -133.66 168.83 17.98 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 125.063 1.477 . . . . 0.0 108.535 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -100.09 161.5 13.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 55.52 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.42 1.088 . . . . 0.0 109.214 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 42' ' ' CYS . 71.3 p . . . . . 0 C--N 1.302 -1.5 0 CA-C-O 114.641 -2.599 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 10.2 mmtt -97.9 106.01 18.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.28 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.607 HD12 ' CH2' ' A' ' 41' ' ' TRP . 9.1 tt -56.53 162.42 2.21 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.556 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.629 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 10.2 pt -136.85 -41.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.537 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.6 -152.03 12.05 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 1.4 m -93.96 166.61 12.08 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.514 0.773 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.8 t -136.04 47.16 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.4 127.52 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.13 68.5 3.27 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.39 59.18 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.21 177.07 11.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.575 0.809 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -81.51 170.8 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.643 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.22 29.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.495 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 36.3 t80 -50.91 140.22 15.72 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.77 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.4 m -92.17 -74.28 0.52 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 124.819 1.325 . . . . 0.0 109.437 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.9 OUTLIER 89.08 -37.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -138.29 75.02 1.5 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.816 0.697 . . . . 0.0 109.795 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -42.54 -70.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.502 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 11.0 t-20 -39.41 -33.74 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.767 0.667 . . . . 0.0 109.568 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.12 -56.89 6.59 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HH21 ' A' ' 25' ' ' ARG . 1.2 tp10 -55.8 -34.61 65.48 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.7 m -75.16 -45.21 42.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.38 -31.44 72.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -34.4 74.65 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.426 1.079 . . . . 0.0 109.964 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.668 HH21 ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -94.23 1.69 55.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.996 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 13.36 82.1 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 124.122 0.889 . . . . 0.0 110.911 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 22.4 m-85 -83.13 168.45 16.84 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.893 0.854 . . . . 0.0 109.928 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.47 162.69 17.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.664 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -32.45 102.47 0.01 OUTLIER Glycine 0 N--CA 1.484 1.893 0 O-C-N 125.444 1.715 . . . . 0.0 111.355 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.589 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -81.51 -169.48 42.4 Favored Glycine 0 N--CA 1.481 1.643 0 O-C-N 125.488 1.346 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -163.42 177.81 8.59 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.845 -1.178 . . . . 0.0 109.905 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.3 m -99.06 149.83 22.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.155 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 21.4 m-80 -151.11 154.67 37.4 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.971 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -111.36 152.26 27.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.607 ' CH2' HD12 ' A' ' 3' ' ' LEU . 38.6 m95 -144.45 158.65 43.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.737 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.629 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 94.6 m -93.57 -175.83 3.9 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 117.252 -1.779 . . . . 0.0 108.574 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.54 76.12 1.49 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.782 1.277 . . . . 0.0 110.599 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--N 1.297 -1.705 0 CA-C-N 112.604 -2.089 . . . . 0.0 110.256 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -108.69 110.94 22.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.528 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 tt -62.49 162.15 10.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.054 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 5' ' ' GLY . 16.2 pt -134.08 -43.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 125.137 1.523 . . . . 0.0 109.495 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 179.85 -148.74 8.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 15' ' ' THR . 3.3 m -99.32 170.18 8.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.957 -0.621 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 8.8 t -136.44 51.34 2.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 17.6 t -131.64 128.93 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.851 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -78.7 61.39 2.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.68 64.2 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.58 -179.83 5.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 124.419 0.717 . . . . 0.0 109.159 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.68 167.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.644 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.89 29.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.378 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -57.65 134.96 56.64 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -117.46 177.81 4.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 125.064 1.478 . . . . 0.0 109.89 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.5 t -142.05 -49.04 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.5 p-10 -111.61 72.44 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.414 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' HD11 ' A' ' 4' ' ' ILE . 5.6 t -40.56 -41.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -61.41 -50.39 73.01 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.277 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -61.91 -57.41 17.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG3' ' NH2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -50.13 -33.57 19.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.9 m -76.21 -43.31 42.95 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.61 -30.93 71.97 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.869 1.356 . . . . 0.0 108.278 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.33 -31.73 72.39 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.012 0.911 . . . . 0.0 109.699 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 21' ' ' GLU . 2.3 mtm-85 -94.4 -1.0 54.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.785 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.83 6.59 79.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 16.6 m-30 -85.47 164.39 17.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.702 0.763 . . . . 0.0 109.956 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -87.69 164.98 15.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.531 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -31.91 97.56 0.01 OUTLIER Glycine 0 N--CA 1.487 2.036 0 O-C-N 125.802 1.939 . . . . 0.0 110.8 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -77.4 -168.12 29.9 Favored Glycine 0 N--CA 1.48 1.617 0 O-C-N 125.393 1.29 . . . . 0.0 110.209 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -163.1 172.25 15.18 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.069 -1.066 . . . . 0.0 110.08 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 63.8 m -83.74 150.51 25.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.479 1.543 0 O-C-N 125.478 1.736 . . . . 0.0 113.187 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 18.9 m . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -152.75 128.24 10.0 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.021 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.22 138.65 38.88 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.528 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 72.3 m95 -125.38 152.29 44.99 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.307 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 68.4 m -84.46 163.26 19.57 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 117.457 -1.697 . . . . 0.0 108.613 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -97.13 54.34 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.966 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.429 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 4.5 t . . . . . 0 N--CA 1.485 1.281 1 CA-C-O 111.405 -4.141 . . . . 0.0 111.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.467 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 1.6 p30 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 44' ' ' THR . 15.7 mmtp -99.79 102.19 13.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.311 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.1 tt -58.6 163.08 3.42 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.577 1.173 . . . . 0.0 108.922 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.548 HD11 ' SG ' ' A' ' 18' ' ' CYS . 17.9 pt -134.65 -42.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 124.693 1.246 . . . . 0.0 109.088 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.75 21.39 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 t -93.77 165.11 12.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.671 -1.265 . . . . 0.0 108.465 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -129.88 37.03 3.99 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.9 t -110.69 124.84 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -79.53 69.34 5.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.54 59.19 0.02 OUTLIER Glycine 0 N--CA 1.486 1.988 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.212 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.39 8.93 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.5 t -80.82 169.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.166 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 42.2 29.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.891 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -60.3 134.7 57.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 125.037 1.461 . . . . 0.0 109.766 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -116.72 170.62 8.45 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 124.817 1.323 . . . . 0.0 108.941 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -141.59 -47.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.678 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -105.15 66.57 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.724 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 4' ' ' ILE . 10.2 t -44.15 -65.01 0.56 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -49.25 -30.35 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.625 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.68 -65.67 2.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.509 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 tt0 -52.76 -31.37 37.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 4' ' ' ILE . 16.4 m -77.16 -40.34 45.79 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.23 -29.79 70.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.79 -32.83 74.08 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.057 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.509 HH11 HG22 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -90.39 1.2 56.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.454 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.14 19.18 79.54 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 16.9 m-85 -76.89 167.33 22.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -64.97 -37.34 87.34 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.511 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.31 -166.71 39.81 Favored Glycine 0 N--CA 1.485 1.905 0 O-C-N 124.79 1.306 . . . . 0.0 110.468 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -163.34 155.68 27.14 Favored Glycine 0 N--CA 1.489 2.198 0 O-C-N 124.866 0.98 . . . . 0.0 111.091 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 55.9 p-80 -163.19 159.27 22.7 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.17 -1.015 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 90.1 m -74.45 149.73 40.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.489 2.193 0 O-C-N 126.287 2.242 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.08 150.79 51.99 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 124.166 0.916 . . . . 0.0 108.988 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.79 147.92 34.67 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.681 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.461 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 38.8 m95 -134.23 158.99 42.31 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.579 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 69.7 m -87.13 172.24 10.09 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 117.133 -1.827 . . . . 0.0 108.12 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.54 58.16 0.85 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 124.016 1.865 . . . . 0.0 110.708 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.476 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 21.4 p . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 112.061 -3.828 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 10.4 mptt -134.99 126.83 29.33 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.733 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 4' ' ' ILE . 2.2 tm? -84.2 163.6 19.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 125.335 1.647 . . . . 0.0 107.826 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' SG ' ' A' ' 22' ' ' CYS . 3.4 pt -136.66 -40.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.995 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -163.49 37.19 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 124.876 1.36 . . . . 0.0 110.298 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.54 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 30.8 t -90.31 172.06 9.03 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.263 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' OG ' ' A' ' 6' ' ' SER . 48.2 t -137.77 41.93 2.32 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.007 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.604 HG21 HG22 ' A' ' 38' ' ' VAL . 76.7 t -116.97 124.97 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.439 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 62.84 2.38 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.54 58.74 0.01 OUTLIER Glycine 0 N--CA 1.483 1.79 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.87 -179.84 7.89 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.82 165.74 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.175 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 41.43 30.65 0.14 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.908 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 15' ' ' THR . 2.9 t80 -65.35 134.42 53.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.309 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.564 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.7 m -111.49 177.45 4.65 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 124.633 1.208 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m -142.81 -50.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' GLY . 13.8 p-10 -102.93 68.94 1.02 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' A' ' 17' ' ' ASP . 14.1 t -41.53 -70.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' CYS . 18.4 t-20 -38.54 -35.96 0.22 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.66 -57.05 8.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 5.5 tp10 -53.9 -35.62 61.83 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 124.532 1.133 . . . . 0.0 108.461 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.2 m -75.33 -44.35 45.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.856 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.3 mt -63.76 -30.98 72.01 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.78 -28.82 69.84 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.398 1.061 . . . . 0.0 109.794 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 14.3 mtm-85 -99.12 6.38 46.51 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.573 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.96 17.57 69.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 15.2 m-30 -83.27 174.47 10.7 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.146 -0.527 . . . . 0.0 109.928 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -87.08 151.98 22.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.39 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.18 104.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 O-C-N 125.632 1.832 . . . . 0.0 110.483 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.504 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -87.43 -177.77 48.44 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -164.52 174.98 10.3 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.8 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.6 m -95.14 150.44 20.2 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.048 1.468 . . . . 0.0 107.374 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.214 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 4.0 m120 -147.58 154.09 40.26 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.95 161.0 15.11 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.272 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.547 ' CE2' HD23 ' A' ' 3' ' ' LEU . 67.8 m95 -148.31 155.5 41.37 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 124.544 1.152 . . . . 0.0 108.483 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.45 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 55.9 m -94.88 164.24 13.0 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.375 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -100.69 59.56 0.95 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.468 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 13.0 t . . . . . 0 C--N 1.313 -1.02 1 CA-C-O 111.607 -4.044 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' HG21 ' A' ' 44' ' ' THR . 12.0 mptt -125.49 94.6 4.19 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.651 1.219 . . . . 0.0 108.234 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.487 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 5.9 tt -57.62 163.61 2.4 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.339 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' SG ' ' A' ' 42' ' ' CYS . 6.3 pt -134.85 -41.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.408 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.08 -148.42 9.58 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.331 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.79 178.56 5.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.971 -1.114 . . . . 0.0 109.732 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 t -138.77 54.26 1.75 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 38' ' ' VAL . 25.4 t -138.4 122.63 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 123.808 0.693 . . . . 0.0 109.452 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.56 67.49 3.48 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.22 55.89 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.94 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.74 178.45 8.47 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -81.44 170.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 m120 44.16 28.83 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.367 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 19.3 t80 -57.06 135.26 56.32 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.826 1.329 . . . . 0.0 109.802 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 16' ' ' SER . 24.4 m -92.57 -76.89 0.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 125.177 1.548 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' THR . 7.6 t 91.51 -39.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.43 78.24 1.72 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.677 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 1.8 t -48.51 -57.45 6.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -54.51 -33.23 59.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.12 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.21 -66.92 2.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 42.7 tt0 -47.88 -38.41 16.21 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 56.5 m -74.65 -41.35 60.49 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.691 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.98 -30.07 71.18 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.21 -33.08 74.99 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 124.356 1.035 . . . . 0.0 108.397 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 5.0 mpt_? -94.22 6.14 49.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.952 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.47 75.02 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 10.0 m-85 -77.92 149.31 34.22 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.606 0.827 . . . . 0.0 109.775 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.78 -43.36 8.55 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.864 -1.517 . . . . 0.0 109.028 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.69 -166.97 39.75 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.408 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -161.8 156.0 27.4 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 124.906 1.004 . . . . 0.0 110.626 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.567 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.1 p-80 -156.12 158.98 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.852 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' O ' ' C ' ' A' ' 33' ' ' GLY . 84.1 m -77.78 150.4 34.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.345 0 O-C-N 125.258 1.599 . . . . 0.0 112.21 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 8' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -131.1 136.51 48.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 145.35 40.2 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 34.0 m95 -129.86 156.51 44.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 125.417 1.698 . . . . 0.0 109.185 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 66.2 m -85.75 170.26 12.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 116.59 -2.044 . . . . 0.0 108.079 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 55.53 1.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.173 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.401 HG21 ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 113.079 -3.343 . . . . 0.0 109.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.524 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.583 ' HB2' HG21 ' A' ' 44' ' ' THR . 5.8 tmtt? -117.79 116.34 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.35 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.6 tt -75.75 162.65 28.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.612 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.77 HD11 ' SG ' ' A' ' 40' ' ' CYS . 8.7 pt -134.37 -43.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 125.026 1.454 . . . . 0.0 108.981 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.72 -161.62 23.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -96.45 155.85 16.59 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.012 0.91 . . . . 0.0 109.922 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 5.2 t -114.17 56.7 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.411 ' CG2' HG12 ' A' ' 38' ' ' VAL . 82.7 t -136.33 116.98 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.295 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -75.41 117.58 17.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -27.25 6.82 Favored Glycine 0 N--CA 1.485 1.959 0 O-C-N 124.638 1.211 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.59 172.84 10.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.441 0.73 . . . . 0.0 109.101 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.7 t -81.23 169.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.69 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 m120 42.34 30.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.698 1.249 . . . . 0.0 108.475 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 6.2 t80 -62.31 143.81 56.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.366 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' SER . 12.4 m -89.47 -73.01 0.53 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 124.465 1.103 . . . . 0.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 15' ' ' THR . 5.3 t 89.41 -37.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 18' ' ' CYS . 19.9 p-10 -139.9 70.35 1.36 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.95 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.6 t -39.53 -65.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -41.58 -48.05 3.94 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -60.45 -68.19 1.79 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' CD ' ' NH2' ' A' ' 25' ' ' ARG . 6.8 tp10 -44.31 -32.85 1.42 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 122.312 1.053 . . . . 0.0 109.385 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 4' ' ' ILE . 13.0 m -76.13 -42.56 46.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.474 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' GLY . 25.1 mt -65.12 -30.8 71.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.71 -30.54 71.49 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.327 1.061 . . . . 0.0 109.152 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' NH2' ' CD ' ' A' ' 21' ' ' GLU . 9.0 mtm180 -102.61 7.33 39.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.637 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.87 14.57 68.01 Favored Glycine 0 N--CA 1.491 2.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.213 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 9.9 m-85 -77.41 175.48 9.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.83 0.824 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.31 150.41 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.983 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.15 94.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.858 0 O-C-N 125.867 1.979 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.52 -170.73 28.77 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 124.959 1.035 . . . . 0.0 110.531 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 16.4 p-80 -163.5 172.37 14.55 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.136 -1.032 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 33' ' ' GLY . 69.0 m -81.89 149.95 28.0 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.793 0 O-C-N 125.593 1.808 . . . . 0.0 112.929 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG12 ' CG2' ' A' ' 8' ' ' VAL . 11.5 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.905 0.86 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -149.48 116.45 5.98 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.664 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.77 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.38 133.49 41.92 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.524 ' CE3' ' HB2' ' A' ' 1' ' ' ASP . 67.4 m95 -119.64 156.8 29.73 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.879 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 4' ' ' ILE . 40.1 m -92.39 174.88 7.06 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.997 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -101.03 61.2 0.95 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 124.999 2.333 . . . . 0.0 111.467 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 2' ' ' LYS . 31.3 p . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 112.743 -3.503 . . . . 0.0 110.435 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 158.82 16.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.611 1.194 . . . . 0.0 108.08 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.3 tt -99.42 164.5 12.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.777 HD11 ' SG ' ' A' ' 22' ' ' CYS . 44.8 mt -132.56 -43.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 125.366 1.666 . . . . 0.0 109.396 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.81 -147.03 12.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 53.5 m -96.14 160.42 14.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.808 -0.696 . . . . 0.0 110.236 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.4 t -138.72 27.3 2.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 69.2 t -93.53 135.08 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -79.13 63.84 3.88 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.732 1.27 . . . . 0.0 107.72 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.56 63.56 0.04 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.19 177.64 11.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.542 0.789 . . . . 0.0 109.294 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.2 t -82.45 168.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.781 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.82 27.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.098 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 5.6 t80 -60.73 134.39 57.03 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.134 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -110.64 167.95 9.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 125.166 1.541 . . . . 0.0 109.831 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.7 m -142.14 -47.43 0.35 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.144 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.34 67.82 0.74 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.924 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' HD12 ' A' ' 4' ' ' ILE . 5.5 t -50.01 -64.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -44.62 -33.08 1.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.611 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.38 -55.95 11.29 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 24.2 tt0 -58.97 -30.56 68.01 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.045 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.2 m -78.12 -41.17 35.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.3 -31.41 72.56 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.48 -30.61 71.64 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.761 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -92.76 2.53 56.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.119 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.41 20.38 75.28 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 14.1 m-85 -77.04 173.2 12.08 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.652 0.854 . . . . 0.0 110.019 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 4.6 mptt -71.05 -35.24 71.86 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.525 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 165.67 -177.43 40.89 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -156.3 159.32 29.34 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 21.8 p-80 -163.32 163.13 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.142 -1.029 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' A' ' 33' ' ' GLY . 92.5 m -78.25 151.42 33.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.495 2.578 0 O-C-N 126.471 2.357 . . . . 0.0 111.522 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.6 p . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 5.0 m-20 -134.43 156.31 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -110.84 154.46 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.53 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CD1' ' C ' ' A' ' 40' ' ' CYS . 32.8 m95 -140.35 156.95 46.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.243 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.686 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -87.39 163.62 16.67 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -97.64 53.9 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.316 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 5.0 t . . . . . 0 C--N 1.305 -1.353 1 CA-C-O 111.378 -4.153 . . . . 0.0 111.963 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -154.0 95.55 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 125.948 2.03 . . . . 0.0 108.913 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.0 tt -56.04 162.82 1.75 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.087 0.867 . . . . 0.0 109.323 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.542 HD11 ' SG ' ' A' ' 18' ' ' CYS . 31.1 pt -134.41 -41.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.822 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.61 -147.86 10.94 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.735 -1.222 . . . . 0.0 110.45 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 14' ' ' TYR . 4.2 m -86.78 -178.59 6.37 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.414 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.01 49.77 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG21 HG12 ' A' ' 38' ' ' VAL . 3.4 t -148.95 125.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.087 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.83 103.61 5.99 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 -18.78 3.38 Favored Glycine 0 N--CA 1.491 2.334 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.94 171.77 8.56 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.8 t -82.13 169.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.021 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.17 29.0 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.25 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 13.0 t80 -57.64 147.66 26.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.892 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' SER . 15.6 m -96.23 -70.74 0.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.601 1.188 . . . . 0.0 109.355 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 88.65 -36.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.34 86.71 2.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.863 1.316 . . . . 0.0 109.421 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 t -66.81 -71.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.183 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -41.97 -32.23 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.126 -0.629 . . . . 0.0 109.557 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -59.37 6.19 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.022 1.451 . . . . 0.0 109.569 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 11.4 tp10 -55.67 -35.75 66.35 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.277 0.56 . . . . 0.0 110.103 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.44 -42.75 58.57 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.91 -30.58 70.98 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.94 -36.43 81.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 124.405 1.066 . . . . 0.0 109.395 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.02 16.04 20.69 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.777 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.81 28.82 53.51 Favored Glycine 0 N--CA 1.49 2.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.745 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 4.4 m-85 -75.94 159.82 30.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.959 0.885 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -57.61 -31.22 66.0 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.855 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 160.43 -173.65 37.03 Favored Glycine 0 N--CA 1.484 1.883 0 O-C-N 124.667 1.229 . . . . 0.0 110.639 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.02 155.8 26.96 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 3.6 p-80 -154.33 166.2 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.948 -1.126 . . . . 0.0 110.158 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 57.5 m -76.96 150.09 35.93 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.477 1.42 0 O-C-N 125.815 1.947 . . . . 0.0 113.133 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 8' ' ' VAL . 4.8 m . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.945 0.879 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -151.43 118.1 5.76 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.098 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -98.0 144.71 27.23 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' TRP . 11.2 m95 -127.06 164.96 20.4 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.047 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -96.21 171.42 8.6 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 125.068 1.48 . . . . 0.0 107.195 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' CD ' ' HD1' ' A' ' 31' ' ' HIS . 1.8 tp10 -97.81 54.0 1.13 Allowed 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.896 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 42' ' ' CYS . 31.8 p . . . . . 0 C--N 1.3 -1.554 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.201 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 48.1 mmtt -100.48 104.75 16.16 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 4' ' ' ILE . 7.9 tt -59.04 162.19 4.49 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.904 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.62 HD11 ' SG ' ' A' ' 18' ' ' CYS . 20.8 pt -134.49 -43.09 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 125.027 1.454 . . . . 0.0 109.123 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 -148.09 10.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.1 t -97.29 164.49 12.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.66 1.219 . . . . 0.0 108.863 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -127.77 50.09 2.07 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.284 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 11' ' ' ALA . 33.1 t -130.02 122.09 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.817 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.5 92.53 2.37 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 -6.91 5.71 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . . . -96.41 178.97 5.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.0 t -81.65 168.8 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.972 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 p30 40.0 31.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 125.386 1.679 . . . . 0.0 108.315 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.6 t80 -55.45 137.34 48.5 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 125.327 1.642 . . . . 0.0 109.522 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' SER . 17.7 m -86.59 -73.76 0.45 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.552 1.157 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.6 OUTLIER 89.39 -36.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -137.75 73.77 1.45 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -46.85 -62.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -27.71 5.99 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.313 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.53 -67.43 1.72 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 34.0 tt0 -49.19 -31.83 9.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.2 m -75.86 -43.59 44.87 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 124.286 0.991 . . . . 0.0 108.338 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.89 -31.1 72.16 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.497 1.123 . . . . 0.0 108.05 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.08 -31.27 72.37 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.696 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -91.05 -3.34 57.27 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.533 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.22 12.09 76.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 23.6 m-85 -81.52 163.87 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.583 0.814 . . . . 0.0 110.038 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' GLY . 3.4 mppt? -86.71 169.14 12.92 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.292 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -31.18 99.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 O-C-N 125.647 1.842 . . . . 0.0 110.932 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.41 -165.96 33.6 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.587 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 32.6 p-80 -164.19 171.98 14.27 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.282 -0.959 . . . . 0.0 109.938 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 20.7 m -101.52 147.44 26.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.481 1.697 0 O-C-N 125.664 1.853 . . . . 0.0 112.615 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -153.22 174.38 14.34 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 123.563 0.539 . . . . 0.0 110.242 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -122.53 147.3 46.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 124.782 1.301 . . . . 0.0 107.997 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.537 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.0 m95 -146.72 160.45 42.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.263 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 93.0 m -94.21 -173.01 2.96 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 117.224 -1.79 . . . . 0.0 108.673 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.587 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 5.5 mt-10 -143.88 76.42 1.51 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.072 0.939 . . . . 0.0 110.272 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 115.952 -1.975 . . . . 0.0 109.969 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.422 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 3.1 m-20 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -120.9 109.97 15.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.476 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -71.74 163.33 28.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.832 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 22' ' ' CYS . 4.9 pt -136.53 -41.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 125.17 1.544 . . . . 0.0 108.74 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -163.06 24.99 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -93.52 163.48 13.55 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.354 -0.923 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -123.06 54.49 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.83 121.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.34 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 71.12 4.06 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.95 59.35 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.8 179.71 8.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.5 t -79.24 170.72 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 40.5 30.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.61 1.194 . . . . 0.0 109.511 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 25.0 t80 -52.99 135.16 37.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.642 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 16' ' ' SER . 50.6 m -92.29 -74.58 0.51 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.485 1.116 . . . . 0.0 109.695 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 15' ' ' THR . 3.6 t 90.21 -39.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.4 p-10 -136.84 73.93 1.47 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.245 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 6.7 t -43.91 -57.96 3.02 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -53.54 -36.03 61.36 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -67.01 -70.19 1.18 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.664 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 46.3 tp10 -45.64 -34.01 3.22 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.412 1.101 . . . . 0.0 110.206 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 4' ' ' ILE . 4.2 m -73.23 -43.59 60.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.697 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.34 -30.99 72.02 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.986 1.429 . . . . 0.0 109.166 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.68 7.73 45.76 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.187 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.72 19.62 69.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.558 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 15.4 m-30 -84.29 172.0 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.913 -0.643 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.03 149.43 25.58 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.43 99.46 0.01 OUTLIER Glycine 0 N--CA 1.486 2.021 0 O-C-N 125.744 1.903 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.42 -174.7 35.78 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 10.9 p-80 -163.94 174.43 11.45 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.19 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' O ' ' C ' ' A' ' 33' ' ' GLY . 99.3 m -90.94 152.58 20.66 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.492 2.414 0 O-C-N 126.058 2.099 . . . . 0.0 111.595 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -125.93 136.29 52.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.233 0.958 . . . . 0.0 109.805 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.6 140.47 38.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.1 m95 -129.66 162.67 27.81 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.04 -1.437 . . . . 0.0 107.851 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 80.9 m -95.21 172.25 8.23 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 117.269 -1.772 . . . . 0.0 108.382 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -101.16 61.23 0.94 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 124.754 2.216 . . . . 0.0 112.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 36.4 p . . . . . 0 C--N 1.305 -1.364 0 CA-C-O 112.489 -3.624 . . . . 0.0 111.252 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.41 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 3.5 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -110.67 98.18 7.41 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.967 -1.469 . . . . 0.0 109.089 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.58 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 8.1 tt -56.16 161.47 2.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.077 0.861 . . . . 0.0 109.062 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' N ' HD23 ' A' ' 3' ' ' LEU . 19.8 pt -136.26 -41.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 124.823 1.327 . . . . 0.0 109.396 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.26 -148.59 9.62 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 124.86 1.35 . . . . 0.0 110.156 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.7 m -94.42 -172.45 2.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.777 -0.711 . . . . 0.0 109.812 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' VAL . 24.5 t -152.89 34.91 0.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 38' ' ' VAL . 2.0 t -126.97 127.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -78.73 62.15 3.18 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 44.47 0.02 OUTLIER Glycine 0 N--CA 1.487 2.055 0 CA-C-N 114.253 -1.34 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.23 179.06 9.09 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -78.2 167.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.634 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.47 29.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.988 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -52.1 135.77 30.86 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 124.902 1.376 . . . . 0.0 110.173 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.513 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.5 t -120.65 175.58 5.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 125.125 1.516 . . . . 0.0 108.931 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.7 -50.5 0.41 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.126 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' CYS . 7.7 p-10 -109.12 69.26 0.7 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.434 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 4' ' ' ILE . 7.6 t -38.26 -58.58 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -45.63 -50.28 13.49 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.311 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -61.61 -65.06 3.47 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 6.1 tp10 -41.19 -37.1 0.85 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 124.376 1.071 . . . . 0.0 108.627 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.646 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.5 m -75.56 -43.9 46.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.517 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 22.2 mt -62.75 -30.29 71.33 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.09 -32.84 74.55 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.261 0.975 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 18.6 mtm-85 -92.18 3.79 54.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.843 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 12.89 83.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 21.8 m-85 -89.89 170.04 10.72 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.994 0.902 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 43' ' ' GLU . 34.3 mtpt -84.64 154.86 22.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.446 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -34.98 96.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 O-C-N 125.341 1.65 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -69.45 -170.83 7.6 Favored Glycine 0 N--CA 1.48 1.607 0 O-C-N 125.386 1.286 . . . . 0.0 110.893 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -161.94 171.46 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.578 -1.311 . . . . 0.0 110.455 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' C ' ' A' ' 33' ' ' GLY . 87.0 m -92.04 151.45 20.45 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.492 2.415 0 O-C-N 125.667 1.855 . . . . 0.0 112.509 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 8' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 35.5 m120 -120.94 137.63 54.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 124.156 0.91 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -107.36 147.28 30.53 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 65.2 m95 -137.06 152.49 50.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 84.2 m -86.45 -171.59 3.62 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.051 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -142.73 74.46 1.45 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 59.7 p . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 112.973 -3.394 . . . . 0.0 109.573 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HE2' ' OH ' ' A' ' 27' ' ' TYR . 3.6 tmtm? -97.73 107.18 19.62 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.7 tt -64.32 162.69 14.36 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.077 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 ' SG ' ' A' ' 18' ' ' CYS . 18.3 pt -135.73 -39.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.117 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 176.33 -148.1 8.96 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.433 ' O ' ' HB ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -104.34 167.37 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.185 -1.008 . . . . 0.0 109.765 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 56.1 m -134.62 43.87 2.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.94 123.79 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 124.779 1.299 . . . . 0.0 109.08 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 73.57 4.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.08 52.08 0.02 OUTLIER Glycine 0 N--CA 1.488 2.102 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.152 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.67 176.57 10.82 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.47 170.64 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.408 ' H ' HG12 ' A' ' 12' ' ' VAL . 35.3 m-20 42.49 30.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.569 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.37 134.28 56.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.999 1.437 . . . . 0.0 109.965 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 6' ' ' SER . 2.8 m -120.46 173.84 6.91 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 124.807 1.317 . . . . 0.0 109.107 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.0 t -142.36 -50.04 0.37 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.919 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -102.58 66.42 0.96 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.057 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.6 t -43.15 -71.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 30' ' ' GLY . 1.7 t-20 -43.64 -28.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.075 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.48 -60.78 4.51 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 1.1 tt0 -56.26 -31.49 63.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 10.9 m -77.1 -41.91 40.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.08 -29.45 70.59 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.8 mt -65.78 -30.41 71.06 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 124.308 1.005 . . . . 0.0 109.309 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -86.94 0.85 54.38 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.613 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.79 14.93 76.67 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.321 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 18.9 m-85 -79.24 140.7 37.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.495 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -43.39 -50.21 6.87 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.334 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.04 169.3 40.83 Favored Glycine 0 N--CA 1.481 1.662 0 O-C-N 125.213 1.571 . . . . 0.0 110.445 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.715 ' H ' ' ND2' ' A' ' 19' ' ' ASN . . . -148.51 154.17 25.68 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -149.85 160.6 43.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 21.0 m -85.06 146.54 27.11 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.484 1.842 0 O-C-N 126.133 2.145 . . . . 0.0 111.95 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.34 175.67 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -121.3 144.94 48.36 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 50.1 m95 -146.95 158.03 43.8 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.514 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 89.7 m -88.33 -174.9 4.81 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 117.837 -1.545 . . . . 0.0 108.11 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.271 44.6 tt0 -141.72 73.66 1.42 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 124.083 0.864 . . . . 0.0 110.364 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 45.3 p . . . . . 0 C--N 1.295 -1.783 0 O-C-N 125.24 1.587 . . . . 0.0 111.675 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 11.9 tptt -134.18 100.51 4.73 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.241 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 4' ' ' ILE . 8.8 tt -59.45 161.56 5.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.609 HD11 ' SG ' ' A' ' 18' ' ' CYS . 9.0 pt -135.82 -42.58 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.727 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.58 -148.39 9.04 Favored Glycine 0 N--CA 1.482 1.703 0 O-C-N 124.987 1.429 . . . . 0.0 109.983 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.475 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 25.1 t -102.61 171.57 7.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.318 -1.353 . . . . 0.0 108.639 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 44.4 t -144.32 40.99 1.35 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.659 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.268 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.58 68.08 3.6 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.95 50.17 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.23 178.41 10.21 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -84.61 168.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.31 29.5 0.23 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.837 1.336 . . . . 0.0 108.225 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE1' ' O ' ' A' ' 15' ' ' THR . 18.6 t80 -57.85 134.24 56.12 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.893 1.37 . . . . 0.0 110.073 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.0 t -117.73 -179.76 3.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.741 1.276 . . . . 0.0 109.15 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' THR . 0.7 OUTLIER -142.05 -49.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.682 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 18' ' ' CYS . 10.5 p-10 -105.24 66.15 0.74 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.096 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.1 t -37.77 -71.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.512 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 59.9 t30 -37.19 -42.85 0.47 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.618 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -64.78 -55.03 24.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' NH2' ' A' ' 25' ' ' ARG . 18.0 tt0 -56.79 -29.94 63.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' SG ' HD13 ' A' ' 4' ' ' ILE . 1.9 m -76.08 -45.45 33.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.11 -32.29 71.97 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.78 -34.75 76.42 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.802 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.605 HH11 ' CA ' ' A' ' 4' ' ' ILE . 4.4 mtm180 -89.5 -0.42 57.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.309 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.85 12.6 79.53 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 18.2 m-30 -83.98 164.69 19.18 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.251 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -87.92 172.38 9.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.369 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -27.89 106.2 0.01 OUTLIER Glycine 0 N--CA 1.485 1.961 0 O-C-N 125.964 2.04 . . . . 0.0 110.834 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.2 -170.17 33.44 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 6.6 p-80 -166.08 176.83 7.4 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 60.4 m -100.68 147.38 26.07 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.768 0 O-C-N 126.126 2.141 . . . . 0.0 112.046 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 8.7 m-80 -155.36 176.38 12.66 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.97 147.81 44.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 122.351 1.072 . . . . 0.0 108.319 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 52.2 m95 -146.16 162.02 38.92 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.399 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.2 m -94.61 -173.51 3.04 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 117.038 -1.865 . . . . 0.0 108.868 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 11.5 tt0 -142.68 75.79 1.5 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.959 0.787 . . . . 0.0 109.944 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 115.057 -2.402 . . . . 0.0 110.439 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 9.7 mptt -130.39 94.24 3.62 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 124.876 1.36 . . . . 0.0 109.303 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -55.66 163.53 1.33 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 113.678 -1.601 . . . . 0.0 108.166 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.686 HD13 ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -134.85 -43.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.111 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.47 -150.78 12.42 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 38.4 m -95.88 170.29 9.4 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.504 -0.848 . . . . 0.0 109.858 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.1 t -140.19 43.81 1.9 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 97.8 t -119.7 129.92 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.43 74.15 4.98 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.25 58.01 0.04 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-N 113.292 -1.777 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.39 173.91 16.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.532 0.784 . . . . 0.0 109.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.4 172.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 41.34 30.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.694 1.246 . . . . 0.0 108.754 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' N ' ' C ' ' A' ' 12' ' ' VAL . 30.0 t80 -51.69 138.79 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.5 m -91.75 -75.21 0.48 Allowed 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.647 1.217 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.2 OUTLIER 88.68 -35.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 20' ' ' GLY . 6.1 p-10 -138.96 72.55 1.41 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.8 t -41.55 -71.46 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -42.23 -32.55 0.5 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.307 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.57 -60.81 5.14 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 tp10 -55.38 -32.78 62.89 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.654 0.74 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.0 m -74.72 -43.89 52.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.642 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -30.78 71.6 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.464 1.102 . . . . 0.0 108.242 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.17 -28.41 70.03 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.729 1.268 . . . . 0.0 109.605 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.39 -1.07 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.484 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.65 82.27 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.552 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 19.2 m-85 -79.52 170.86 15.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.95 0.881 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.626 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.7 156.57 20.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.742 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.31 103.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.102 0 O-C-N 125.166 1.541 . . . . 0.0 110.352 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -83.11 -171.23 47.19 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.99 173.92 11.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.547 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 99.5 m -93.93 150.62 20.2 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 125.05 1.469 . . . . 0.0 107.678 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -36.95 140.32 0.31 Allowed Glycine 0 N--CA 1.483 1.821 0 O-C-N 125.63 1.831 . . . . 0.0 111.022 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -81.6 -48.88 11.2 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.323 -0.939 . . . . 0.0 109.149 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.29 36.1 4.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.913 0.758 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.78 49.39 0.09 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.245 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -48.4 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.329 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' ALA . 3.0 p -170.25 -40.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 38.1 m-20 -119.6 150.64 39.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.736 1.273 . . . . 0.0 109.846 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -107.81 155.79 19.85 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD12 ' A' ' 3' ' ' LEU . 24.7 m95 -142.98 158.67 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.193 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 82.5 m -94.37 164.5 12.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.808 -1.957 . . . . 0.0 107.551 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -97.55 55.43 1.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.209 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.626 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 12.5 t . . . . . 0 C--N 1.31 -1.152 0 CA-C-O 111.85 -3.928 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 5.2 mmtm -100.98 111.4 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 4' ' ' ILE . 5.2 tt -66.49 163.7 17.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.126 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.579 HD13 ' SG ' ' A' ' 22' ' ' CYS . 21.8 pt -135.09 -41.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.35 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.24 -148.93 9.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -99.43 177.96 5.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.811 -0.695 . . . . 0.0 109.743 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -146.23 49.56 1.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.9 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 38' ' ' VAL . 3.9 t -144.85 126.88 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.675 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.88 61.66 1.96 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 125.215 1.572 . . . . 0.0 107.013 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.67 39.51 0.03 OUTLIER Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.35 176.66 11.74 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.265 0.627 . . . . 0.0 109.435 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.41 171.4 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 12' ' ' VAL . 13.8 m120 42.22 30.09 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.115 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -51.41 135.7 26.83 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 16' ' ' SER . 1.1 t -123.63 -178.13 3.94 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.802 1.314 . . . . 0.0 108.594 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 15' ' ' THR . 38.7 t -143.12 -56.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.394 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -101.67 70.2 1.25 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.791 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 11.2 t -41.18 -72.85 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -41.0 -32.67 0.25 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.272 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.18 -60.57 5.09 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.554 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 25' ' ' ARG . 5.3 tt0 -58.32 -29.32 65.8 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 4' ' ' ILE . 7.4 m -77.03 -42.5 38.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.68 -30.1 71.25 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -33.48 74.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.553 HH11 HG22 ' A' ' 4' ' ' ILE . 2.0 mtm180 -86.68 -2.27 58.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.155 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.54 14.32 76.32 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.3 m-85 -77.66 148.93 34.77 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.175 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -47.93 -42.2 26.66 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.508 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.24 -168.79 40.23 Favored Glycine 0 N--CA 1.483 1.799 0 O-C-N 125.165 1.541 . . . . 0.0 110.158 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.44 160.72 32.97 Favored Glycine 0 N--CA 1.484 1.876 0 O-C-N 124.67 0.865 . . . . 0.0 111.208 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.31 168.01 28.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.286 -0.957 . . . . 0.0 109.357 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 73.0 m -85.54 151.3 24.04 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 37' ' ' ASN . . . -26.37 -83.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 O-C-N 125.652 1.845 . . . . 0.0 112.437 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -145.17 -51.31 0.26 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 125.091 1.112 . . . . 0.0 109.329 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.6 t80 -169.74 81.35 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.27 0.981 . . . . 0.0 110.328 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 82.51 35.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.582 1.176 . . . . 0.0 109.464 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 11.1 t-20 -61.97 -31.33 71.67 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.782 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.409 HG23 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 86.29 7.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.64 1.213 . . . . 0.0 107.806 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -143.04 132.15 23.09 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -109.41 137.68 46.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -125.33 157.49 36.58 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 125.271 1.607 . . . . 0.0 108.043 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 98.7 m -84.38 161.28 20.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 116.341 -2.143 . . . . 0.0 107.992 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -99.69 57.18 1.0 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.954 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.656 ' HA ' ' CE ' ' A' ' 28' ' ' LYS . 14.2 t . . . . . 0 C--N 1.31 -1.142 0 CA-C-O 112.695 -3.526 . . . . 0.0 109.187 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 9.3 mptt -115.91 102.57 9.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.554 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 4.8 tt -56.33 162.38 2.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.051 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.645 HD11 ' SG ' ' A' ' 18' ' ' CYS . 2.9 pt -133.98 -45.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.79 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.25 -148.94 10.26 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 125.033 1.458 . . . . 0.0 109.861 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.65 155.83 17.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.139 -1.031 . . . . 0.0 109.279 -179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 43.0 t -124.01 48.77 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 59.7 t -125.39 118.88 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.571 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 96.04 2.63 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.01 -9.76 5.69 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.451 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -96.31 176.71 5.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -82.28 168.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 114.178 -1.373 . . . . 0.0 107.987 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 42.31 30.08 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.461 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.7 t80 -53.44 140.62 27.26 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 125.28 1.613 . . . . 0.0 109.633 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' SER . 3.4 m -88.0 -74.28 0.46 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 124.687 1.242 . . . . 0.0 109.733 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 90.06 -38.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -138.19 72.86 1.42 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -42.57 -72.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -39.08 -32.62 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.16 -60.19 4.6 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 4' ' ' ILE . 39.5 tp10 -55.43 -32.17 62.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.137 0.97 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.9 m -75.75 -44.89 39.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.105 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.22 -31.56 72.73 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 124.513 1.133 . . . . 0.0 108.202 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.757 1.286 . . . . 0.0 109.948 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.602 ' NH1' ' HA ' ' A' ' 4' ' ' ILE . 48.8 mtt180 -93.6 -4.12 51.38 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.158 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.03 79.95 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 m-30 -81.22 162.6 23.5 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.354 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' NZ ' ' OG1' ' A' ' 44' ' ' THR . 2.3 mppt? -79.71 163.61 24.38 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -32.12 104.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.479 1.737 . . . . 0.0 110.436 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -165.44 39.08 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.837 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -163.95 173.4 12.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 109.585 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 52.6 m -98.56 146.27 25.97 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.287 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 21.82 -124.05 0.01 OUTLIER Glycine 0 N--CA 1.483 1.778 0 O-C-N 126.292 2.245 . . . . 0.0 112.033 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.9 t -159.91 -44.53 0.05 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 125.274 1.22 . . . . 0.0 108.869 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 21.4 t80 -172.39 85.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.502 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 84.39 53.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.866 1.354 . . . . 0.0 109.173 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 11.4 t-20 -106.47 -154.09 0.51 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.099 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.587 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 16.9 m -164.45 31.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -152.55 174.75 13.54 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 123.532 0.52 . . . . 0.0 110.369 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -123.95 147.62 47.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 36.8 m95 -145.77 160.59 41.53 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.615 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.9 m -93.26 -175.94 3.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 117.327 -1.749 . . . . 0.0 108.288 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 39.8 mt-10 -142.97 75.78 1.5 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 124.358 1.036 . . . . 0.0 110.53 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' NZ ' ' A' ' 28' ' ' LYS . 1.1 t . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 115.706 -2.092 . . . . 0.0 110.725 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -108.28 103.8 13.05 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.3 tt -59.88 163.08 4.84 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.303 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.571 HD11 ' SG ' ' A' ' 18' ' ' CYS . 14.9 pt -135.07 -41.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 125.063 1.477 . . . . 0.0 109.257 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.77 -147.02 9.8 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.131 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.53 -175.3 3.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.797 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 13.7 t -150.17 54.36 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 ' CG2' HG23 ' A' ' 38' ' ' VAL . 2.6 t -146.73 129.92 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.985 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 67.89 5.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.64 42.69 0.02 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 174.77 12.4 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 13' ' ' ASN . 2.4 t -79.98 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.77 1.294 . . . . 0.0 107.655 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.416 ' H ' HG12 ' A' ' 12' ' ' VAL . 4.4 m120 42.71 29.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.376 1.047 . . . . 0.0 108.876 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 18.6 t80 -47.43 136.39 9.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.207 1.567 . . . . 0.0 109.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 16' ' ' SER . 37.2 m -96.85 -75.79 0.53 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 124.675 1.234 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' THR . 1.6 t 89.89 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 p-10 -137.35 75.78 1.55 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.133 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.571 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -44.5 -59.8 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 13.6 t-20 -50.86 -33.17 22.76 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.221 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -70.77 -63.93 3.01 Favored Glycine 0 N--CA 1.486 1.973 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.482 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 26.7 tt0 -53.68 -30.77 44.97 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m -75.92 -43.16 46.45 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.1 -31.31 72.46 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.578 1.174 . . . . 0.0 108.234 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 25' ' ' ARG . 2.3 mt -62.97 -28.27 69.97 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.719 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.77 -2.76 40.38 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.056 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 10.17 80.46 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.53 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.9 m-85 -80.41 167.07 20.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.989 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.24 166.06 14.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.853 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.485 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -33.1 98.61 0.01 OUTLIER Glycine 0 N--CA 1.485 1.954 0 O-C-N 125.584 1.803 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -73.88 -166.78 13.98 Favored Glycine 0 N--CA 1.48 1.63 0 O-C-N 125.84 1.553 . . . . 0.0 110.324 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.425 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 50.1 p-80 -162.48 171.16 17.52 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.898 -1.151 . . . . 0.0 110.366 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -92.24 150.46 20.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 37' ' ' ASN . . . -39.07 -81.31 0.02 OUTLIER Glycine 0 N--CA 1.472 1.096 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.645 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -160.94 -74.29 0.06 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.735 0.779 . . . . 0.0 109.79 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -129.77 -89.29 0.49 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 113.779 -1.555 . . . . 0.0 111.495 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.35 1.28 29.48 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 123.852 0.72 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' CG ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 t-20 -45.71 -42.03 11.27 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.863 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 8' ' ' VAL . 9.1 p 46.16 24.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 125.075 1.484 . . . . 0.0 108.792 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 37' ' ' ASN . 3.4 m-20 -133.15 123.24 25.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.722 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 143.54 27.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 19.1 m95 -130.06 151.85 50.15 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.478 -2.147 . . . . 0.0 109.339 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 92.2 m -89.75 162.32 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 116.546 -2.061 . . . . 0.0 107.7 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.16 57.25 1.06 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.593 1.187 . . . . 0.0 111.433 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.454 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 3.2 t . . . . . 0 C--N 1.304 -1.406 1 CA-C-O 111.519 -4.086 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -125.93 127.31 45.78 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.439 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 4' ' ' ILE . 1.6 tm? -73.0 163.57 27.98 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.312 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.601 HG21 ' SG ' ' A' ' 22' ' ' CYS . 8.5 pt -136.77 -39.96 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 124.928 1.392 . . . . 0.0 108.684 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.37 -159.18 32.43 Favored Glycine 0 N--CA 1.486 2.022 0 O-C-N 124.799 1.312 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 167.16 11.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.308 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.74 47.29 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.565 HG21 HG22 ' A' ' 38' ' ' VAL . 69.9 t -119.26 127.43 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.176 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -77.58 70.3 3.94 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.471 -1.241 . . . . 0.0 107.709 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.91 56.9 0.04 OUTLIER Glycine 0 N--CA 1.485 1.954 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.6 173.82 15.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.387 0.698 . . . . 0.0 109.195 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.2 t -80.86 171.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.42 ' H ' HG12 ' A' ' 12' ' ' VAL . 50.9 m-20 43.61 28.76 0.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.941 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' N ' ' C ' ' A' ' 12' ' ' VAL . 38.6 t80 -51.99 140.53 20.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.841 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' SER . 4.9 m -89.95 -75.43 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 124.781 1.301 . . . . 0.0 109.792 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER 87.54 -36.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.64 74.23 1.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 123.941 0.776 . . . . 0.0 109.88 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 t -42.7 -72.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.5 -27.79 1.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.317 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.9 -63.05 3.85 Favored Glycine 0 N--CA 1.486 2.003 0 O-C-N 125.137 1.523 . . . . 0.0 109.628 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 11.4 tp10 -51.94 -37.1 51.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.4 m -72.34 -42.45 65.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.637 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -30.69 71.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.85 -33.55 75.5 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 124.716 1.26 . . . . 0.0 109.333 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 1.3 mpt_? -97.87 14.05 28.5 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.89 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 54.91 30.17 52.73 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.636 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 8.5 m-85 -76.85 178.04 7.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.53 -33.44 64.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.359 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 159.68 179.57 34.58 Favored Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.418 1.074 . . . . 0.0 110.555 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.64 156.99 27.79 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.3 p-80 -153.61 157.39 39.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.044 -1.078 . . . . 0.0 109.757 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 95.3 m -78.19 150.11 33.59 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.52 154.33 3.41 Favored Glycine 0 N--CA 1.483 1.821 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.205 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.2 t -96.42 -68.04 0.82 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.758 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -97.33 21.69 9.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.638 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.97 53.55 0.1 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.608 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' O ' HG12 ' A' ' 38' ' ' VAL . 18.5 p30 -62.08 -154.53 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.441 1.088 . . . . 0.0 108.231 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 88.77 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -145.95 157.9 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.488 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -117.47 150.7 38.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.592 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CE2' HD23 ' A' ' 3' ' ' LEU . 40.5 m95 -133.66 168.83 17.98 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 125.063 1.477 . . . . 0.0 108.535 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -100.09 161.5 13.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 55.52 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.42 1.088 . . . . 0.0 109.214 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 42' ' ' CYS . 71.3 p . . . . . 0 C--N 1.302 -1.5 0 CA-C-O 114.641 -2.599 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 10.2 mmtt -97.9 106.01 18.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.28 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.607 HD12 ' CH2' ' A' ' 41' ' ' TRP . 9.1 tt -56.53 162.42 2.21 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.556 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.629 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 10.2 pt -136.85 -41.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.537 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.6 -152.03 12.05 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 1.4 m -93.96 166.61 12.08 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.514 0.773 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.8 t -136.04 47.16 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.4 127.52 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.13 68.5 3.27 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.39 59.18 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.21 177.07 11.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.575 0.809 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -81.51 170.8 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.643 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.22 29.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.495 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 36.3 t80 -50.91 140.22 15.72 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.77 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.4 m -92.17 -74.28 0.52 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 124.819 1.325 . . . . 0.0 109.437 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.9 OUTLIER 89.08 -37.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -138.29 75.02 1.5 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.816 0.697 . . . . 0.0 109.795 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -42.54 -70.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.502 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 11.0 t-20 -39.41 -33.74 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.767 0.667 . . . . 0.0 109.568 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.12 -56.89 6.59 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HH21 ' A' ' 25' ' ' ARG . 1.2 tp10 -55.8 -34.61 65.48 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.7 m -75.16 -45.21 42.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.38 -31.44 72.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -34.4 74.65 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.426 1.079 . . . . 0.0 109.964 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.668 HH21 ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -94.23 1.69 55.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.996 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 13.36 82.1 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 124.122 0.889 . . . . 0.0 110.911 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 22.4 m-85 -83.13 168.45 16.84 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.893 0.854 . . . . 0.0 109.928 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.47 162.69 17.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.664 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.502 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -32.45 102.47 0.01 OUTLIER Glycine 0 N--CA 1.484 1.893 0 O-C-N 125.444 1.715 . . . . 0.0 111.355 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.589 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -81.51 -169.48 42.4 Favored Glycine 0 N--CA 1.481 1.643 0 O-C-N 125.488 1.346 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -163.42 177.81 8.59 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.845 -1.178 . . . . 0.0 109.905 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.3 m -99.06 149.83 22.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.83 145.05 11.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.155 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.3 t -91.86 -65.27 1.02 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 125.041 1.083 . . . . 0.0 109.048 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -95.38 21.09 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.61 53.61 0.11 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 38' ' ' VAL . 8.8 t-20 -60.48 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 125.085 1.491 . . . . 0.0 108.152 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 37' ' ' ASN . 2.6 m 75.9 -1.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 21.4 m-80 -151.11 154.67 37.4 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.971 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -111.36 152.26 27.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.607 ' CH2' HD12 ' A' ' 3' ' ' LEU . 38.6 m95 -144.45 158.65 43.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.737 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.629 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 94.6 m -93.57 -175.83 3.9 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 117.252 -1.779 . . . . 0.0 108.574 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.54 76.12 1.49 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.782 1.277 . . . . 0.0 110.599 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--N 1.297 -1.705 0 CA-C-N 112.604 -2.089 . . . . 0.0 110.256 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -108.69 110.94 22.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.528 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 tt -62.49 162.15 10.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.054 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 5' ' ' GLY . 16.2 pt -134.08 -43.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 125.137 1.523 . . . . 0.0 109.495 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 179.85 -148.74 8.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 15' ' ' THR . 3.3 m -99.32 170.18 8.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.957 -0.621 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 8.8 t -136.44 51.34 2.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 17.6 t -131.64 128.93 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.851 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -78.7 61.39 2.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.68 64.2 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.58 -179.83 5.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 124.419 0.717 . . . . 0.0 109.159 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.68 167.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.644 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.89 29.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.378 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -57.65 134.96 56.64 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -117.46 177.81 4.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 125.064 1.478 . . . . 0.0 109.89 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.5 t -142.05 -49.04 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.5 p-10 -111.61 72.44 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.414 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' HD11 ' A' ' 4' ' ' ILE . 5.6 t -40.56 -41.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -61.41 -50.39 73.01 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.277 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -61.91 -57.41 17.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG3' ' NH2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -50.13 -33.57 19.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.9 m -76.21 -43.31 42.95 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.61 -30.93 71.97 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.869 1.356 . . . . 0.0 108.278 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.33 -31.73 72.39 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.012 0.911 . . . . 0.0 109.699 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 21' ' ' GLU . 2.3 mtm-85 -94.4 -1.0 54.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.785 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.83 6.59 79.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 16.6 m-30 -85.47 164.39 17.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.702 0.763 . . . . 0.0 109.956 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -87.69 164.98 15.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.531 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -31.91 97.56 0.01 OUTLIER Glycine 0 N--CA 1.487 2.036 0 O-C-N 125.802 1.939 . . . . 0.0 110.8 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -77.4 -168.12 29.9 Favored Glycine 0 N--CA 1.48 1.617 0 O-C-N 125.393 1.29 . . . . 0.0 110.209 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -163.1 172.25 15.18 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.069 -1.066 . . . . 0.0 110.08 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 63.8 m -83.74 150.51 25.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -29.0 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.543 0 O-C-N 125.478 1.736 . . . . 0.0 113.187 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.3 p -148.18 -56.49 0.22 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.096 0.951 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 10.0 t80 -172.49 85.31 0.07 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.84 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 88.27 32.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.904 1.378 . . . . 0.0 109.089 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.422 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 13.3 t-20 -79.98 -7.25 58.7 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.57 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 18.9 m 42.98 29.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 124.578 1.174 . . . . 0.0 109.982 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -152.75 128.24 10.0 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.021 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.22 138.65 38.88 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.528 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 72.3 m95 -125.38 152.29 44.99 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.307 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 68.4 m -84.46 163.26 19.57 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 117.457 -1.697 . . . . 0.0 108.613 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -97.13 54.34 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.966 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.429 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 4.5 t . . . . . 0 N--CA 1.485 1.281 1 CA-C-O 111.405 -4.141 . . . . 0.0 111.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.467 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 1.6 p30 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 44' ' ' THR . 15.7 mmtp -99.79 102.19 13.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.311 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.1 tt -58.6 163.08 3.42 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.577 1.173 . . . . 0.0 108.922 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.548 HD11 ' SG ' ' A' ' 18' ' ' CYS . 17.9 pt -134.65 -42.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 124.693 1.246 . . . . 0.0 109.088 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.75 21.39 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 t -93.77 165.11 12.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.671 -1.265 . . . . 0.0 108.465 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -129.88 37.03 3.99 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.9 t -110.69 124.84 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -79.53 69.34 5.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.54 59.19 0.02 OUTLIER Glycine 0 N--CA 1.486 1.988 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.212 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.39 8.93 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.5 t -80.82 169.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.166 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 42.2 29.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.891 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -60.3 134.7 57.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 125.037 1.461 . . . . 0.0 109.766 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -116.72 170.62 8.45 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 124.817 1.323 . . . . 0.0 108.941 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -141.59 -47.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.678 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -105.15 66.57 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.724 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 4' ' ' ILE . 10.2 t -44.15 -65.01 0.56 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -49.25 -30.35 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.625 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.68 -65.67 2.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.509 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 tt0 -52.76 -31.37 37.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 4' ' ' ILE . 16.4 m -77.16 -40.34 45.79 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.23 -29.79 70.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.79 -32.83 74.08 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.057 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.509 HH11 HG22 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -90.39 1.2 56.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.454 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.14 19.18 79.54 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 16.9 m-85 -76.89 167.33 22.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -64.97 -37.34 87.34 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.511 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.31 -166.71 39.81 Favored Glycine 0 N--CA 1.485 1.905 0 O-C-N 124.79 1.306 . . . . 0.0 110.468 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -163.34 155.68 27.14 Favored Glycine 0 N--CA 1.489 2.198 0 O-C-N 124.866 0.98 . . . . 0.0 111.091 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 55.9 p-80 -163.19 159.27 22.7 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.17 -1.015 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 90.1 m -74.45 149.73 40.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -22.33 -92.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 O-C-N 126.287 2.242 . . . . 0.0 112.473 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.9 t -178.2 -64.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.844 0.967 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -122.75 58.18 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 123.961 0.788 . . . . 0.0 109.776 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -164.44 -40.9 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 43.98 62.94 1.77 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.753 -1.567 . . . . 0.0 107.903 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p -122.83 -43.46 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.914 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.08 150.79 51.99 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 124.166 0.916 . . . . 0.0 108.988 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.79 147.92 34.67 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.681 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.461 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 38.8 m95 -134.23 158.99 42.31 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.579 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 69.7 m -87.13 172.24 10.09 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 117.133 -1.827 . . . . 0.0 108.12 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.54 58.16 0.85 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 124.016 1.865 . . . . 0.0 110.708 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.476 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 21.4 p . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 112.061 -3.828 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 10.4 mptt -134.99 126.83 29.33 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.733 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 4' ' ' ILE . 2.2 tm? -84.2 163.6 19.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 125.335 1.647 . . . . 0.0 107.826 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' SG ' ' A' ' 22' ' ' CYS . 3.4 pt -136.66 -40.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.995 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -163.49 37.19 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 124.876 1.36 . . . . 0.0 110.298 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.54 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 30.8 t -90.31 172.06 9.03 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.263 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' OG ' ' A' ' 6' ' ' SER . 48.2 t -137.77 41.93 2.32 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.007 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.604 HG21 HG22 ' A' ' 38' ' ' VAL . 76.7 t -116.97 124.97 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.439 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 62.84 2.38 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.54 58.74 0.01 OUTLIER Glycine 0 N--CA 1.483 1.79 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.87 -179.84 7.89 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.82 165.74 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.175 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 41.43 30.65 0.14 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.908 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 15' ' ' THR . 2.9 t80 -65.35 134.42 53.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.309 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.564 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.7 m -111.49 177.45 4.65 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 124.633 1.208 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m -142.81 -50.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' GLY . 13.8 p-10 -102.93 68.94 1.02 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' A' ' 17' ' ' ASP . 14.1 t -41.53 -70.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' CYS . 18.4 t-20 -38.54 -35.96 0.22 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.66 -57.05 8.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 5.5 tp10 -53.9 -35.62 61.83 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 124.532 1.133 . . . . 0.0 108.461 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.2 m -75.33 -44.35 45.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.856 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.3 mt -63.76 -30.98 72.01 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.78 -28.82 69.84 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.398 1.061 . . . . 0.0 109.794 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 14.3 mtm-85 -99.12 6.38 46.51 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.573 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.96 17.57 69.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 15.2 m-30 -83.27 174.47 10.7 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.146 -0.527 . . . . 0.0 109.928 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -87.08 151.98 22.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.39 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.18 104.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 O-C-N 125.632 1.832 . . . . 0.0 110.483 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.504 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -87.43 -177.77 48.44 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -164.52 174.98 10.3 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.8 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.6 m -95.14 150.44 20.2 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.048 1.468 . . . . 0.0 107.374 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.18 147.52 2.58 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 p -92.87 -69.29 0.75 Allowed 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.27 0.629 . . . . 0.0 109.319 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -95.0 17.51 13.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.056 0.847 . . . . 0.0 110.094 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.52 53.79 0.11 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.724 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 32' ' ' CYS . 10.4 t-20 -60.87 -155.57 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 88.37 -14.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 4.0 m120 -147.58 154.09 40.26 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.95 161.0 15.11 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.272 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.547 ' CE2' HD23 ' A' ' 3' ' ' LEU . 67.8 m95 -148.31 155.5 41.37 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 124.544 1.152 . . . . 0.0 108.483 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.45 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 55.9 m -94.88 164.24 13.0 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.375 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -100.69 59.56 0.95 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.468 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 13.0 t . . . . . 0 C--N 1.313 -1.02 1 CA-C-O 111.607 -4.044 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' HG21 ' A' ' 44' ' ' THR . 12.0 mptt -125.49 94.6 4.19 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.651 1.219 . . . . 0.0 108.234 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.487 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 5.9 tt -57.62 163.61 2.4 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.339 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' SG ' ' A' ' 42' ' ' CYS . 6.3 pt -134.85 -41.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.408 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.08 -148.42 9.58 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.331 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.79 178.56 5.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.971 -1.114 . . . . 0.0 109.732 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 t -138.77 54.26 1.75 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 38' ' ' VAL . 25.4 t -138.4 122.63 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 123.808 0.693 . . . . 0.0 109.452 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.56 67.49 3.48 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.22 55.89 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.94 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.74 178.45 8.47 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -81.44 170.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 m120 44.16 28.83 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.367 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 19.3 t80 -57.06 135.26 56.32 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.826 1.329 . . . . 0.0 109.802 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 16' ' ' SER . 24.4 m -92.57 -76.89 0.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 125.177 1.548 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' THR . 7.6 t 91.51 -39.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.43 78.24 1.72 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.677 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 1.8 t -48.51 -57.45 6.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -54.51 -33.23 59.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.12 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.21 -66.92 2.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 42.7 tt0 -47.88 -38.41 16.21 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 56.5 m -74.65 -41.35 60.49 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.691 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.98 -30.07 71.18 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.21 -33.08 74.99 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 124.356 1.035 . . . . 0.0 108.397 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 5.0 mpt_? -94.22 6.14 49.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.952 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.47 75.02 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 10.0 m-85 -77.92 149.31 34.22 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.606 0.827 . . . . 0.0 109.775 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.78 -43.36 8.55 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.864 -1.517 . . . . 0.0 109.028 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.69 -166.97 39.75 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.408 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -161.8 156.0 27.4 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 124.906 1.004 . . . . 0.0 110.626 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.567 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.1 p-80 -156.12 158.98 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.852 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' O ' ' C ' ' A' ' 33' ' ' GLY . 84.1 m -77.78 150.4 34.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -27.14 -51.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.258 1.599 . . . . 0.0 112.21 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -165.05 -51.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 124.898 0.999 . . . . 0.0 109.528 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.3 t80 -169.77 80.82 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 82.12 32.85 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.728 1.267 . . . . 0.0 109.072 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 12.4 t-20 -57.53 -18.71 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.581 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 8' ' ' VAL . 0.4 OUTLIER 87.49 -11.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.234 1.584 . . . . 0.0 107.941 179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -131.1 136.51 48.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 145.35 40.2 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 34.0 m95 -129.86 156.51 44.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 125.417 1.698 . . . . 0.0 109.185 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 66.2 m -85.75 170.26 12.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 116.59 -2.044 . . . . 0.0 108.079 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 55.53 1.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.173 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.401 HG21 ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 113.079 -3.343 . . . . 0.0 109.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.524 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.583 ' HB2' HG21 ' A' ' 44' ' ' THR . 5.8 tmtt? -117.79 116.34 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.35 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.6 tt -75.75 162.65 28.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.612 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.77 HD11 ' SG ' ' A' ' 40' ' ' CYS . 8.7 pt -134.37 -43.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 125.026 1.454 . . . . 0.0 108.981 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.72 -161.62 23.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -96.45 155.85 16.59 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.012 0.91 . . . . 0.0 109.922 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 5.2 t -114.17 56.7 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.411 ' CG2' HG12 ' A' ' 38' ' ' VAL . 82.7 t -136.33 116.98 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.295 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -75.41 117.58 17.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -27.25 6.82 Favored Glycine 0 N--CA 1.485 1.959 0 O-C-N 124.638 1.211 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.59 172.84 10.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.441 0.73 . . . . 0.0 109.101 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.7 t -81.23 169.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.69 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 m120 42.34 30.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.698 1.249 . . . . 0.0 108.475 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 6.2 t80 -62.31 143.81 56.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.366 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' SER . 12.4 m -89.47 -73.01 0.53 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 124.465 1.103 . . . . 0.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 15' ' ' THR . 5.3 t 89.41 -37.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 18' ' ' CYS . 19.9 p-10 -139.9 70.35 1.36 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.95 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.6 t -39.53 -65.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -41.58 -48.05 3.94 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -60.45 -68.19 1.79 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' CD ' ' NH2' ' A' ' 25' ' ' ARG . 6.8 tp10 -44.31 -32.85 1.42 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 122.312 1.053 . . . . 0.0 109.385 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 4' ' ' ILE . 13.0 m -76.13 -42.56 46.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.474 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' GLY . 25.1 mt -65.12 -30.8 71.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.71 -30.54 71.49 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.327 1.061 . . . . 0.0 109.152 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' NH2' ' CD ' ' A' ' 21' ' ' GLU . 9.0 mtm180 -102.61 7.33 39.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.637 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.87 14.57 68.01 Favored Glycine 0 N--CA 1.491 2.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.213 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 9.9 m-85 -77.41 175.48 9.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.83 0.824 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.31 150.41 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.983 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.15 94.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.858 0 O-C-N 125.867 1.979 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.52 -170.73 28.77 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 124.959 1.035 . . . . 0.0 110.531 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 16.4 p-80 -163.5 172.37 14.55 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.136 -1.032 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 33' ' ' GLY . 69.0 m -81.89 149.95 28.0 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . -26.71 -88.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.793 0 O-C-N 125.593 1.808 . . . . 0.0 112.929 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.9 t -153.91 -52.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.757 0.916 . . . . 0.0 109.686 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 24.9 t80 -172.72 85.52 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.287 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.07 29.19 0.05 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.728 1.268 . . . . 0.0 109.165 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.554 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 17.2 t-20 -79.12 -12.9 60.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.469 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG12 ' CG2' ' A' ' 8' ' ' VAL . 11.5 m 44.6 34.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 124.572 1.17 . . . . 0.0 110.161 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 70.6 m-80 -149.48 116.45 5.98 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.77 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.38 133.49 41.92 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.524 ' CE3' ' HB2' ' A' ' 1' ' ' ASP . 67.4 m95 -119.64 156.8 29.73 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.879 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 4' ' ' ILE . 40.1 m -92.39 174.88 7.06 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.997 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -101.03 61.2 0.95 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 124.999 2.333 . . . . 0.0 111.467 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 2' ' ' LYS . 31.3 p . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 112.743 -3.503 . . . . 0.0 110.435 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 158.82 16.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.611 1.194 . . . . 0.0 108.08 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.3 tt -99.42 164.5 12.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.777 HD11 ' SG ' ' A' ' 22' ' ' CYS . 44.8 mt -132.56 -43.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 125.366 1.666 . . . . 0.0 109.396 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.81 -147.03 12.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 53.5 m -96.14 160.42 14.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.808 -0.696 . . . . 0.0 110.236 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.655 ' SG ' ' OD1' ' A' ' 37' ' ' ASN . 35.4 t -138.72 27.3 2.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 69.2 t -93.53 135.08 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -79.13 63.84 3.88 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.732 1.27 . . . . 0.0 107.72 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.56 63.56 0.04 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.19 177.64 11.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.542 0.789 . . . . 0.0 109.294 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.2 t -82.45 168.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.781 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.82 27.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.098 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 5.6 t80 -60.73 134.39 57.03 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.134 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -110.64 167.95 9.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 125.166 1.541 . . . . 0.0 109.831 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.7 m -142.14 -47.43 0.35 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.144 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.34 67.82 0.74 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.924 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' HD12 ' A' ' 4' ' ' ILE . 5.5 t -50.01 -64.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -44.62 -33.08 1.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.611 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.38 -55.95 11.29 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 24.2 tt0 -58.97 -30.56 68.01 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.045 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.2 m -78.12 -41.17 35.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.3 -31.41 72.56 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.48 -30.61 71.64 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.761 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -92.76 2.53 56.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.119 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.41 20.38 75.28 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 14.1 m-85 -77.04 173.2 12.08 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.652 0.854 . . . . 0.0 110.019 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 4.6 mptt -71.05 -35.24 71.86 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.525 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 165.67 -177.43 40.89 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -156.3 159.32 29.34 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 21.8 p-80 -163.32 163.13 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.142 -1.029 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' A' ' 33' ' ' GLY . 92.5 m -78.25 151.42 33.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -19.8 -96.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.578 0 O-C-N 126.471 2.357 . . . . 0.0 111.522 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -176.54 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.657 0.857 . . . . 0.0 109.717 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -118.94 38.16 3.89 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.091 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.17 48.41 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.566 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.655 ' OD1' ' SG ' ' A' ' 7' ' ' CYS . 11.1 t-20 -38.05 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.6 p -144.65 -43.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 5.0 m-20 -134.43 156.31 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -110.84 154.46 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.53 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CD1' ' C ' ' A' ' 40' ' ' CYS . 32.8 m95 -140.35 156.95 46.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.243 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.686 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -87.39 163.62 16.67 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -97.64 53.9 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.316 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 5.0 t . . . . . 0 C--N 1.305 -1.353 1 CA-C-O 111.378 -4.153 . . . . 0.0 111.963 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -154.0 95.55 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 125.948 2.03 . . . . 0.0 108.913 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.0 tt -56.04 162.82 1.75 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.087 0.867 . . . . 0.0 109.323 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.542 HD11 ' SG ' ' A' ' 18' ' ' CYS . 31.1 pt -134.41 -41.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.822 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.61 -147.86 10.94 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.735 -1.222 . . . . 0.0 110.45 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 14' ' ' TYR . 4.2 m -86.78 -178.59 6.37 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.414 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.01 49.77 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG21 HG12 ' A' ' 38' ' ' VAL . 3.4 t -148.95 125.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.087 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.83 103.61 5.99 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 -18.78 3.38 Favored Glycine 0 N--CA 1.491 2.334 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.94 171.77 8.56 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.8 t -82.13 169.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.021 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.17 29.0 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.25 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 13.0 t80 -57.64 147.66 26.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.892 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' SER . 15.6 m -96.23 -70.74 0.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.601 1.188 . . . . 0.0 109.355 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 88.65 -36.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.34 86.71 2.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.863 1.316 . . . . 0.0 109.421 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 t -66.81 -71.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.183 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -41.97 -32.23 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.126 -0.629 . . . . 0.0 109.557 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -59.37 6.19 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.022 1.451 . . . . 0.0 109.569 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 11.4 tp10 -55.67 -35.75 66.35 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.277 0.56 . . . . 0.0 110.103 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.44 -42.75 58.57 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.91 -30.58 70.98 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.94 -36.43 81.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 124.405 1.066 . . . . 0.0 109.395 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.02 16.04 20.69 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.777 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.81 28.82 53.51 Favored Glycine 0 N--CA 1.49 2.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.745 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 4.4 m-85 -75.94 159.82 30.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.959 0.885 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -57.61 -31.22 66.0 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.855 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 160.43 -173.65 37.03 Favored Glycine 0 N--CA 1.484 1.883 0 O-C-N 124.667 1.229 . . . . 0.0 110.639 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.02 155.8 26.96 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 3.6 p-80 -154.33 166.2 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.948 -1.126 . . . . 0.0 110.158 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 57.5 m -76.96 150.09 35.93 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 37' ' ' ASN . . . -27.43 -88.37 0.01 OUTLIER Glycine 0 N--CA 1.477 1.42 0 O-C-N 125.815 1.947 . . . . 0.0 113.133 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -148.32 -57.07 0.22 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.617 1.199 . . . . 0.0 111.449 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 10.0 t80 -172.68 85.82 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.716 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 87.83 33.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.951 1.407 . . . . 0.0 109.052 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 5.6 t-20 -82.84 -11.96 57.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.239 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 8' ' ' VAL . 4.8 m 42.47 34.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.05 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -151.43 118.1 5.76 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.098 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -98.0 144.71 27.23 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 41' ' ' TRP . 11.2 m95 -127.06 164.96 20.4 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.047 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -96.21 171.42 8.6 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 125.068 1.48 . . . . 0.0 107.195 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' CD ' ' HD1' ' A' ' 31' ' ' HIS . 1.8 tp10 -97.81 54.0 1.13 Allowed 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.896 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 42' ' ' CYS . 31.8 p . . . . . 0 C--N 1.3 -1.554 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.201 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 48.1 mmtt -100.48 104.75 16.16 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 4' ' ' ILE . 7.9 tt -59.04 162.19 4.49 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.904 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.62 HD11 ' SG ' ' A' ' 18' ' ' CYS . 20.8 pt -134.49 -43.09 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 125.027 1.454 . . . . 0.0 109.123 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 -148.09 10.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.1 t -97.29 164.49 12.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.66 1.219 . . . . 0.0 108.863 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -127.77 50.09 2.07 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.284 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 11' ' ' ALA . 33.1 t -130.02 122.09 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.817 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.5 92.53 2.37 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 -6.91 5.71 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . . . -96.41 178.97 5.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.0 t -81.65 168.8 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.972 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 p30 40.0 31.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 125.386 1.679 . . . . 0.0 108.315 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.6 t80 -55.45 137.34 48.5 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 125.327 1.642 . . . . 0.0 109.522 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' SER . 17.7 m -86.59 -73.76 0.45 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.552 1.157 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.6 OUTLIER 89.39 -36.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -137.75 73.77 1.45 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -46.85 -62.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -27.71 5.99 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.313 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.53 -67.43 1.72 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 34.0 tt0 -49.19 -31.83 9.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.2 m -75.86 -43.59 44.87 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 124.286 0.991 . . . . 0.0 108.338 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.89 -31.1 72.16 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.497 1.123 . . . . 0.0 108.05 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.08 -31.27 72.37 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.696 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -91.05 -3.34 57.27 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.533 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.22 12.09 76.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 23.6 m-85 -81.52 163.87 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.583 0.814 . . . . 0.0 110.038 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' GLY . 3.4 mppt? -86.71 169.14 12.92 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.292 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -31.18 99.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 O-C-N 125.647 1.842 . . . . 0.0 110.932 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.41 -165.96 33.6 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.587 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 32.6 p-80 -164.19 171.98 14.27 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.282 -0.959 . . . . 0.0 109.938 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 20.7 m -101.52 147.44 26.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 21.44 -124.16 0.01 OUTLIER Glycine 0 N--CA 1.481 1.697 0 O-C-N 125.664 1.853 . . . . 0.0 112.615 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -158.53 -45.06 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.179 1.164 . . . . 0.0 109.218 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 23.0 t80 -172.04 85.46 0.07 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.456 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 84.19 53.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.794 1.309 . . . . 0.0 109.289 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.588 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 6.8 t-20 -106.9 -154.02 0.51 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 113.492 -1.685 . . . . 0.0 107.971 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' ASN . 8.1 m -165.9 35.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 123.914 0.759 . . . . 0.0 108.991 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -153.22 174.38 14.34 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 123.563 0.539 . . . . 0.0 110.242 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -122.53 147.3 46.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 124.782 1.301 . . . . 0.0 107.997 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.537 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.0 m95 -146.72 160.45 42.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.263 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 93.0 m -94.21 -173.01 2.96 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 117.224 -1.79 . . . . 0.0 108.673 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.587 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 5.5 mt-10 -143.88 76.42 1.51 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.072 0.939 . . . . 0.0 110.272 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 115.952 -1.975 . . . . 0.0 109.969 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.422 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 3.1 m-20 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -120.9 109.97 15.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.476 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -71.74 163.33 28.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.832 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 22' ' ' CYS . 4.9 pt -136.53 -41.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 125.17 1.544 . . . . 0.0 108.74 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -163.06 24.99 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -93.52 163.48 13.55 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.354 -0.923 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -123.06 54.49 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.83 121.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.34 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 71.12 4.06 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.95 59.35 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.8 179.71 8.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.5 t -79.24 170.72 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 40.5 30.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.61 1.194 . . . . 0.0 109.511 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 25.0 t80 -52.99 135.16 37.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.642 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 16' ' ' SER . 50.6 m -92.29 -74.58 0.51 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.485 1.116 . . . . 0.0 109.695 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 15' ' ' THR . 3.6 t 90.21 -39.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.4 p-10 -136.84 73.93 1.47 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.245 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 6.7 t -43.91 -57.96 3.02 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -53.54 -36.03 61.36 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -67.01 -70.19 1.18 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.664 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 46.3 tp10 -45.64 -34.01 3.22 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.412 1.101 . . . . 0.0 110.206 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 4' ' ' ILE . 4.2 m -73.23 -43.59 60.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.697 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.34 -30.99 72.02 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.986 1.429 . . . . 0.0 109.166 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.68 7.73 45.76 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.187 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.72 19.62 69.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.558 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 15.4 m-30 -84.29 172.0 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.913 -0.643 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.03 149.43 25.58 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.43 99.46 0.01 OUTLIER Glycine 0 N--CA 1.486 2.021 0 O-C-N 125.744 1.903 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.42 -174.7 35.78 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 10.9 p-80 -163.94 174.43 11.45 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.19 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' O ' ' C ' ' A' ' 33' ' ' GLY . 99.3 m -90.94 152.58 20.66 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -19.51 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 O-C-N 126.058 2.099 . . . . 0.0 111.595 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -166.7 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 O-C-N 124.556 0.798 . . . . 0.0 108.972 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -125.54 39.61 3.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.856 0.722 . . . . 0.0 109.811 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.86 56.13 0.11 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -37.98 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.226 0.954 . . . . 0.0 109.755 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 36' ' ' ALA . 15.3 m -136.55 -48.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.496 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -125.93 136.29 52.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.233 0.958 . . . . 0.0 109.805 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.6 140.47 38.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.1 m95 -129.66 162.67 27.81 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.04 -1.437 . . . . 0.0 107.851 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 80.9 m -95.21 172.25 8.23 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 117.269 -1.772 . . . . 0.0 108.382 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -101.16 61.23 0.94 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 124.754 2.216 . . . . 0.0 112.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 36.4 p . . . . . 0 C--N 1.305 -1.364 0 CA-C-O 112.489 -3.624 . . . . 0.0 111.252 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.41 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 3.5 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -110.67 98.18 7.41 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.967 -1.469 . . . . 0.0 109.089 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 8.1 tt -56.16 161.47 2.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.077 0.861 . . . . 0.0 109.062 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' N ' HD23 ' A' ' 3' ' ' LEU . 19.8 pt -136.26 -41.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 124.823 1.327 . . . . 0.0 109.396 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.26 -148.59 9.62 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 124.86 1.35 . . . . 0.0 110.156 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.7 m -94.42 -172.45 2.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.777 -0.711 . . . . 0.0 109.812 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' VAL . 24.5 t -152.89 34.91 0.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 38' ' ' VAL . 2.0 t -126.97 127.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -78.73 62.15 3.18 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 44.47 0.02 OUTLIER Glycine 0 N--CA 1.487 2.055 0 CA-C-N 114.253 -1.34 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.23 179.06 9.09 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -78.2 167.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.634 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.47 29.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.988 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -52.1 135.77 30.86 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 124.902 1.376 . . . . 0.0 110.173 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.513 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.5 t -120.65 175.58 5.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 125.125 1.516 . . . . 0.0 108.931 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.7 -50.5 0.41 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.126 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' CYS . 7.7 p-10 -109.12 69.26 0.7 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.434 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 4' ' ' ILE . 7.6 t -38.26 -58.58 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -45.63 -50.28 13.49 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.311 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -61.61 -65.06 3.47 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 6.1 tp10 -41.19 -37.1 0.85 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 124.376 1.071 . . . . 0.0 108.627 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.646 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.5 m -75.56 -43.9 46.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.517 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 22.2 mt -62.75 -30.29 71.33 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.09 -32.84 74.55 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.261 0.975 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 18.6 mtm-85 -92.18 3.79 54.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.843 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 12.89 83.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 21.8 m-85 -89.89 170.04 10.72 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.994 0.902 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 43' ' ' GLU . 34.3 mtpt -84.64 154.86 22.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.446 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -34.98 96.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 O-C-N 125.341 1.65 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -69.45 -170.83 7.6 Favored Glycine 0 N--CA 1.48 1.607 0 O-C-N 125.386 1.286 . . . . 0.0 110.893 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -161.94 171.46 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.578 -1.311 . . . . 0.0 110.455 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' C ' ' A' ' 33' ' ' GLY . 87.0 m -92.04 151.45 20.45 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -20.7 -92.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.415 0 O-C-N 125.667 1.855 . . . . 0.0 112.509 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 p -176.07 -70.3 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 124.949 1.029 . . . . 0.0 110.13 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -119.23 39.21 3.63 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.364 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.61 49.89 0.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.191 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -40.82 95.3 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 8' ' ' VAL . 2.5 p -152.28 -45.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 124.777 1.298 . . . . 0.0 109.241 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 35.5 m120 -120.94 137.63 54.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 124.156 0.91 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -107.36 147.28 30.53 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 65.2 m95 -137.06 152.49 50.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 84.2 m -86.45 -171.59 3.62 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.051 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -142.73 74.46 1.45 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 59.7 p . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 112.973 -3.394 . . . . 0.0 109.573 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HE2' ' OH ' ' A' ' 27' ' ' TYR . 3.6 tmtm? -97.73 107.18 19.62 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.7 tt -64.32 162.69 14.36 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.077 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 ' SG ' ' A' ' 18' ' ' CYS . 18.3 pt -135.73 -39.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.117 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 176.33 -148.1 8.96 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.433 ' O ' ' HB ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -104.34 167.37 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.185 -1.008 . . . . 0.0 109.765 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 56.1 m -134.62 43.87 2.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.94 123.79 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 124.779 1.299 . . . . 0.0 109.08 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 73.57 4.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.08 52.08 0.02 OUTLIER Glycine 0 N--CA 1.488 2.102 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.152 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.67 176.57 10.82 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.47 170.64 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.408 ' H ' HG12 ' A' ' 12' ' ' VAL . 35.3 m-20 42.49 30.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.569 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.37 134.28 56.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.999 1.437 . . . . 0.0 109.965 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 6' ' ' SER . 2.8 m -120.46 173.84 6.91 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 124.807 1.317 . . . . 0.0 109.107 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.0 t -142.36 -50.04 0.37 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.919 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -102.58 66.42 0.96 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.057 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.6 t -43.15 -71.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 30' ' ' GLY . 1.7 t-20 -43.64 -28.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.075 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.48 -60.78 4.51 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 1.1 tt0 -56.26 -31.49 63.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 10.9 m -77.1 -41.91 40.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.08 -29.45 70.59 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.8 mt -65.78 -30.41 71.06 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 124.308 1.005 . . . . 0.0 109.309 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -86.94 0.85 54.38 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.613 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.79 14.93 76.67 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.321 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 18.9 m-85 -79.24 140.7 37.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.495 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -43.39 -50.21 6.87 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.334 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.04 169.3 40.83 Favored Glycine 0 N--CA 1.481 1.662 0 O-C-N 125.213 1.571 . . . . 0.0 110.445 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.715 ' H ' ' ND2' ' A' ' 19' ' ' ASN . . . -148.51 154.17 25.68 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -149.85 160.6 43.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 21.0 m -85.06 146.54 27.11 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.618 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 21.73 -126.25 0.01 OUTLIER Glycine 0 N--CA 1.484 1.842 0 O-C-N 126.133 2.145 . . . . 0.0 111.95 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -156.07 -45.2 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 125.081 1.106 . . . . 0.0 108.92 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.5 t80 -172.35 85.53 0.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.24 52.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.863 1.352 . . . . 0.0 109.219 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 9.9 t-20 -105.53 -152.71 0.47 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.806 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 13.5 m -165.55 33.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -153.34 175.67 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -121.3 144.94 48.36 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 50.1 m95 -146.95 158.03 43.8 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.514 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 89.7 m -88.33 -174.9 4.81 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 117.837 -1.545 . . . . 0.0 108.11 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.271 44.6 tt0 -141.72 73.66 1.42 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 124.083 0.864 . . . . 0.0 110.364 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 45.3 p . . . . . 0 C--N 1.295 -1.783 0 O-C-N 125.24 1.587 . . . . 0.0 111.675 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 11.9 tptt -134.18 100.51 4.73 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.241 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 4' ' ' ILE . 8.8 tt -59.45 161.56 5.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.609 HD11 ' SG ' ' A' ' 18' ' ' CYS . 9.0 pt -135.82 -42.58 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.727 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.58 -148.39 9.04 Favored Glycine 0 N--CA 1.482 1.703 0 O-C-N 124.987 1.429 . . . . 0.0 109.983 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.475 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 25.1 t -102.61 171.57 7.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.318 -1.353 . . . . 0.0 108.639 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 44.4 t -144.32 40.99 1.35 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.659 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.268 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.58 68.08 3.6 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.95 50.17 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.23 178.41 10.21 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -84.61 168.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.31 29.5 0.23 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.837 1.336 . . . . 0.0 108.225 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE1' ' O ' ' A' ' 15' ' ' THR . 18.6 t80 -57.85 134.24 56.12 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.893 1.37 . . . . 0.0 110.073 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.0 t -117.73 -179.76 3.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.741 1.276 . . . . 0.0 109.15 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' THR . 0.7 OUTLIER -142.05 -49.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.682 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 18' ' ' CYS . 10.5 p-10 -105.24 66.15 0.74 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.096 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.1 t -37.77 -71.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 59.9 t30 -37.19 -42.85 0.47 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.618 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -64.78 -55.03 24.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' NH2' ' A' ' 25' ' ' ARG . 18.0 tt0 -56.79 -29.94 63.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' SG ' HD13 ' A' ' 4' ' ' ILE . 1.9 m -76.08 -45.45 33.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.11 -32.29 71.97 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.78 -34.75 76.42 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.802 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.605 HH11 ' CA ' ' A' ' 4' ' ' ILE . 4.4 mtm180 -89.5 -0.42 57.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.309 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.85 12.6 79.53 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 18.2 m-30 -83.98 164.69 19.18 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.251 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -87.92 172.38 9.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.369 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -27.89 106.2 0.01 OUTLIER Glycine 0 N--CA 1.485 1.961 0 O-C-N 125.964 2.04 . . . . 0.0 110.834 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.2 -170.17 33.44 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 6.6 p-80 -166.08 176.83 7.4 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 60.4 m -100.68 147.38 26.07 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.626 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 22.06 -125.87 0.01 OUTLIER Glycine 0 N--CA 1.483 1.768 0 O-C-N 126.126 2.141 . . . . 0.0 112.046 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t -155.59 -45.64 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 125.239 1.199 . . . . 0.0 108.901 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 22.3 t80 -171.99 85.47 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.389 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.24 52.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.817 1.323 . . . . 0.0 109.327 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.626 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 16.8 t-20 -105.29 -152.57 0.47 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.899 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -166.52 34.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 123.85 0.719 . . . . 0.0 109.491 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 8.7 m-80 -155.36 176.38 12.66 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.97 147.81 44.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 122.351 1.072 . . . . 0.0 108.319 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 52.2 m95 -146.16 162.02 38.92 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.399 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.2 m -94.61 -173.51 3.04 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 117.038 -1.865 . . . . 0.0 108.868 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 11.5 tt0 -142.68 75.79 1.5 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.959 0.787 . . . . 0.0 109.944 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 115.057 -2.402 . . . . 0.0 110.439 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 9.7 mptt -130.39 94.24 3.62 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 124.876 1.36 . . . . 0.0 109.303 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -55.66 163.53 1.33 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 113.678 -1.601 . . . . 0.0 108.166 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.686 HD13 ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -134.85 -43.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.111 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.47 -150.78 12.42 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 38.4 m -95.88 170.29 9.4 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.504 -0.848 . . . . 0.0 109.858 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.1 t -140.19 43.81 1.9 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 97.8 t -119.7 129.92 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.43 74.15 4.98 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.25 58.01 0.04 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-N 113.292 -1.777 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.39 173.91 16.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.532 0.784 . . . . 0.0 109.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.4 172.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 41.34 30.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.694 1.246 . . . . 0.0 108.754 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' N ' ' C ' ' A' ' 12' ' ' VAL . 30.0 t80 -51.69 138.79 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.5 m -91.75 -75.21 0.48 Allowed 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.647 1.217 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.2 OUTLIER 88.68 -35.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 20' ' ' GLY . 6.1 p-10 -138.96 72.55 1.41 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.8 t -41.55 -71.46 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -32.55 0.5 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.57 -60.81 5.14 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 tp10 -55.38 -32.78 62.89 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.654 0.74 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.0 m -74.72 -43.89 52.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.642 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -30.78 71.6 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.464 1.102 . . . . 0.0 108.242 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.17 -28.41 70.03 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.729 1.268 . . . . 0.0 109.605 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.39 -1.07 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.484 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.65 82.27 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.552 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 19.2 m-85 -79.52 170.86 15.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.95 0.881 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.626 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.7 156.57 20.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.742 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.31 103.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.102 0 O-C-N 125.166 1.541 . . . . 0.0 110.352 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -83.11 -171.23 47.19 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.99 173.92 11.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.547 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 99.5 m -93.93 150.62 20.2 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 125.05 1.469 . . . . 0.0 107.678 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 O-C-N 125.63 1.831 . . . . 0.0 111.022 179.746 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.0 p . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 38.1 m-20 -119.6 150.64 39.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.736 1.273 . . . . 0.0 109.846 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -107.81 155.79 19.85 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD12 ' A' ' 3' ' ' LEU . 24.7 m95 -142.98 158.67 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.193 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 82.5 m -94.37 164.5 12.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.808 -1.957 . . . . 0.0 107.551 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -97.55 55.43 1.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.209 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.626 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 12.5 t . . . . . 0 C--N 1.31 -1.152 0 CA-C-O 111.85 -3.928 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 5.2 mmtm -100.98 111.4 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 4' ' ' ILE . 5.2 tt -66.49 163.7 17.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.126 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.579 HD13 ' SG ' ' A' ' 22' ' ' CYS . 21.8 pt -135.09 -41.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.35 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.24 -148.93 9.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -99.43 177.96 5.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.811 -0.695 . . . . 0.0 109.743 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -146.23 49.56 1.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.9 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 38' ' ' VAL . 3.9 t -144.85 126.88 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.675 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.88 61.66 1.96 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 125.215 1.572 . . . . 0.0 107.013 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.67 39.51 0.03 OUTLIER Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.35 176.66 11.74 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.265 0.627 . . . . 0.0 109.435 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.41 171.4 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 12' ' ' VAL . 13.8 m120 42.22 30.09 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.115 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -51.41 135.7 26.83 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 16' ' ' SER . 1.1 t -123.63 -178.13 3.94 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.802 1.314 . . . . 0.0 108.594 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 15' ' ' THR . 38.7 t -143.12 -56.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.394 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -101.67 70.2 1.25 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.791 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 11.2 t -41.18 -72.85 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -41.0 -32.67 0.25 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.272 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.18 -60.57 5.09 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.554 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 25' ' ' ARG . 5.3 tt0 -58.32 -29.32 65.8 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 4' ' ' ILE . 7.4 m -77.03 -42.5 38.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.68 -30.1 71.25 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -33.48 74.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.553 HH11 HG22 ' A' ' 4' ' ' ILE . 2.0 mtm180 -86.68 -2.27 58.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.155 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.54 14.32 76.32 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.548 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.3 m-85 -77.66 148.93 34.77 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.175 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -47.93 -42.2 26.66 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.508 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.24 -168.79 40.23 Favored Glycine 0 N--CA 1.483 1.799 0 O-C-N 125.165 1.541 . . . . 0.0 110.158 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.44 160.72 32.97 Favored Glycine 0 N--CA 1.484 1.876 0 O-C-N 124.67 0.865 . . . . 0.0 111.208 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.31 168.01 28.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.286 -0.957 . . . . 0.0 109.357 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 73.0 m -85.54 151.3 24.04 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.489 2.169 0 O-C-N 125.652 1.845 . . . . 0.0 112.437 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.409 HG23 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -143.04 132.15 23.09 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -109.41 137.68 46.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -125.33 157.49 36.58 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 125.271 1.607 . . . . 0.0 108.043 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 98.7 m -84.38 161.28 20.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 116.341 -2.143 . . . . 0.0 107.992 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -99.69 57.18 1.0 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.954 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.656 ' HA ' ' CE ' ' A' ' 28' ' ' LYS . 14.2 t . . . . . 0 C--N 1.31 -1.142 0 CA-C-O 112.695 -3.526 . . . . 0.0 109.187 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 9.3 mptt -115.91 102.57 9.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.554 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 4.8 tt -56.33 162.38 2.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.051 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.645 HD11 ' SG ' ' A' ' 18' ' ' CYS . 2.9 pt -133.98 -45.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.79 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.25 -148.94 10.26 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 125.033 1.458 . . . . 0.0 109.861 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.65 155.83 17.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.139 -1.031 . . . . 0.0 109.279 -179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 43.0 t -124.01 48.77 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 59.7 t -125.39 118.88 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.571 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 96.04 2.63 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.01 -9.76 5.69 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.451 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -96.31 176.71 5.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -82.28 168.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 114.178 -1.373 . . . . 0.0 107.987 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 42.31 30.08 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.461 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.7 t80 -53.44 140.62 27.26 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 125.28 1.613 . . . . 0.0 109.633 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' SER . 3.4 m -88.0 -74.28 0.46 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 124.687 1.242 . . . . 0.0 109.733 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 90.06 -38.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -138.19 72.86 1.42 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -42.57 -72.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -39.08 -32.62 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.16 -60.19 4.6 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 4' ' ' ILE . 39.5 tp10 -55.43 -32.17 62.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.137 0.97 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.9 m -75.75 -44.89 39.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.105 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.22 -31.56 72.73 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 124.513 1.133 . . . . 0.0 108.202 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.757 1.286 . . . . 0.0 109.948 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.602 ' NH1' ' HA ' ' A' ' 4' ' ' ILE . 48.8 mtt180 -93.6 -4.12 51.38 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.158 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.03 79.95 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 m-30 -81.22 162.6 23.5 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.354 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' NZ ' ' OG1' ' A' ' 44' ' ' THR . 2.3 mppt? -79.71 163.61 24.38 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -32.12 104.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.479 1.737 . . . . 0.0 110.436 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -165.44 39.08 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.837 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -163.95 173.4 12.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 109.585 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 52.6 m -98.56 146.27 25.97 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.287 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.778 0 O-C-N 126.292 2.245 . . . . 0.0 112.033 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -152.55 174.75 13.54 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 123.532 0.52 . . . . 0.0 110.369 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -123.95 147.62 47.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 36.8 m95 -145.77 160.59 41.53 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.615 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.9 m -93.26 -175.94 3.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 117.327 -1.749 . . . . 0.0 108.288 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 39.8 mt-10 -142.97 75.78 1.5 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 124.358 1.036 . . . . 0.0 110.53 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' NZ ' ' A' ' 28' ' ' LYS . 1.1 t . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 115.706 -2.092 . . . . 0.0 110.725 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -108.28 103.8 13.05 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.3 tt -59.88 163.08 4.84 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.303 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.571 HD11 ' SG ' ' A' ' 18' ' ' CYS . 14.9 pt -135.07 -41.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 125.063 1.477 . . . . 0.0 109.257 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.77 -147.02 9.8 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.131 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.53 -175.3 3.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.797 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 13.7 t -150.17 54.36 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 ' CG2' HG23 ' A' ' 38' ' ' VAL . 2.6 t -146.73 129.92 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.985 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 67.89 5.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.64 42.69 0.02 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 174.77 12.4 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 13' ' ' ASN . 2.4 t -79.98 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.77 1.294 . . . . 0.0 107.655 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.416 ' H ' HG12 ' A' ' 12' ' ' VAL . 4.4 m120 42.71 29.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.376 1.047 . . . . 0.0 108.876 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 18.6 t80 -47.43 136.39 9.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.207 1.567 . . . . 0.0 109.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 16' ' ' SER . 37.2 m -96.85 -75.79 0.53 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 124.675 1.234 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' THR . 1.6 t 89.89 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 p-10 -137.35 75.78 1.55 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.133 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.571 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -44.5 -59.8 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -33.17 22.76 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.221 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -70.77 -63.93 3.01 Favored Glycine 0 N--CA 1.486 1.973 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.482 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 26.7 tt0 -53.68 -30.77 44.97 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m -75.92 -43.16 46.45 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.1 -31.31 72.46 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.578 1.174 . . . . 0.0 108.234 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 25' ' ' ARG . 2.3 mt -62.97 -28.27 69.97 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.719 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.77 -2.76 40.38 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.056 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 10.17 80.46 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.53 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.9 m-85 -80.41 167.07 20.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.989 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.24 166.06 14.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.853 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.1 98.61 0.01 OUTLIER Glycine 0 N--CA 1.485 1.954 0 O-C-N 125.584 1.803 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -73.88 -166.78 13.98 Favored Glycine 0 N--CA 1.48 1.63 0 O-C-N 125.84 1.553 . . . . 0.0 110.324 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.425 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 50.1 p-80 -162.48 171.16 17.52 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.898 -1.151 . . . . 0.0 110.366 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -92.24 150.46 20.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.645 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 8' ' ' VAL . 9.1 p . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -133.15 123.24 25.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.722 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 143.54 27.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 19.1 m95 -130.06 151.85 50.15 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.478 -2.147 . . . . 0.0 109.339 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 92.2 m -89.75 162.32 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 116.546 -2.061 . . . . 0.0 107.7 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.16 57.25 1.06 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.593 1.187 . . . . 0.0 111.433 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.454 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 3.2 t . . . . . 0 C--N 1.304 -1.406 1 CA-C-O 111.519 -4.086 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -125.93 127.31 45.78 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.439 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 4' ' ' ILE . 1.6 tm? -73.0 163.57 27.98 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.312 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.601 HG21 ' SG ' ' A' ' 22' ' ' CYS . 8.5 pt -136.77 -39.96 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 124.928 1.392 . . . . 0.0 108.684 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.37 -159.18 32.43 Favored Glycine 0 N--CA 1.486 2.022 0 O-C-N 124.799 1.312 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 167.16 11.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.308 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.74 47.29 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.565 HG21 HG22 ' A' ' 38' ' ' VAL . 69.9 t -119.26 127.43 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.176 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -77.58 70.3 3.94 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.471 -1.241 . . . . 0.0 107.709 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.91 56.9 0.04 OUTLIER Glycine 0 N--CA 1.485 1.954 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.6 173.82 15.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.387 0.698 . . . . 0.0 109.195 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.2 t -80.86 171.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.42 ' H ' HG12 ' A' ' 12' ' ' VAL . 50.9 m-20 43.61 28.76 0.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.941 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' N ' ' C ' ' A' ' 12' ' ' VAL . 38.6 t80 -51.99 140.53 20.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.841 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' SER . 4.9 m -89.95 -75.43 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 124.781 1.301 . . . . 0.0 109.792 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER 87.54 -36.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.64 74.23 1.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 123.941 0.776 . . . . 0.0 109.88 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 t -42.7 -72.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.5 -27.79 1.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.317 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.9 -63.05 3.85 Favored Glycine 0 N--CA 1.486 2.003 0 O-C-N 125.137 1.523 . . . . 0.0 109.628 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 11.4 tp10 -51.94 -37.1 51.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.4 m -72.34 -42.45 65.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.637 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -30.69 71.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.85 -33.55 75.5 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 124.716 1.26 . . . . 0.0 109.333 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 1.3 mpt_? -97.87 14.05 28.5 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.89 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 54.91 30.17 52.73 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.636 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 8.5 m-85 -76.85 178.04 7.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.53 -33.44 64.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.359 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 159.68 179.57 34.58 Favored Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.418 1.074 . . . . 0.0 110.555 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.64 156.99 27.79 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.3 p-80 -153.61 157.39 39.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.044 -1.078 . . . . 0.0 109.757 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 95.3 m -78.19 150.11 33.59 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.205 179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -145.95 157.9 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.488 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -117.47 150.7 38.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.592 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CE2' HD23 ' A' ' 3' ' ' LEU . 40.5 m95 -133.66 168.83 17.98 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 125.063 1.477 . . . . 0.0 108.535 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -100.09 161.5 13.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 55.52 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.42 1.088 . . . . 0.0 109.214 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 42' ' ' CYS . 71.3 p . . . . . 0 C--N 1.302 -1.5 0 CA-C-O 114.641 -2.599 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 10.2 mmtt -97.9 106.01 18.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.28 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.607 HD12 ' CH2' ' A' ' 41' ' ' TRP . 9.1 tt -56.53 162.42 2.21 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.556 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.629 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 10.2 pt -136.85 -41.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.537 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.6 -152.03 12.05 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 1.4 m -93.96 166.61 12.08 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.514 0.773 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.8 t -136.04 47.16 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.4 127.52 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.13 68.5 3.27 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.39 59.18 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.21 177.07 11.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.575 0.809 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -81.51 170.8 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.643 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.22 29.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.495 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 36.3 t80 -50.91 140.22 15.72 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.77 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.4 m -92.17 -74.28 0.52 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 124.819 1.325 . . . . 0.0 109.437 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.9 OUTLIER 89.08 -37.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -138.29 75.02 1.5 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.816 0.697 . . . . 0.0 109.795 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -42.54 -70.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.4 OUTLIER -39.41 -33.74 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.767 0.667 . . . . 0.0 109.568 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.12 -56.89 6.59 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HH21 ' A' ' 25' ' ' ARG . 1.2 tp10 -55.8 -34.61 65.48 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.7 m -75.16 -45.21 42.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.38 -31.44 72.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -34.4 74.65 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.426 1.079 . . . . 0.0 109.964 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.668 HH21 ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -94.23 1.69 55.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.996 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 13.36 82.1 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 124.122 0.889 . . . . 0.0 110.911 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 22.4 m-85 -83.13 168.45 16.84 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.893 0.854 . . . . 0.0 109.928 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.47 162.69 17.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.664 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.45 102.47 0.01 OUTLIER Glycine 0 N--CA 1.484 1.893 0 O-C-N 125.444 1.715 . . . . 0.0 111.355 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.589 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -81.51 -169.48 42.4 Favored Glycine 0 N--CA 1.481 1.643 0 O-C-N 125.488 1.346 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -163.42 177.81 8.59 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.845 -1.178 . . . . 0.0 109.905 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.3 m -99.06 149.83 22.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.155 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 21.4 m-80 -151.11 154.67 37.4 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.971 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -111.36 152.26 27.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.607 ' CH2' HD12 ' A' ' 3' ' ' LEU . 38.6 m95 -144.45 158.65 43.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.737 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.629 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 94.6 m -93.57 -175.83 3.9 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 117.252 -1.779 . . . . 0.0 108.574 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.54 76.12 1.49 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.782 1.277 . . . . 0.0 110.599 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--N 1.297 -1.705 0 CA-C-N 112.604 -2.089 . . . . 0.0 110.256 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -108.69 110.94 22.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.528 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 tt -62.49 162.15 10.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.054 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 5' ' ' GLY . 16.2 pt -134.08 -43.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 125.137 1.523 . . . . 0.0 109.495 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 179.85 -148.74 8.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 15' ' ' THR . 3.3 m -99.32 170.18 8.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.957 -0.621 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 8.8 t -136.44 51.34 2.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 17.6 t -131.64 128.93 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.851 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -78.7 61.39 2.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.68 64.2 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.58 -179.83 5.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 124.419 0.717 . . . . 0.0 109.159 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.68 167.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.644 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.89 29.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.378 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -57.65 134.96 56.64 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -117.46 177.81 4.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 125.064 1.478 . . . . 0.0 109.89 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.5 t -142.05 -49.04 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.5 p-10 -111.61 72.44 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.414 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' HD11 ' A' ' 4' ' ' ILE . 5.6 t -40.56 -41.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -50.39 73.01 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.277 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -61.91 -57.41 17.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG3' ' NH2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -50.13 -33.57 19.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.503 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.9 m -76.21 -43.31 42.95 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.61 -30.93 71.97 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.869 1.356 . . . . 0.0 108.278 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.33 -31.73 72.39 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.012 0.911 . . . . 0.0 109.699 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 21' ' ' GLU . 2.3 mtm-85 -94.4 -1.0 54.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.785 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.83 6.59 79.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 16.6 m-30 -85.47 164.39 17.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.702 0.763 . . . . 0.0 109.956 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -87.69 164.98 15.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.531 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -31.91 97.56 0.01 OUTLIER Glycine 0 N--CA 1.487 2.036 0 O-C-N 125.802 1.939 . . . . 0.0 110.8 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -77.4 -168.12 29.9 Favored Glycine 0 N--CA 1.48 1.617 0 O-C-N 125.393 1.29 . . . . 0.0 110.209 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -163.1 172.25 15.18 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.069 -1.066 . . . . 0.0 110.08 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 63.8 m -83.74 150.51 25.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.479 1.543 0 O-C-N 125.478 1.736 . . . . 0.0 113.187 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 18.9 m . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.455 0.645 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -152.75 128.24 10.0 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.021 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.22 138.65 38.88 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.528 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 72.3 m95 -125.38 152.29 44.99 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.307 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 68.4 m -84.46 163.26 19.57 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 117.457 -1.697 . . . . 0.0 108.613 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -97.13 54.34 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.966 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.429 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 4.5 t . . . . . 0 N--CA 1.485 1.281 1 CA-C-O 111.405 -4.141 . . . . 0.0 111.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.467 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 1.6 p30 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 44' ' ' THR . 15.7 mmtp -99.79 102.19 13.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.311 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.1 tt -58.6 163.08 3.42 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.577 1.173 . . . . 0.0 108.922 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.548 HD11 ' SG ' ' A' ' 18' ' ' CYS . 17.9 pt -134.65 -42.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 124.693 1.246 . . . . 0.0 109.088 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.75 21.39 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 t -93.77 165.11 12.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.671 -1.265 . . . . 0.0 108.465 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -129.88 37.03 3.99 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.9 t -110.69 124.84 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -79.53 69.34 5.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.54 59.19 0.02 OUTLIER Glycine 0 N--CA 1.486 1.988 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.212 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.39 8.93 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.5 t -80.82 169.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.166 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 42.2 29.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.891 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -60.3 134.7 57.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 125.037 1.461 . . . . 0.0 109.766 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -116.72 170.62 8.45 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 124.817 1.323 . . . . 0.0 108.941 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -141.59 -47.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.678 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -105.15 66.57 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.724 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 4' ' ' ILE . 10.2 t -44.15 -65.01 0.56 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -49.25 -30.35 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.625 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.68 -65.67 2.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.509 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 tt0 -52.76 -31.37 37.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 4' ' ' ILE . 16.4 m -77.16 -40.34 45.79 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.23 -29.79 70.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.79 -32.83 74.08 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.057 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.509 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -90.39 1.2 56.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.454 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.14 19.18 79.54 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 16.9 m-85 -76.89 167.33 22.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -64.97 -37.34 87.34 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.511 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.31 -166.71 39.81 Favored Glycine 0 N--CA 1.485 1.905 0 O-C-N 124.79 1.306 . . . . 0.0 110.468 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -163.34 155.68 27.14 Favored Glycine 0 N--CA 1.489 2.198 0 O-C-N 124.866 0.98 . . . . 0.0 111.091 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 55.9 p-80 -163.19 159.27 22.7 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.17 -1.015 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 90.1 m -74.45 149.73 40.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.489 2.193 0 O-C-N 126.287 2.242 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.08 150.79 51.99 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 124.166 0.916 . . . . 0.0 108.988 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.79 147.92 34.67 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.681 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.461 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 38.8 m95 -134.23 158.99 42.31 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.579 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 69.7 m -87.13 172.24 10.09 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 117.133 -1.827 . . . . 0.0 108.12 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.54 58.16 0.85 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 124.016 1.865 . . . . 0.0 110.708 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.476 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 21.4 p . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 112.061 -3.828 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 10.4 mptt -134.99 126.83 29.33 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.733 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 4' ' ' ILE . 2.2 tm? -84.2 163.6 19.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 125.335 1.647 . . . . 0.0 107.826 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' SG ' ' A' ' 22' ' ' CYS . 3.4 pt -136.66 -40.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.995 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -163.49 37.19 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 124.876 1.36 . . . . 0.0 110.298 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 7' ' ' CYS . 30.8 t -90.31 172.06 9.03 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.263 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' OG ' ' A' ' 6' ' ' SER . 48.2 t -137.77 41.93 2.32 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.007 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.604 HG21 HG22 ' A' ' 38' ' ' VAL . 76.7 t -116.97 124.97 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.439 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 62.84 2.38 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.54 58.74 0.01 OUTLIER Glycine 0 N--CA 1.483 1.79 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.87 -179.84 7.89 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.82 165.74 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.175 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 41.43 30.65 0.14 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.908 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 15' ' ' THR . 2.9 t80 -65.35 134.42 53.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.309 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.564 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.7 m -111.49 177.45 4.65 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 124.633 1.208 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m -142.81 -50.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' GLY . 13.8 p-10 -102.93 68.94 1.02 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' A' ' 17' ' ' ASP . 14.1 t -41.53 -70.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -38.54 -35.96 0.22 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.66 -57.05 8.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 5.5 tp10 -53.9 -35.62 61.83 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 124.532 1.133 . . . . 0.0 108.461 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.2 m -75.33 -44.35 45.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.856 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.3 mt -63.76 -30.98 72.01 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.78 -28.82 69.84 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.398 1.061 . . . . 0.0 109.794 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 14.3 mtm-85 -99.12 6.38 46.51 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.573 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.96 17.57 69.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 15.2 m-30 -83.27 174.47 10.7 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.146 -0.527 . . . . 0.0 109.928 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -87.08 151.98 22.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.39 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.18 104.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 O-C-N 125.632 1.832 . . . . 0.0 110.483 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.504 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -87.43 -177.77 48.44 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -164.52 174.98 10.3 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.8 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.6 m -95.14 150.44 20.2 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.048 1.468 . . . . 0.0 107.374 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.214 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.437 HD22 HG13 ' A' ' 38' ' ' VAL . 12.5 m-80 -147.58 154.09 40.26 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.95 161.0 15.11 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.272 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.547 ' CE2' HD23 ' A' ' 3' ' ' LEU . 67.8 m95 -148.31 155.5 41.37 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 124.544 1.152 . . . . 0.0 108.483 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.45 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 55.9 m -94.88 164.24 13.0 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.375 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -100.69 59.56 0.95 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.468 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 13.0 t . . . . . 0 C--N 1.313 -1.02 1 CA-C-O 111.607 -4.044 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' HG21 ' A' ' 44' ' ' THR . 12.0 mptt -125.49 94.6 4.19 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.651 1.219 . . . . 0.0 108.234 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.487 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 5.9 tt -57.62 163.61 2.4 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.339 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' SG ' ' A' ' 42' ' ' CYS . 6.3 pt -134.85 -41.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.408 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.08 -148.42 9.58 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.331 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.79 178.56 5.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.971 -1.114 . . . . 0.0 109.732 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 t -138.77 54.26 1.75 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 38' ' ' VAL . 25.4 t -138.4 122.63 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 123.808 0.693 . . . . 0.0 109.452 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.56 67.49 3.48 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.22 55.89 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.94 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.74 178.45 8.47 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -81.44 170.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 m120 44.16 28.83 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.367 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 19.3 t80 -57.06 135.26 56.32 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.826 1.329 . . . . 0.0 109.802 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 16' ' ' SER . 24.4 m -92.57 -76.89 0.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 125.177 1.548 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' THR . 7.6 t 91.51 -39.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.43 78.24 1.72 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.677 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 1.8 t -48.51 -57.45 6.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 30' ' ' GLY . 2.8 m120 -54.51 -33.23 59.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.12 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.21 -66.92 2.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 42.7 tt0 -47.88 -38.41 16.21 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 56.5 m -74.65 -41.35 60.49 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.691 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.98 -30.07 71.18 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.21 -33.08 74.99 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 124.356 1.035 . . . . 0.0 108.397 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 5.0 mpt_? -94.22 6.14 49.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.952 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.47 75.02 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 10.0 m-85 -77.92 149.31 34.22 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.606 0.827 . . . . 0.0 109.775 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.78 -43.36 8.55 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.864 -1.517 . . . . 0.0 109.028 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.69 -166.97 39.75 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.408 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -161.8 156.0 27.4 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 124.906 1.004 . . . . 0.0 110.626 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.567 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.1 p-80 -156.12 158.98 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.852 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' O ' ' C ' ' A' ' 33' ' ' GLY . 84.1 m -77.78 150.4 34.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.345 0 O-C-N 125.258 1.599 . . . . 0.0 112.21 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 8' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -131.1 136.51 48.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 145.35 40.2 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 34.0 m95 -129.86 156.51 44.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 125.417 1.698 . . . . 0.0 109.185 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 66.2 m -85.75 170.26 12.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 116.59 -2.044 . . . . 0.0 108.079 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 55.53 1.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.173 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.401 HG21 ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 113.079 -3.343 . . . . 0.0 109.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.524 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.583 ' HB2' HG21 ' A' ' 44' ' ' THR . 5.8 tmtt? -117.79 116.34 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.35 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.6 tt -75.75 162.65 28.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.612 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.77 HD11 ' SG ' ' A' ' 40' ' ' CYS . 8.7 pt -134.37 -43.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 125.026 1.454 . . . . 0.0 108.981 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.72 -161.62 23.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -96.45 155.85 16.59 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.012 0.91 . . . . 0.0 109.922 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 5.2 t -114.17 56.7 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.411 ' CG2' HG12 ' A' ' 38' ' ' VAL . 82.7 t -136.33 116.98 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.295 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -75.41 117.58 17.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -27.25 6.82 Favored Glycine 0 N--CA 1.485 1.959 0 O-C-N 124.638 1.211 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.59 172.84 10.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.441 0.73 . . . . 0.0 109.101 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.7 t -81.23 169.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.69 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 m120 42.34 30.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.698 1.249 . . . . 0.0 108.475 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 6.2 t80 -62.31 143.81 56.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.366 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' SER . 12.4 m -89.47 -73.01 0.53 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 124.465 1.103 . . . . 0.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 15' ' ' THR . 5.3 t 89.41 -37.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 18' ' ' CYS . 19.9 p-10 -139.9 70.35 1.36 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.95 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.6 t -39.53 -65.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -41.58 -48.05 3.94 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -60.45 -68.19 1.79 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' CD ' ' NH2' ' A' ' 25' ' ' ARG . 6.8 tp10 -44.31 -32.85 1.42 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 122.312 1.053 . . . . 0.0 109.385 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 4' ' ' ILE . 13.0 m -76.13 -42.56 46.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.474 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' GLY . 25.1 mt -65.12 -30.8 71.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.71 -30.54 71.49 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.327 1.061 . . . . 0.0 109.152 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' NH2' ' CD ' ' A' ' 21' ' ' GLU . 9.0 mtm180 -102.61 7.33 39.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.637 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.87 14.57 68.01 Favored Glycine 0 N--CA 1.491 2.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.213 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 9.9 m-85 -77.41 175.48 9.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.83 0.824 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.31 150.41 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.983 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.15 94.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.858 0 O-C-N 125.867 1.979 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.52 -170.73 28.77 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 124.959 1.035 . . . . 0.0 110.531 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 16.4 p-80 -163.5 172.37 14.55 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.136 -1.032 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 33' ' ' GLY . 69.0 m -81.89 149.95 28.0 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.793 0 O-C-N 125.593 1.808 . . . . 0.0 112.929 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG12 ' CG2' ' A' ' 8' ' ' VAL . 11.5 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.905 0.86 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -149.48 116.45 5.98 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.664 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.77 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.38 133.49 41.92 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.524 ' CE3' ' HB2' ' A' ' 1' ' ' ASP . 67.4 m95 -119.64 156.8 29.73 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.879 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 4' ' ' ILE . 40.1 m -92.39 174.88 7.06 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.997 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -101.03 61.2 0.95 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 124.999 2.333 . . . . 0.0 111.467 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 2' ' ' LYS . 31.3 p . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 112.743 -3.503 . . . . 0.0 110.435 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 158.82 16.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.611 1.194 . . . . 0.0 108.08 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.3 tt -99.42 164.5 12.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.777 HD11 ' SG ' ' A' ' 22' ' ' CYS . 44.8 mt -132.56 -43.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 125.366 1.666 . . . . 0.0 109.396 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.81 -147.03 12.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.532 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 53.5 m -96.14 160.42 14.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.808 -0.696 . . . . 0.0 110.236 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.4 t -138.72 27.3 2.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 69.2 t -93.53 135.08 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -79.13 63.84 3.88 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.732 1.27 . . . . 0.0 107.72 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.56 63.56 0.04 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.19 177.64 11.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.542 0.789 . . . . 0.0 109.294 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.2 t -82.45 168.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.781 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.82 27.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.098 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 5.6 t80 -60.73 134.39 57.03 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.134 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -110.64 167.95 9.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 125.166 1.541 . . . . 0.0 109.831 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.7 m -142.14 -47.43 0.35 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.144 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.34 67.82 0.74 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.924 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' HD12 ' A' ' 4' ' ' ILE . 5.5 t -50.01 -64.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -33.08 1.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.611 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.38 -55.95 11.29 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 24.2 tt0 -58.97 -30.56 68.01 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.045 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.2 m -78.12 -41.17 35.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.3 -31.41 72.56 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.48 -30.61 71.64 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.761 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -92.76 2.53 56.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.119 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.41 20.38 75.28 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 14.1 m-85 -77.04 173.2 12.08 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.652 0.854 . . . . 0.0 110.019 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 4.6 mptt -71.05 -35.24 71.86 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.525 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 165.67 -177.43 40.89 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -156.3 159.32 29.34 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 21.8 p-80 -163.32 163.13 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.142 -1.029 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' A' ' 33' ' ' GLY . 92.5 m -78.25 151.42 33.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.495 2.578 0 O-C-N 126.471 2.357 . . . . 0.0 111.522 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.6 p . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -134.43 156.31 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -110.84 154.46 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.53 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CD1' ' C ' ' A' ' 40' ' ' CYS . 32.8 m95 -140.35 156.95 46.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.243 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.686 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -87.39 163.62 16.67 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -97.64 53.9 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.316 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 5.0 t . . . . . 0 C--N 1.305 -1.353 1 CA-C-O 111.378 -4.153 . . . . 0.0 111.963 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -154.0 95.55 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 125.948 2.03 . . . . 0.0 108.913 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.0 tt -56.04 162.82 1.75 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.087 0.867 . . . . 0.0 109.323 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.542 HD11 ' SG ' ' A' ' 18' ' ' CYS . 31.1 pt -134.41 -41.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.822 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.61 -147.86 10.94 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.735 -1.222 . . . . 0.0 110.45 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 14' ' ' TYR . 4.2 m -86.78 -178.59 6.37 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.414 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.01 49.77 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG21 HG12 ' A' ' 38' ' ' VAL . 3.4 t -148.95 125.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.087 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.83 103.61 5.99 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 -18.78 3.38 Favored Glycine 0 N--CA 1.491 2.334 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.94 171.77 8.56 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.8 t -82.13 169.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.021 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.17 29.0 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.25 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 13.0 t80 -57.64 147.66 26.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.892 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' SER . 15.6 m -96.23 -70.74 0.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.601 1.188 . . . . 0.0 109.355 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 88.65 -36.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.34 86.71 2.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.863 1.316 . . . . 0.0 109.421 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 t -66.81 -71.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.183 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -41.97 -32.23 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.126 -0.629 . . . . 0.0 109.557 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -59.37 6.19 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.022 1.451 . . . . 0.0 109.569 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 11.4 tp10 -55.67 -35.75 66.35 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.277 0.56 . . . . 0.0 110.103 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.44 -42.75 58.57 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.91 -30.58 70.98 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.94 -36.43 81.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 124.405 1.066 . . . . 0.0 109.395 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.02 16.04 20.69 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.777 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.81 28.82 53.51 Favored Glycine 0 N--CA 1.49 2.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.745 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 4.4 m-85 -75.94 159.82 30.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.959 0.885 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -57.61 -31.22 66.0 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.855 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 160.43 -173.65 37.03 Favored Glycine 0 N--CA 1.484 1.883 0 O-C-N 124.667 1.229 . . . . 0.0 110.639 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.02 155.8 26.96 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 3.6 p-80 -154.33 166.2 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.948 -1.126 . . . . 0.0 110.158 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 57.5 m -76.96 150.09 35.93 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.477 1.42 0 O-C-N 125.815 1.947 . . . . 0.0 113.133 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 8' ' ' VAL . 4.8 m . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.945 0.879 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -151.43 118.1 5.76 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.098 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -98.0 144.71 27.23 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' TRP . 11.2 m95 -127.06 164.96 20.4 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.047 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -96.21 171.42 8.6 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 125.068 1.48 . . . . 0.0 107.195 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' CD ' ' HD1' ' A' ' 31' ' ' HIS . 1.8 tp10 -97.81 54.0 1.13 Allowed 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.896 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 42' ' ' CYS . 31.8 p . . . . . 0 C--N 1.3 -1.554 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.201 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 48.1 mmtt -100.48 104.75 16.16 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 4' ' ' ILE . 7.9 tt -59.04 162.19 4.49 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.904 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.62 HD11 ' SG ' ' A' ' 18' ' ' CYS . 20.8 pt -134.49 -43.09 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 125.027 1.454 . . . . 0.0 109.123 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 -148.09 10.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.1 t -97.29 164.49 12.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.66 1.219 . . . . 0.0 108.863 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -127.77 50.09 2.07 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.284 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 11' ' ' ALA . 33.1 t -130.02 122.09 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.817 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.5 92.53 2.37 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 -6.91 5.71 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . . . -96.41 178.97 5.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.0 t -81.65 168.8 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.972 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 p30 40.0 31.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 125.386 1.679 . . . . 0.0 108.315 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.6 t80 -55.45 137.34 48.5 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 125.327 1.642 . . . . 0.0 109.522 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' SER . 17.7 m -86.59 -73.76 0.45 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.552 1.157 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.6 OUTLIER 89.39 -36.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -137.75 73.77 1.45 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -46.85 -62.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -27.71 5.99 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.313 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.53 -67.43 1.72 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 34.0 tt0 -49.19 -31.83 9.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.2 m -75.86 -43.59 44.87 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 124.286 0.991 . . . . 0.0 108.338 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.89 -31.1 72.16 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.497 1.123 . . . . 0.0 108.05 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.08 -31.27 72.37 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.696 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -91.05 -3.34 57.27 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.533 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.22 12.09 76.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 23.6 m-85 -81.52 163.87 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.583 0.814 . . . . 0.0 110.038 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' GLY . 3.4 mppt? -86.71 169.14 12.92 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.292 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -31.18 99.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 O-C-N 125.647 1.842 . . . . 0.0 110.932 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.41 -165.96 33.6 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.587 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 32.6 p-80 -164.19 171.98 14.27 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.282 -0.959 . . . . 0.0 109.938 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 20.7 m -101.52 147.44 26.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.483 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.481 1.697 0 O-C-N 125.664 1.853 . . . . 0.0 112.615 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -153.22 174.38 14.34 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 123.563 0.539 . . . . 0.0 110.242 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -122.53 147.3 46.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 124.782 1.301 . . . . 0.0 107.997 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.537 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.0 m95 -146.72 160.45 42.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.263 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 93.0 m -94.21 -173.01 2.96 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 117.224 -1.79 . . . . 0.0 108.673 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.587 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 5.5 mt-10 -143.88 76.42 1.51 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.072 0.939 . . . . 0.0 110.272 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 115.952 -1.975 . . . . 0.0 109.969 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.422 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 3.1 m-20 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -120.9 109.97 15.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.476 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -71.74 163.33 28.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.832 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 22' ' ' CYS . 4.9 pt -136.53 -41.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 125.17 1.544 . . . . 0.0 108.74 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -163.06 24.99 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -93.52 163.48 13.55 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.354 -0.923 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -123.06 54.49 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.83 121.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.34 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 71.12 4.06 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.95 59.35 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.8 179.71 8.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.5 t -79.24 170.72 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 40.5 30.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.61 1.194 . . . . 0.0 109.511 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 25.0 t80 -52.99 135.16 37.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.642 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 16' ' ' SER . 50.6 m -92.29 -74.58 0.51 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.485 1.116 . . . . 0.0 109.695 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 15' ' ' THR . 3.6 t 90.21 -39.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.4 p-10 -136.84 73.93 1.47 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.245 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 6.7 t -43.91 -57.96 3.02 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.54 -36.03 61.36 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -67.01 -70.19 1.18 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.664 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 46.3 tp10 -45.64 -34.01 3.22 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.412 1.101 . . . . 0.0 110.206 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 4' ' ' ILE . 4.2 m -73.23 -43.59 60.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.697 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.34 -30.99 72.02 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.986 1.429 . . . . 0.0 109.166 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.68 7.73 45.76 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.187 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.72 19.62 69.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.558 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 15.4 m-30 -84.29 172.0 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.913 -0.643 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.03 149.43 25.58 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.43 99.46 0.01 OUTLIER Glycine 0 N--CA 1.486 2.021 0 O-C-N 125.744 1.903 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.42 -174.7 35.78 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 10.9 p-80 -163.94 174.43 11.45 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.19 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' O ' ' C ' ' A' ' 33' ' ' GLY . 99.3 m -90.94 152.58 20.66 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.492 2.414 0 O-C-N 126.058 2.099 . . . . 0.0 111.595 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -125.93 136.29 52.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.233 0.958 . . . . 0.0 109.805 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.6 140.47 38.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.1 m95 -129.66 162.67 27.81 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.04 -1.437 . . . . 0.0 107.851 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 80.9 m -95.21 172.25 8.23 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 117.269 -1.772 . . . . 0.0 108.382 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -101.16 61.23 0.94 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 124.754 2.216 . . . . 0.0 112.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 36.4 p . . . . . 0 C--N 1.305 -1.364 0 CA-C-O 112.489 -3.624 . . . . 0.0 111.252 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.41 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 3.5 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -110.67 98.18 7.41 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.967 -1.469 . . . . 0.0 109.089 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.58 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 8.1 tt -56.16 161.47 2.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.077 0.861 . . . . 0.0 109.062 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.524 ' N ' HD23 ' A' ' 3' ' ' LEU . 19.8 pt -136.26 -41.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 124.823 1.327 . . . . 0.0 109.396 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.26 -148.59 9.62 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 124.86 1.35 . . . . 0.0 110.156 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.7 m -94.42 -172.45 2.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.777 -0.711 . . . . 0.0 109.812 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' VAL . 24.5 t -152.89 34.91 0.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 38' ' ' VAL . 2.0 t -126.97 127.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -78.73 62.15 3.18 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 44.47 0.02 OUTLIER Glycine 0 N--CA 1.487 2.055 0 CA-C-N 114.253 -1.34 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.23 179.06 9.09 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -78.2 167.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.634 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.47 29.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.988 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -52.1 135.77 30.86 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 124.902 1.376 . . . . 0.0 110.173 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.513 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.5 t -120.65 175.58 5.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 125.125 1.516 . . . . 0.0 108.931 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.7 -50.5 0.41 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.126 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' CYS . 7.7 p-10 -109.12 69.26 0.7 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.434 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 4' ' ' ILE . 7.6 t -38.26 -58.58 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -45.63 -50.28 13.49 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.311 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -61.61 -65.06 3.47 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 6.1 tp10 -41.19 -37.1 0.85 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 124.376 1.071 . . . . 0.0 108.627 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.646 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.5 m -75.56 -43.9 46.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.517 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 22.2 mt -62.75 -30.29 71.33 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.09 -32.84 74.55 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.261 0.975 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 18.6 mtm-85 -92.18 3.79 54.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.843 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 12.89 83.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 21.8 m-85 -89.89 170.04 10.72 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.994 0.902 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 43' ' ' GLU . 34.3 mtpt -84.64 154.86 22.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.446 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -34.98 96.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 O-C-N 125.341 1.65 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -69.45 -170.83 7.6 Favored Glycine 0 N--CA 1.48 1.607 0 O-C-N 125.386 1.286 . . . . 0.0 110.893 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -161.94 171.46 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.578 -1.311 . . . . 0.0 110.455 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' C ' ' A' ' 33' ' ' GLY . 87.0 m -92.04 151.45 20.45 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.492 2.415 0 O-C-N 125.667 1.855 . . . . 0.0 112.509 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 8' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 35.5 m120 -120.94 137.63 54.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 124.156 0.91 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -107.36 147.28 30.53 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 65.2 m95 -137.06 152.49 50.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 84.2 m -86.45 -171.59 3.62 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.051 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -142.73 74.46 1.45 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 59.7 p . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 112.973 -3.394 . . . . 0.0 109.573 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HE2' ' OH ' ' A' ' 27' ' ' TYR . 3.6 tmtm? -97.73 107.18 19.62 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.7 tt -64.32 162.69 14.36 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.077 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 ' SG ' ' A' ' 18' ' ' CYS . 18.3 pt -135.73 -39.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.117 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 176.33 -148.1 8.96 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.433 ' O ' ' HB ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -104.34 167.37 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.185 -1.008 . . . . 0.0 109.765 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 56.1 m -134.62 43.87 2.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.94 123.79 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 124.779 1.299 . . . . 0.0 109.08 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 73.57 4.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.08 52.08 0.02 OUTLIER Glycine 0 N--CA 1.488 2.102 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.152 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.67 176.57 10.82 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.47 170.64 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.408 ' H ' HG12 ' A' ' 12' ' ' VAL . 35.3 m-20 42.49 30.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.569 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.37 134.28 56.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.999 1.437 . . . . 0.0 109.965 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 6' ' ' SER . 2.8 m -120.46 173.84 6.91 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 124.807 1.317 . . . . 0.0 109.107 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.0 t -142.36 -50.04 0.37 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.919 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -102.58 66.42 0.96 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.057 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.6 t -43.15 -71.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.505 HD22 ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -43.64 -28.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.075 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.48 -60.78 4.51 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 1.1 tt0 -56.26 -31.49 63.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 10.9 m -77.1 -41.91 40.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' CD1' HD22 ' A' ' 19' ' ' ASN . 17.6 mt -64.08 -29.45 70.59 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.8 mt -65.78 -30.41 71.06 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 124.308 1.005 . . . . 0.0 109.309 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -86.94 0.85 54.38 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.613 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.79 14.93 76.67 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.321 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 18.9 m-85 -79.24 140.7 37.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.495 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -43.39 -50.21 6.87 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.334 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.04 169.3 40.83 Favored Glycine 0 N--CA 1.481 1.662 0 O-C-N 125.213 1.571 . . . . 0.0 110.445 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -148.51 154.17 25.68 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -149.85 160.6 43.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 21.0 m -85.06 146.54 27.11 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.484 1.842 0 O-C-N 126.133 2.145 . . . . 0.0 111.95 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' ND2' ' OG ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -153.34 175.67 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -121.3 144.94 48.36 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 50.1 m95 -146.95 158.03 43.8 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.514 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 89.7 m -88.33 -174.9 4.81 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 117.837 -1.545 . . . . 0.0 108.11 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.271 44.6 tt0 -141.72 73.66 1.42 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 124.083 0.864 . . . . 0.0 110.364 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 45.3 p . . . . . 0 C--N 1.295 -1.783 0 O-C-N 125.24 1.587 . . . . 0.0 111.675 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 11.9 tptt -134.18 100.51 4.73 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.241 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 4' ' ' ILE . 8.8 tt -59.45 161.56 5.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.609 HD11 ' SG ' ' A' ' 18' ' ' CYS . 9.0 pt -135.82 -42.58 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.727 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.58 -148.39 9.04 Favored Glycine 0 N--CA 1.482 1.703 0 O-C-N 124.987 1.429 . . . . 0.0 109.983 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.475 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 25.1 t -102.61 171.57 7.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.318 -1.353 . . . . 0.0 108.639 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 44.4 t -144.32 40.99 1.35 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.659 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.268 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.58 68.08 3.6 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.95 50.17 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.23 178.41 10.21 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -84.61 168.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.31 29.5 0.23 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.837 1.336 . . . . 0.0 108.225 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE1' ' O ' ' A' ' 15' ' ' THR . 18.6 t80 -57.85 134.24 56.12 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.893 1.37 . . . . 0.0 110.073 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.0 t -117.73 -179.76 3.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.741 1.276 . . . . 0.0 109.15 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' THR . 0.7 OUTLIER -142.05 -49.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.682 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 18' ' ' CYS . 10.5 p-10 -105.24 66.15 0.74 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.096 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.1 t -37.77 -71.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.512 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 59.9 t30 -37.19 -42.85 0.47 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.618 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -64.78 -55.03 24.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' NH2' ' A' ' 25' ' ' ARG . 18.0 tt0 -56.79 -29.94 63.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' SG ' HD13 ' A' ' 4' ' ' ILE . 1.9 m -76.08 -45.45 33.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.11 -32.29 71.97 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.78 -34.75 76.42 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.802 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.605 HH11 ' CA ' ' A' ' 4' ' ' ILE . 4.4 mtm180 -89.5 -0.42 57.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.309 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.85 12.6 79.53 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 18.2 m-30 -83.98 164.69 19.18 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.251 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -87.92 172.38 9.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.369 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -27.89 106.2 0.01 OUTLIER Glycine 0 N--CA 1.485 1.961 0 O-C-N 125.964 2.04 . . . . 0.0 110.834 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.2 -170.17 33.44 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 6.6 p-80 -166.08 176.83 7.4 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 60.4 m -100.68 147.38 26.07 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . . . . . . 0 N--CA 1.483 1.768 0 O-C-N 126.126 2.141 . . . . 0.0 112.046 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 8.7 m-80 -155.36 176.38 12.66 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.97 147.81 44.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 122.351 1.072 . . . . 0.0 108.319 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 52.2 m95 -146.16 162.02 38.92 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.399 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.2 m -94.61 -173.51 3.04 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 117.038 -1.865 . . . . 0.0 108.868 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 11.5 tt0 -142.68 75.79 1.5 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.959 0.787 . . . . 0.0 109.944 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 115.057 -2.402 . . . . 0.0 110.439 179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 9.7 mptt -130.39 94.24 3.62 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 124.876 1.36 . . . . 0.0 109.303 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -55.66 163.53 1.33 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 113.678 -1.601 . . . . 0.0 108.166 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.686 HD13 ' SG ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -134.85 -43.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.111 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.47 -150.78 12.42 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 38.4 m -95.88 170.29 9.4 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.504 -0.848 . . . . 0.0 109.858 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.1 t -140.19 43.81 1.9 Allowed 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 97.8 t -119.7 129.92 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.43 74.15 4.98 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.25 58.01 0.04 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-N 113.292 -1.777 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.39 173.91 16.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.532 0.784 . . . . 0.0 109.308 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.4 172.59 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 41.34 30.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.694 1.246 . . . . 0.0 108.754 -179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' N ' ' C ' ' A' ' 12' ' ' VAL . 30.0 t80 -51.69 138.79 22.5 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.5 m -91.75 -75.21 0.48 Allowed 'General case' 0 C--N 1.311 -1.109 0 O-C-N 124.647 1.217 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.2 OUTLIER 88.68 -35.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 20' ' ' GLY . 6.1 p-10 -138.96 72.55 1.41 Allowed 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.8 t -41.55 -71.46 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -42.23 -32.55 0.5 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.57 -60.81 5.14 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.8 tp10 -55.38 -32.78 62.89 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.654 0.74 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.0 m -74.72 -43.89 52.74 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.642 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.49 -30.78 71.6 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 124.464 1.102 . . . . 0.0 108.242 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 mt -63.17 -28.41 70.03 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 124.729 1.268 . . . . 0.0 109.605 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.487 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.39 -1.07 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.484 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.47 14.65 82.27 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.552 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 19.2 m-85 -79.52 170.86 15.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.95 0.881 . . . . 0.0 109.891 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.626 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.7 156.57 20.59 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.742 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.31 103.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.102 0 O-C-N 125.166 1.541 . . . . 0.0 110.352 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -83.11 -171.23 47.19 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.99 173.92 11.04 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.016 -1.092 . . . . 0.0 109.547 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 99.5 m -93.93 150.62 20.2 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 125.05 1.469 . . . . 0.0 107.678 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -36.95 140.32 0.31 Allowed Glycine 0 N--CA 1.483 1.821 0 O-C-N 125.63 1.831 . . . . 0.0 111.022 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 t -81.6 -48.88 11.2 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.323 -0.939 . . . . 0.0 109.149 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.29 36.1 4.5 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 123.913 0.758 . . . . 0.0 109.747 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.78 49.39 0.09 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.245 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -48.4 90.57 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.329 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 36' ' ' ALA . 3.0 p -170.25 -40.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 38.1 m-20 -119.6 150.64 39.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.736 1.273 . . . . 0.0 109.846 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -107.81 155.79 19.85 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD12 ' A' ' 3' ' ' LEU . 24.7 m95 -142.98 158.67 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.193 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.552 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 82.5 m -94.37 164.5 12.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.808 -1.957 . . . . 0.0 107.551 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -97.55 55.43 1.24 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.209 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.626 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 12.5 t . . . . . 0 C--N 1.31 -1.152 0 CA-C-O 111.85 -3.928 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.43 ' HA ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 5.2 mmtm -100.98 111.4 23.59 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 4' ' ' ILE . 5.2 tt -66.49 163.7 17.98 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.126 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.579 HD13 ' SG ' ' A' ' 22' ' ' CYS . 21.8 pt -135.09 -41.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.35 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.24 -148.93 9.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 m -99.43 177.96 5.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.811 -0.695 . . . . 0.0 109.743 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 t -146.23 49.56 1.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.9 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.409 HG21 HG23 ' A' ' 38' ' ' VAL . 3.9 t -144.85 126.88 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.675 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.88 61.66 1.96 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 125.215 1.572 . . . . 0.0 107.013 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.67 39.51 0.03 OUTLIER Glycine 0 N--CA 1.486 2.015 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.35 176.66 11.74 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 124.265 0.627 . . . . 0.0 109.435 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.41 171.4 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.428 ' H ' HG12 ' A' ' 12' ' ' VAL . 13.8 m120 42.22 30.09 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.115 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -51.41 135.7 26.83 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.967 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 16' ' ' SER . 1.1 t -123.63 -178.13 3.94 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 124.802 1.314 . . . . 0.0 108.594 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 15' ' ' THR . 38.7 t -143.12 -56.04 0.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.394 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -101.67 70.2 1.25 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.791 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 11.2 t -41.18 -72.85 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -41.0 -32.67 0.25 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.272 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.18 -60.57 5.09 Favored Glycine 0 N--CA 1.486 1.985 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.554 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 25' ' ' ARG . 5.3 tt0 -58.32 -29.32 65.8 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 4' ' ' ILE . 7.4 m -77.03 -42.5 38.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.1 mt -63.68 -30.1 71.25 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -33.48 74.95 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.553 HH11 HG22 ' A' ' 4' ' ' ILE . 2.0 mtm180 -86.68 -2.27 58.39 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.155 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.54 14.32 76.32 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.548 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.3 m-85 -77.66 148.93 34.77 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.175 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.656 ' CE ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -47.93 -42.2 26.66 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.508 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.24 -168.79 40.23 Favored Glycine 0 N--CA 1.483 1.799 0 O-C-N 125.165 1.541 . . . . 0.0 110.158 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.44 160.72 32.97 Favored Glycine 0 N--CA 1.484 1.876 0 O-C-N 124.67 0.865 . . . . 0.0 111.208 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.31 168.01 28.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.286 -0.957 . . . . 0.0 109.357 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 73.0 m -85.54 151.3 24.04 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' HA3' ' CB ' ' A' ' 37' ' ' ASN . . . -26.37 -83.99 0.01 OUTLIER Glycine 0 N--CA 1.489 2.169 0 O-C-N 125.652 1.845 . . . . 0.0 112.437 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -145.17 -51.31 0.26 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 125.091 1.112 . . . . 0.0 109.329 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 4.6 t80 -169.74 81.35 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.27 0.981 . . . . 0.0 110.328 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 82.51 35.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 124.582 1.176 . . . . 0.0 109.464 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 41.4 t30 -61.97 -31.33 71.67 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 113.538 -1.664 . . . . 0.0 108.782 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.409 HG23 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 86.29 7.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.64 1.213 . . . . 0.0 107.806 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HB2' ' ND2' ' A' ' 37' ' ' ASN . 9.6 m120 -143.04 132.15 23.09 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -109.41 137.68 46.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -125.33 157.49 36.58 Favored 'General case' 0 C--N 1.309 -1.195 0 O-C-N 125.271 1.607 . . . . 0.0 108.043 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 98.7 m -84.38 161.28 20.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 116.341 -2.143 . . . . 0.0 107.992 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -99.69 57.18 1.0 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.954 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.656 ' HA ' ' CE ' ' A' ' 28' ' ' LYS . 14.2 t . . . . . 0 C--N 1.31 -1.142 0 CA-C-O 112.695 -3.526 . . . . 0.0 109.187 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 9.3 mptt -115.91 102.57 9.8 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.554 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 4.8 tt -56.33 162.38 2.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.051 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.645 HD11 ' SG ' ' A' ' 18' ' ' CYS . 2.9 pt -133.98 -45.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.79 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.25 -148.94 10.26 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 125.033 1.458 . . . . 0.0 109.861 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.65 155.83 17.86 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 114.139 -1.031 . . . . 0.0 109.279 -179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 43.0 t -124.01 48.77 1.85 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 11' ' ' ALA . 59.7 t -125.39 118.88 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.571 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.05 96.04 2.63 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.01 -9.76 5.69 Favored Glycine 0 N--CA 1.49 2.268 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.451 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . . . -96.31 176.71 5.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -82.28 168.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 114.178 -1.373 . . . . 0.0 107.987 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m120 42.31 30.08 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.461 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.417 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.7 t80 -53.44 140.62 27.26 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 125.28 1.613 . . . . 0.0 109.633 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' SER . 3.4 m -88.0 -74.28 0.46 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 124.687 1.242 . . . . 0.0 109.733 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 90.06 -38.1 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -138.19 72.86 1.42 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -42.57 -72.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -39.08 -32.62 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.16 -60.19 4.6 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 4' ' ' ILE . 39.5 tp10 -55.43 -32.17 62.5 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.137 0.97 . . . . 0.0 110.578 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.9 m -75.75 -44.89 39.43 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.105 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.22 -31.56 72.73 Favored 'General case' 0 C--N 1.312 -1.025 0 O-C-N 124.513 1.133 . . . . 0.0 108.202 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.757 1.286 . . . . 0.0 109.948 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.602 ' NH1' ' HA ' ' A' ' 4' ' ' ILE . 48.8 mtt180 -93.6 -4.12 51.38 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.334 -1.757 . . . . 0.0 111.158 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.15 13.03 79.95 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 11.9 m-30 -81.22 162.6 23.5 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.354 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' NZ ' ' OG1' ' A' ' 44' ' ' THR . 2.3 mppt? -79.71 163.61 24.38 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.674 -1.603 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -32.12 104.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 O-C-N 125.479 1.737 . . . . 0.0 110.436 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.05 -165.44 39.08 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.444 -1.36 . . . . 0.0 109.837 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -163.95 173.4 12.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 109.585 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 52.6 m -98.56 146.27 25.97 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.287 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 21.82 -124.05 0.01 OUTLIER Glycine 0 N--CA 1.483 1.778 0 O-C-N 126.292 2.245 . . . . 0.0 112.033 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.9 t -159.91 -44.53 0.05 Allowed 'General case' 0 N--CA 1.484 1.249 0 O-C-N 125.274 1.22 . . . . 0.0 108.869 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 21.4 t80 -172.39 85.59 0.07 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.502 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 84.39 53.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.866 1.354 . . . . 0.0 109.173 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 11.4 t-20 -106.47 -154.09 0.51 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.099 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.587 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 16.9 m -164.45 31.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -152.55 174.75 13.54 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 123.532 0.52 . . . . 0.0 110.369 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -123.95 147.62 47.58 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.52 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 36.8 m95 -145.77 160.59 41.53 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.615 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.9 m -93.26 -175.94 3.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 117.327 -1.749 . . . . 0.0 108.288 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.535 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 39.8 mt-10 -142.97 75.78 1.5 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 124.358 1.036 . . . . 0.0 110.53 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.442 ' OG1' ' NZ ' ' A' ' 28' ' ' LYS . 1.1 t . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 115.706 -2.092 . . . . 0.0 110.725 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.5 mmtt -108.28 103.8 13.05 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.3 tt -59.88 163.08 4.84 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.303 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.571 HD11 ' SG ' ' A' ' 18' ' ' CYS . 14.9 pt -135.07 -41.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 125.063 1.477 . . . . 0.0 109.257 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.77 -147.02 9.8 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.131 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.53 -175.3 3.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.611 -0.795 . . . . 0.0 109.797 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 13.7 t -150.17 54.36 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 ' CG2' HG23 ' A' ' 38' ' ' VAL . 2.6 t -146.73 129.92 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.985 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 67.89 5.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.64 42.69 0.02 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 113.714 -1.585 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.15 174.77 12.4 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 13' ' ' ASN . 2.4 t -79.98 171.56 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.77 1.294 . . . . 0.0 107.655 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.416 ' H ' HG12 ' A' ' 12' ' ' VAL . 4.4 m120 42.71 29.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 124.376 1.047 . . . . 0.0 108.876 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 18.6 t80 -47.43 136.39 9.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 125.207 1.567 . . . . 0.0 109.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 16' ' ' SER . 37.2 m -96.85 -75.79 0.53 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 124.675 1.234 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' THR . 1.6 t 89.89 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.6 p-10 -137.35 75.78 1.55 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.133 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.571 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -44.5 -59.8 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -50.86 -33.17 22.76 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.221 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -70.77 -63.93 3.01 Favored Glycine 0 N--CA 1.486 1.973 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.482 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 26.7 tt0 -53.68 -30.77 44.97 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 5.3 m -75.92 -43.16 46.45 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -65.1 -31.31 72.46 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.578 1.174 . . . . 0.0 108.234 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 25' ' ' ARG . 2.3 mt -62.97 -28.27 69.97 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.719 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.77 -2.76 40.38 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 113.972 -1.467 . . . . 0.0 110.056 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 10.17 80.46 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.53 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 20.9 m-85 -80.41 167.07 20.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.989 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.24 166.06 14.6 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.853 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -33.1 98.61 0.01 OUTLIER Glycine 0 N--CA 1.485 1.954 0 O-C-N 125.584 1.803 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -73.88 -166.78 13.98 Favored Glycine 0 N--CA 1.48 1.63 0 O-C-N 125.84 1.553 . . . . 0.0 110.324 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.425 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 50.1 p-80 -162.48 171.16 17.52 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 113.898 -1.151 . . . . 0.0 110.366 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -92.24 150.46 20.87 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 37' ' ' ASN . . . -39.07 -81.31 0.02 OUTLIER Glycine 0 N--CA 1.472 1.096 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.645 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 p -160.94 -74.29 0.06 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.735 0.779 . . . . 0.0 109.79 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -129.77 -89.29 0.49 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 113.779 -1.555 . . . . 0.0 111.495 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.35 1.28 29.48 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 123.852 0.72 . . . . 0.0 110.518 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.596 ' CG ' ' HA3' ' A' ' 33' ' ' GLY . 1.8 t-20 -45.71 -42.03 11.27 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.863 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' CG2' ' A' ' 8' ' ' VAL . 9.1 p 46.16 24.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 125.075 1.484 . . . . 0.0 108.792 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' N ' ' C ' ' A' ' 37' ' ' ASN . 3.4 m-20 -133.15 123.24 25.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.722 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 143.54 27.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 19.1 m95 -130.06 151.85 50.15 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.478 -2.147 . . . . 0.0 109.339 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.53 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 92.2 m -89.75 162.32 15.6 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 116.546 -2.061 . . . . 0.0 107.7 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.16 57.25 1.06 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 122.593 1.187 . . . . 0.0 111.433 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.454 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 3.2 t . . . . . 0 C--N 1.304 -1.406 1 CA-C-O 111.519 -4.086 . . . . 0.0 110.219 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -125.93 127.31 45.78 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 112.412 -2.176 . . . . 0.0 109.439 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 4' ' ' ILE . 1.6 tm? -73.0 163.57 27.98 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.048 -1.061 . . . . 0.0 108.312 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.601 HG21 ' SG ' ' A' ' 22' ' ' CYS . 8.5 pt -136.77 -39.96 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 124.928 1.392 . . . . 0.0 108.684 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.37 -159.18 32.43 Favored Glycine 0 N--CA 1.486 2.022 0 O-C-N 124.799 1.312 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.17 167.16 11.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.308 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.74 47.29 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.565 HG21 HG22 ' A' ' 38' ' ' VAL . 69.9 t -119.26 127.43 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.176 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -77.58 70.3 3.94 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.471 -1.241 . . . . 0.0 107.709 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.91 56.9 0.04 OUTLIER Glycine 0 N--CA 1.485 1.954 0 CA-C-N 113.49 -1.687 . . . . 0.0 110.956 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.6 173.82 15.81 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.387 0.698 . . . . 0.0 109.195 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.2 t -80.86 171.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.42 ' H ' HG12 ' A' ' 12' ' ' VAL . 50.9 m-20 43.61 28.76 0.22 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.941 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' N ' ' C ' ' A' ' 12' ' ' VAL . 38.6 t80 -51.99 140.53 20.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.841 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' SER . 4.9 m -89.95 -75.43 0.45 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 124.781 1.301 . . . . 0.0 109.792 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 15' ' ' THR . 0.0 OUTLIER 87.54 -36.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -137.64 74.23 1.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 123.941 0.776 . . . . 0.0 109.88 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.521 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.9 t -42.7 -72.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -46.5 -27.79 1.21 Allowed 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.317 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.9 -63.05 3.85 Favored Glycine 0 N--CA 1.486 2.003 0 O-C-N 125.137 1.523 . . . . 0.0 109.628 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 11.4 tp10 -51.94 -37.1 51.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.601 ' SG ' HG21 ' A' ' 4' ' ' ILE . 1.4 m -72.34 -42.45 65.34 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.637 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 mt -63.03 -30.69 71.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.85 -33.55 75.5 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 124.716 1.26 . . . . 0.0 109.333 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 1.3 mpt_? -97.87 14.05 28.5 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.89 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 54.91 30.17 52.73 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.636 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 8.5 m-85 -76.85 178.04 7.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.53 -33.44 64.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.359 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 159.68 179.57 34.58 Favored Glycine 0 N--CA 1.487 2.047 0 O-C-N 124.418 1.074 . . . . 0.0 110.555 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.64 156.99 27.79 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.3 p-80 -153.61 157.39 39.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.044 -1.078 . . . . 0.0 109.757 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 95.3 m -78.19 150.11 33.59 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.52 154.33 3.41 Favored Glycine 0 N--CA 1.483 1.821 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.205 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.2 t -96.42 -68.04 0.82 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.4 -0.92 . . . . 0.0 108.758 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -97.33 21.69 9.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.638 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.97 53.55 0.1 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.608 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' O ' HG12 ' A' ' 38' ' ' VAL . 18.5 p30 -62.08 -154.53 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.441 1.088 . . . . 0.0 108.231 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 88.77 -15.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -145.95 157.9 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.488 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.6 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -117.47 150.7 38.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.592 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CE2' HD23 ' A' ' 3' ' ' LEU . 40.5 m95 -133.66 168.83 17.98 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 125.063 1.477 . . . . 0.0 108.535 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -100.09 161.5 13.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.11 55.52 1.16 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.42 1.088 . . . . 0.0 109.214 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 42' ' ' CYS . 71.3 p . . . . . 0 C--N 1.302 -1.5 0 CA-C-O 114.641 -2.599 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 10.2 mmtt -97.9 106.01 18.24 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.28 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.607 HD12 ' CH2' ' A' ' 41' ' ' TRP . 9.1 tt -56.53 162.42 2.21 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 113.838 -1.528 . . . . 0.0 108.556 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.629 ' CG2' ' SG ' ' A' ' 42' ' ' CYS . 10.2 pt -136.85 -41.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 113.923 -1.49 . . . . 0.0 108.537 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.6 -152.03 12.05 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 1.4 m -93.96 166.61 12.08 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 124.514 0.773 . . . . 0.0 109.652 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.8 t -136.04 47.16 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.4 127.52 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -77.13 68.5 3.27 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.39 59.18 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.288 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.21 177.07 11.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 124.575 0.809 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.9 t -81.51 170.8 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.643 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.22 29.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.495 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 36.3 t80 -50.91 140.22 15.72 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.053 -1.431 . . . . 0.0 109.77 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 16' ' ' SER . 4.4 m -92.17 -74.28 0.52 Allowed 'General case' 0 C--N 1.307 -1.262 0 O-C-N 124.819 1.325 . . . . 0.0 109.437 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.9 OUTLIER 89.08 -37.28 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -138.29 75.02 1.5 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.816 0.697 . . . . 0.0 109.795 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.0 t -42.54 -70.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.4 OUTLIER -39.41 -33.74 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 123.767 0.667 . . . . 0.0 109.568 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.12 -56.89 6.59 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.668 ' HG3' HH21 ' A' ' 25' ' ' ARG . 1.2 tp10 -55.8 -34.61 65.48 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.7 m -75.16 -45.21 42.25 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.38 -31.44 72.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -34.4 74.65 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 124.426 1.079 . . . . 0.0 109.964 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.668 HH21 ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -94.23 1.69 55.98 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.573 -1.649 . . . . 0.0 110.996 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 13.36 82.1 Favored Glycine 0 N--CA 1.49 2.246 0 O-C-N 124.122 0.889 . . . . 0.0 110.911 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 22.4 m-85 -83.13 168.45 16.84 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.893 0.854 . . . . 0.0 109.928 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.47 162.69 17.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.664 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.45 102.47 0.01 OUTLIER Glycine 0 N--CA 1.484 1.893 0 O-C-N 125.444 1.715 . . . . 0.0 111.355 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.589 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -81.51 -169.48 42.4 Favored Glycine 0 N--CA 1.481 1.643 0 O-C-N 125.488 1.346 . . . . 0.0 110.776 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -163.42 177.81 8.59 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.845 -1.178 . . . . 0.0 109.905 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.3 m -99.06 149.83 22.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.83 145.05 11.04 Favored Glycine 0 N--CA 1.482 1.752 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.155 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.3 t -91.86 -65.27 1.02 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 125.041 1.083 . . . . 0.0 109.048 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -95.38 21.09 8.48 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.61 53.61 0.11 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 38' ' ' VAL . 8.8 t-20 -60.48 -155.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 125.085 1.491 . . . . 0.0 108.152 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 37' ' ' ASN . 2.6 m 75.9 -1.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 21.4 m-80 -151.11 154.67 37.4 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.971 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.502 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -111.36 152.26 27.5 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.607 ' CH2' HD12 ' A' ' 3' ' ' LEU . 38.6 m95 -144.45 158.65 43.65 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.737 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.629 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 94.6 m -93.57 -175.83 3.9 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 117.252 -1.779 . . . . 0.0 108.574 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -144.54 76.12 1.49 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.782 1.277 . . . . 0.0 110.599 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 C--N 1.297 -1.705 0 CA-C-N 112.604 -2.089 . . . . 0.0 110.256 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -108.69 110.94 22.48 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.528 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 9.7 tt -62.49 162.15 10.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.054 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 5' ' ' GLY . 16.2 pt -134.08 -43.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 125.137 1.523 . . . . 0.0 109.495 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 179.85 -148.74 8.16 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 15' ' ' THR . 3.3 m -99.32 170.18 8.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.957 -0.621 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 8.8 t -136.44 51.34 2.01 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 17.6 t -131.64 128.93 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.265 -0.879 . . . . 0.0 108.851 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -78.7 61.39 2.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.68 64.2 0.01 OUTLIER Glycine 0 N--CA 1.48 1.622 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.58 -179.83 5.09 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 124.419 0.717 . . . . 0.0 109.159 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.68 167.42 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.644 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 42.89 29.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.378 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -57.65 134.96 56.64 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.137 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -117.46 177.81 4.61 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 125.064 1.478 . . . . 0.0 109.89 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.5 t -142.05 -49.04 0.37 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.506 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 20' ' ' GLY . 4.5 p-10 -111.61 72.44 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.414 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' HD11 ' A' ' 4' ' ' ILE . 5.6 t -40.56 -41.94 1.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.41 -50.39 73.01 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.277 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -61.91 -57.41 17.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG3' ' NH2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -50.13 -33.57 19.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.503 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.9 m -76.21 -43.31 42.95 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.4 mt -63.61 -30.93 71.97 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 124.869 1.356 . . . . 0.0 108.278 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.33 -31.73 72.39 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.012 0.911 . . . . 0.0 109.699 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' NH2' ' HG3' ' A' ' 21' ' ' GLU . 2.3 mtm-85 -94.4 -1.0 54.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.785 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.83 6.59 79.51 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 16.6 m-30 -85.47 164.39 17.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.702 0.763 . . . . 0.0 109.956 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -87.69 164.98 15.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.898 -1.501 . . . . 0.0 109.531 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -31.91 97.56 0.01 OUTLIER Glycine 0 N--CA 1.487 2.036 0 O-C-N 125.802 1.939 . . . . 0.0 110.8 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.503 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -77.4 -168.12 29.9 Favored Glycine 0 N--CA 1.48 1.617 0 O-C-N 125.393 1.29 . . . . 0.0 110.209 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -163.1 172.25 15.18 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.069 -1.066 . . . . 0.0 110.08 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 63.8 m -83.74 150.51 25.78 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -29.0 -87.89 0.01 OUTLIER Glycine 0 N--CA 1.479 1.543 0 O-C-N 125.478 1.736 . . . . 0.0 113.187 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.3 p -148.18 -56.49 0.22 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.096 0.951 . . . . 0.0 110.931 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 10.0 t80 -172.49 85.31 0.07 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.84 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 88.27 32.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.904 1.378 . . . . 0.0 109.089 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 39' ' ' ASN . 52.7 t30 -79.98 -7.25 58.7 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.57 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.412 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 18.9 m 42.98 29.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 O-C-N 124.578 1.174 . . . . 0.0 109.982 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' HB2' ' ND2' ' A' ' 37' ' ' ASN . 60.9 m-80 -152.75 128.24 10.0 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.021 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.22 138.65 38.88 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.528 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 72.3 m95 -125.38 152.29 44.99 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.423 -1.717 . . . . 0.0 108.307 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 68.4 m -84.46 163.26 19.57 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 117.457 -1.697 . . . . 0.0 108.613 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -97.13 54.34 1.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.014 -1.448 . . . . 0.0 109.966 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.429 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 4.5 t . . . . . 0 N--CA 1.485 1.281 1 CA-C-O 111.405 -4.141 . . . . 0.0 111.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.467 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 1.6 p30 . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' HB2' HG21 ' A' ' 44' ' ' THR . 15.7 mmtp -99.79 102.19 13.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.311 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.1 tt -58.6 163.08 3.42 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 124.577 1.173 . . . . 0.0 108.922 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.548 HD11 ' SG ' ' A' ' 18' ' ' CYS . 17.9 pt -134.65 -42.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 124.693 1.246 . . . . 0.0 109.088 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.75 21.39 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 t -93.77 165.11 12.85 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.671 -1.265 . . . . 0.0 108.465 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.9 t -129.88 37.03 3.99 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.9 t -110.69 124.84 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 67.5 m95 -79.53 69.34 5.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.54 59.19 0.02 OUTLIER Glycine 0 N--CA 1.486 1.988 0 CA-C-N 113.042 -1.89 . . . . 0.0 111.212 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.59 179.39 8.93 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.5 t -80.82 169.59 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.166 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 42.2 29.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.891 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -60.3 134.7 57.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 125.037 1.461 . . . . 0.0 109.766 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -116.72 170.62 8.45 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 124.817 1.323 . . . . 0.0 108.941 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -141.59 -47.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.678 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -105.15 66.57 0.76 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.724 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' HD11 ' A' ' 4' ' ' ILE . 10.2 t -44.15 -65.01 0.56 Allowed 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -49.25 -30.35 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.625 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.68 -65.67 2.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.509 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 2.6 tt0 -52.76 -31.37 37.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' HG21 ' A' ' 4' ' ' ILE . 16.4 m -77.16 -40.34 45.79 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.8 mt -65.23 -29.79 70.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.79 -32.83 74.08 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.057 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.509 ' NE ' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -90.39 1.2 56.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.454 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.14 19.18 79.54 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.604 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 16.9 m-85 -76.89 167.33 22.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.6 OUTLIER -64.97 -37.34 87.34 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.511 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.31 -166.71 39.81 Favored Glycine 0 N--CA 1.485 1.905 0 O-C-N 124.79 1.306 . . . . 0.0 110.468 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -163.34 155.68 27.14 Favored Glycine 0 N--CA 1.489 2.198 0 O-C-N 124.866 0.98 . . . . 0.0 111.091 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 55.9 p-80 -163.19 159.27 22.7 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.17 -1.015 . . . . 0.0 110.059 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 90.1 m -74.45 149.73 40.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -22.33 -92.77 0.01 OUTLIER Glycine 0 N--CA 1.489 2.193 0 O-C-N 126.287 2.242 . . . . 0.0 112.473 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.9 t -178.2 -64.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.844 0.967 . . . . 0.0 109.325 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -122.75 58.18 1.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 123.961 0.788 . . . . 0.0 109.776 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -164.44 -40.9 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 43.98 62.94 1.77 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.753 -1.567 . . . . 0.0 107.903 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 p -122.83 -43.46 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 112.961 -1.927 . . . . 0.0 108.914 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -131.08 150.79 51.99 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 124.166 0.916 . . . . 0.0 108.988 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.79 147.92 34.67 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.681 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.461 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 38.8 m95 -134.23 158.99 42.31 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.579 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 69.7 m -87.13 172.24 10.09 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 117.133 -1.827 . . . . 0.0 108.12 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -101.54 58.16 0.85 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 124.016 1.865 . . . . 0.0 110.708 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.476 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 21.4 p . . . . . 0 C--N 1.303 -1.426 0 CA-C-O 112.061 -3.828 . . . . 0.0 110.335 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 10.4 mptt -134.99 126.83 29.33 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.733 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 4' ' ' ILE . 2.2 tm? -84.2 163.6 19.63 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 125.335 1.647 . . . . 0.0 107.826 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' SG ' ' A' ' 22' ' ' CYS . 3.4 pt -136.66 -40.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.995 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -163.49 37.19 Favored Glycine 0 N--CA 1.484 1.893 0 O-C-N 124.876 1.36 . . . . 0.0 110.298 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 7' ' ' CYS . 30.8 t -90.31 172.06 9.03 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 114.074 -1.063 . . . . 0.0 109.263 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' OG ' ' A' ' 6' ' ' SER . 48.2 t -137.77 41.93 2.32 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.007 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.604 HG21 HG22 ' A' ' 38' ' ' VAL . 76.7 t -116.97 124.97 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.439 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.27 62.84 2.38 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.54 58.74 0.01 OUTLIER Glycine 0 N--CA 1.483 1.79 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.015 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.87 -179.84 7.89 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.82 165.74 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.175 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m120 41.43 30.65 0.14 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 114.239 -1.346 . . . . 0.0 108.908 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 15' ' ' THR . 2.9 t80 -65.35 134.42 53.51 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.309 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.564 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.7 m -111.49 177.45 4.65 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 124.633 1.208 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.1 m -142.81 -50.6 0.36 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' GLY . 13.8 p-10 -102.93 68.94 1.02 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' A' ' 17' ' ' ASP . 14.1 t -41.53 -70.64 0.1 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -38.54 -35.96 0.22 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.412 0.625 . . . . 0.0 109.655 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -68.66 -57.05 8.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 5.5 tp10 -53.9 -35.62 61.83 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 124.532 1.133 . . . . 0.0 108.461 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 4' ' ' ILE . 3.2 m -75.33 -44.35 45.75 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.856 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.3 mt -63.76 -30.98 72.01 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 mt -64.78 -28.82 69.84 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.398 1.061 . . . . 0.0 109.794 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 14.3 mtm-85 -99.12 6.38 46.51 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.573 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.96 17.57 69.78 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 15.2 m-30 -83.27 174.47 10.7 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.146 -0.527 . . . . 0.0 109.928 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.1 OUTLIER -87.08 151.98 22.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.39 -179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.18 104.14 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 O-C-N 125.632 1.832 . . . . 0.0 110.483 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.504 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -87.43 -177.77 48.44 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -164.52 174.98 10.3 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.982 -1.109 . . . . 0.0 109.8 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 98.6 m -95.14 150.44 20.2 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.048 1.468 . . . . 0.0 107.374 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -46.18 147.52 2.58 Favored Glycine 0 N--CA 1.484 1.838 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.214 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.7 p -92.87 -69.29 0.75 Allowed 'General case' 0 C--N 1.307 -1.263 0 O-C-N 124.27 0.629 . . . . 0.0 109.319 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -95.0 17.51 13.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.056 0.847 . . . . 0.0 110.094 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.52 53.79 0.11 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.724 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 32' ' ' CYS . 10.4 t-20 -60.87 -155.57 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 8' ' ' VAL . 0.3 OUTLIER 88.37 -14.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.437 HD22 HG13 ' A' ' 38' ' ' VAL . 12.5 m-80 -147.58 154.09 40.26 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.95 161.0 15.11 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.094 -1.412 . . . . 0.0 107.272 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.547 ' CE2' HD23 ' A' ' 3' ' ' LEU . 67.8 m95 -148.31 155.5 41.37 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 124.544 1.152 . . . . 0.0 108.483 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.45 ' SG ' ' CG2' ' A' ' 4' ' ' ILE . 55.9 m -94.88 164.24 13.0 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.375 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -100.69 59.56 0.95 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.468 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.554 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 13.0 t . . . . . 0 C--N 1.313 -1.02 1 CA-C-O 111.607 -4.044 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HD3' HG21 ' A' ' 44' ' ' THR . 12.0 mptt -125.49 94.6 4.19 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 124.651 1.219 . . . . 0.0 108.234 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.487 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 5.9 tt -57.62 163.61 2.4 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.339 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.425 HG23 ' SG ' ' A' ' 42' ' ' CYS . 6.3 pt -134.85 -41.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.408 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.08 -148.42 9.58 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.331 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.79 178.56 5.87 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.971 -1.114 . . . . 0.0 109.732 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.7 t -138.77 54.26 1.75 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 38' ' ' VAL . 25.4 t -138.4 122.63 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 123.808 0.693 . . . . 0.0 109.452 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.56 67.49 3.48 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.22 55.89 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.94 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.74 178.45 8.47 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -81.44 170.38 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 m120 44.16 28.83 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.367 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 19.3 t80 -57.06 135.26 56.32 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 124.826 1.329 . . . . 0.0 109.802 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 16' ' ' SER . 24.4 m -92.57 -76.89 0.45 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 125.177 1.548 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' THR . 7.6 t 91.51 -39.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -135.43 78.24 1.72 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.677 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 1.8 t -48.51 -57.45 6.12 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 30' ' ' GLY . 2.8 m120 -54.51 -33.23 59.56 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.12 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.21 -66.92 2.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 25' ' ' ARG . 42.7 tt0 -47.88 -38.41 16.21 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 56.5 m -74.65 -41.35 60.49 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.691 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.98 -30.07 71.18 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mt -64.21 -33.08 74.99 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 124.356 1.035 . . . . 0.0 108.397 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 5.0 mpt_? -94.22 6.14 49.56 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.952 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.47 75.02 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 10.0 m-85 -77.92 149.31 34.22 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 124.606 0.827 . . . . 0.0 109.775 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.78 -43.36 8.55 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 113.864 -1.517 . . . . 0.0 109.028 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.69 -166.97 39.75 Favored Glycine 0 N--CA 1.484 1.862 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.408 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -161.8 156.0 27.4 Favored Glycine 0 N--CA 1.485 1.945 0 O-C-N 124.906 1.004 . . . . 0.0 110.626 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.567 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.1 p-80 -156.12 158.98 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.035 -1.082 . . . . 0.0 109.852 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' O ' ' C ' ' A' ' 33' ' ' GLY . 84.1 m -77.78 150.4 34.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -27.14 -51.98 0.07 OUTLIER Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.258 1.599 . . . . 0.0 112.21 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 t -165.05 -51.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 124.898 0.999 . . . . 0.0 109.528 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.3 t80 -169.77 80.82 0.11 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.516 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 82.12 32.85 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.728 1.267 . . . . 0.0 109.072 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 12.4 t-20 -57.53 -18.71 20.57 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.581 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' CG2' ' A' ' 8' ' ' VAL . 0.4 OUTLIER 87.49 -11.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 125.234 1.584 . . . . 0.0 107.941 179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -131.1 136.51 48.45 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 145.35 40.2 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 34.0 m95 -129.86 156.51 44.26 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 125.417 1.698 . . . . 0.0 109.185 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.58 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 66.2 m -85.75 170.26 12.63 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 116.59 -2.044 . . . . 0.0 108.079 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 55.53 1.2 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.173 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.401 HG21 ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 113.079 -3.343 . . . . 0.0 109.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.524 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.583 ' HB2' HG21 ' A' ' 44' ' ' THR . 5.8 tmtt? -117.79 116.34 26.81 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.35 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.6 tt -75.75 162.65 28.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.612 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.77 HD11 ' SG ' ' A' ' 40' ' ' CYS . 8.7 pt -134.37 -43.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 125.026 1.454 . . . . 0.0 108.981 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.72 -161.62 23.47 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -96.45 155.85 16.59 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.012 0.91 . . . . 0.0 109.922 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 5.2 t -114.17 56.7 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.411 ' CG2' HG12 ' A' ' 38' ' ' VAL . 82.7 t -136.33 116.98 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.295 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -75.41 117.58 17.37 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -27.25 6.82 Favored Glycine 0 N--CA 1.485 1.959 0 O-C-N 124.638 1.211 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.59 172.84 10.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.441 0.73 . . . . 0.0 109.101 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.7 t -81.23 169.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.69 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 m120 42.34 30.35 0.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.698 1.249 . . . . 0.0 108.475 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 6.2 t80 -62.31 143.81 56.46 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.366 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' SER . 12.4 m -89.47 -73.01 0.53 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 124.465 1.103 . . . . 0.0 110.012 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 15' ' ' THR . 5.3 t 89.41 -37.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 18' ' ' CYS . 19.9 p-10 -139.9 70.35 1.36 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.95 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.6 t -39.53 -65.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -41.58 -48.05 3.94 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -60.45 -68.19 1.79 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' CD ' ' NH2' ' A' ' 25' ' ' ARG . 6.8 tp10 -44.31 -32.85 1.42 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 122.312 1.053 . . . . 0.0 109.385 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 4' ' ' ILE . 13.0 m -76.13 -42.56 46.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.474 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' GLY . 25.1 mt -65.12 -30.8 71.76 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -62.71 -30.54 71.49 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 122.327 1.061 . . . . 0.0 109.152 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' NH2' ' CD ' ' A' ' 21' ' ' GLU . 9.0 mtm180 -102.61 7.33 39.97 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.637 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.87 14.57 68.01 Favored Glycine 0 N--CA 1.491 2.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.213 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.462 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 9.9 m-85 -77.41 175.48 9.75 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.83 0.824 . . . . 0.0 109.565 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -88.31 150.41 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.983 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -32.15 94.42 0.01 OUTLIER Glycine 0 N--CA 1.484 1.858 0 O-C-N 125.867 1.979 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.52 -170.73 28.77 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 124.959 1.035 . . . . 0.0 110.531 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 16.4 p-80 -163.5 172.37 14.55 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.136 -1.032 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' O ' ' C ' ' A' ' 33' ' ' GLY . 69.0 m -81.89 149.95 28.0 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . -26.71 -88.13 0.01 OUTLIER Glycine 0 N--CA 1.483 1.793 0 O-C-N 125.593 1.808 . . . . 0.0 112.929 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.9 t -153.91 -52.56 0.1 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 124.757 0.916 . . . . 0.0 109.686 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 24.9 t80 -172.72 85.52 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.287 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.07 29.19 0.05 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.728 1.268 . . . . 0.0 109.165 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.554 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 17.2 t-20 -79.12 -12.9 60.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.469 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG12 ' CG2' ' A' ' 8' ' ' VAL . 11.5 m 44.6 34.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 124.572 1.17 . . . . 0.0 110.161 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . 70.6 m-80 -149.48 116.45 5.98 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.664 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.77 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -97.38 133.49 41.92 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.524 ' CE3' ' HB2' ' A' ' 1' ' ' ASP . 67.4 m95 -119.64 156.8 29.73 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 113.623 -1.626 . . . . 0.0 107.879 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.604 ' SG ' HG21 ' A' ' 4' ' ' ILE . 40.1 m -92.39 174.88 7.06 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.997 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -101.03 61.2 0.95 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 124.999 2.333 . . . . 0.0 111.467 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 2' ' ' LYS . 31.3 p . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 112.743 -3.503 . . . . 0.0 110.435 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.42 158.82 16.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.611 1.194 . . . . 0.0 108.08 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.3 tt -99.42 164.5 12.08 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.777 HD11 ' SG ' ' A' ' 22' ' ' CYS . 44.8 mt -132.56 -43.96 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 125.366 1.666 . . . . 0.0 109.396 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.81 -147.03 12.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.532 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 53.5 m -96.14 160.42 14.45 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.808 -0.696 . . . . 0.0 110.236 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.805 ' SG ' ' ND2' ' A' ' 37' ' ' ASN . 35.4 t -138.72 27.3 2.47 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' A' ' 38' ' ' VAL . 69.2 t -93.53 135.08 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -79.13 63.84 3.88 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 124.732 1.27 . . . . 0.0 107.72 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.56 63.56 0.04 OUTLIER Glycine 0 N--CA 1.482 1.718 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.517 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.19 177.64 11.11 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.542 0.789 . . . . 0.0 109.294 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.2 t -82.45 168.36 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 114.327 -1.306 . . . . 0.0 107.781 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.82 27.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.098 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' N ' ' C ' ' A' ' 12' ' ' VAL . 5.6 t80 -60.73 134.39 57.03 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.134 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.3 m -110.64 167.95 9.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 125.166 1.541 . . . . 0.0 109.831 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.7 m -142.14 -47.43 0.35 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.144 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.34 67.82 0.74 Allowed 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.924 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' HD12 ' A' ' 4' ' ' ILE . 5.5 t -50.01 -64.21 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.62 -33.08 1.67 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.611 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.38 -55.95 11.29 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 24.2 tt0 -58.97 -30.56 68.01 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.045 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.777 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.2 m -78.12 -41.17 35.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.5 mt -63.3 -31.41 72.56 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.48 -30.61 71.64 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.761 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' N ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -92.76 2.53 56.7 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.119 179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.41 20.38 75.28 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.686 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 14.1 m-85 -77.04 173.2 12.08 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.652 0.854 . . . . 0.0 110.019 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 4.6 mptt -71.05 -35.24 71.86 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.107 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.525 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 165.67 -177.43 40.89 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -156.3 159.32 29.34 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 21.8 p-80 -163.32 163.13 25.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 114.142 -1.029 . . . . 0.0 110.273 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' A' ' 33' ' ' GLY . 92.5 m -78.25 151.42 33.08 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -19.8 -96.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.578 0 O-C-N 126.471 2.357 . . . . 0.0 111.522 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -176.54 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 124.657 0.857 . . . . 0.0 109.717 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -118.94 38.16 3.89 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.091 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.17 48.41 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.566 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.805 ' ND2' ' SG ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -38.05 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 3.6 p -144.65 -43.99 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 0.6 OUTLIER -134.43 156.31 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -110.84 154.46 23.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 113.596 -1.638 . . . . 0.0 107.53 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.456 ' CD1' ' C ' ' A' ' 40' ' ' CYS . 32.8 m95 -140.35 156.95 46.24 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 113.007 -1.906 . . . . 0.0 109.243 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.686 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -87.39 163.62 16.67 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -97.64 53.9 1.15 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.316 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 5.0 t . . . . . 0 C--N 1.305 -1.353 1 CA-C-O 111.378 -4.153 . . . . 0.0 111.963 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -154.0 95.55 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 125.948 2.03 . . . . 0.0 108.913 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 4' ' ' ILE . 9.0 tt -56.04 162.82 1.75 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.087 0.867 . . . . 0.0 109.323 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.542 HD11 ' SG ' ' A' ' 18' ' ' CYS . 31.1 pt -134.41 -41.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.822 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.61 -147.86 10.94 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.735 -1.222 . . . . 0.0 110.45 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 14' ' ' TYR . 4.2 m -86.78 -178.59 6.37 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.414 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.01 49.77 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG21 HG12 ' A' ' 38' ' ' VAL . 3.4 t -148.95 125.19 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.087 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.83 103.61 5.99 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 -18.78 3.38 Favored Glycine 0 N--CA 1.491 2.334 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.94 171.77 8.56 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.408 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.8 t -82.13 169.61 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 114.268 -1.333 . . . . 0.0 108.021 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 44.17 29.0 0.31 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.25 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 13.0 t80 -57.64 147.66 26.72 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.892 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 16' ' ' SER . 15.6 m -96.23 -70.74 0.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.601 1.188 . . . . 0.0 109.355 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.4 OUTLIER 88.65 -36.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -138.34 86.71 2.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.863 1.316 . . . . 0.0 109.421 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 t -66.81 -71.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.183 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -41.97 -32.23 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.126 -0.629 . . . . 0.0 109.557 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.58 -59.37 6.19 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 125.022 1.451 . . . . 0.0 109.569 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 11.4 tp10 -55.67 -35.75 66.35 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.277 0.56 . . . . 0.0 110.103 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.44 -42.75 58.57 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.91 -30.58 70.98 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.94 -36.43 81.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 124.405 1.066 . . . . 0.0 109.395 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -97.02 16.04 20.69 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.777 179.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.81 28.82 53.51 Favored Glycine 0 N--CA 1.49 2.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.315 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.745 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 4.4 m-85 -75.94 159.82 30.51 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.959 0.885 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -57.61 -31.22 66.0 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.855 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.55 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 160.43 -173.65 37.03 Favored Glycine 0 N--CA 1.484 1.883 0 O-C-N 124.667 1.229 . . . . 0.0 110.639 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.02 155.8 26.96 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD1' ' CD ' ' A' ' 43' ' ' GLU . 3.6 p-80 -154.33 166.2 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.948 -1.126 . . . . 0.0 110.158 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 33' ' ' GLY . 57.5 m -76.96 150.09 35.93 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' HA3' ' CB ' ' A' ' 37' ' ' ASN . . . -27.43 -88.37 0.01 OUTLIER Glycine 0 N--CA 1.477 1.42 0 O-C-N 125.815 1.947 . . . . 0.0 113.133 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -148.32 -57.07 0.22 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.617 1.199 . . . . 0.0 111.449 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 10.0 t80 -172.68 85.82 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 112.728 -2.033 . . . . 0.0 110.716 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 87.83 33.12 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.951 1.407 . . . . 0.0 109.052 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 5.6 t-20 -82.84 -11.96 57.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.239 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 8' ' ' VAL . 4.8 m 42.47 34.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.05 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -151.43 118.1 5.76 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.098 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.81 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -98.0 144.71 27.23 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 41' ' ' TRP . 11.2 m95 -127.06 164.96 20.4 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 112.535 -2.121 . . . . 0.0 109.047 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -96.21 171.42 8.6 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 125.068 1.48 . . . . 0.0 107.195 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' CD ' ' HD1' ' A' ' 31' ' ' HIS . 1.8 tp10 -97.81 54.0 1.13 Allowed 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.896 -178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 42' ' ' CYS . 31.8 p . . . . . 0 C--N 1.3 -1.554 0 CA-C-O 117.264 -1.351 . . . . 0.0 109.201 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 48.1 mmtt -100.48 104.75 16.16 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 4' ' ' ILE . 7.9 tt -59.04 162.19 4.49 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.904 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.62 HD11 ' SG ' ' A' ' 18' ' ' CYS . 20.8 pt -134.49 -43.09 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 125.027 1.454 . . . . 0.0 109.123 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 -148.09 10.45 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.344 -1.103 . . . . 0.0 110.344 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.1 t -97.29 164.49 12.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.66 1.219 . . . . 0.0 108.863 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.7 t -127.77 50.09 2.07 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.284 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 11' ' ' ALA . 33.1 t -130.02 122.09 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.817 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.5 92.53 2.37 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 -6.91 5.71 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 8' ' ' VAL . . . -96.41 178.97 5.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.0 t -81.65 168.8 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.972 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 p30 40.0 31.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 125.386 1.679 . . . . 0.0 108.315 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' N ' ' C ' ' A' ' 12' ' ' VAL . 17.6 t80 -55.45 137.34 48.5 Favored 'General case' 0 C--N 1.314 -0.937 0 O-C-N 125.327 1.642 . . . . 0.0 109.522 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 16' ' ' SER . 17.7 m -86.59 -73.76 0.45 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 124.552 1.157 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 15' ' ' THR . 0.6 OUTLIER 89.39 -36.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -137.75 73.77 1.45 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -46.85 -62.17 1.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -50.05 -27.71 5.99 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.313 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.53 -67.43 1.72 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CG ' ' NH2' ' A' ' 25' ' ' ARG . 34.0 tt0 -49.19 -31.83 9.21 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' HG21 ' A' ' 4' ' ' ILE . 7.2 m -75.86 -43.59 44.87 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 124.286 0.991 . . . . 0.0 108.338 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.89 -31.1 72.16 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.497 1.123 . . . . 0.0 108.05 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -63.08 -31.27 72.37 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.696 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' NH2' ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -91.05 -3.34 57.27 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.533 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.22 12.09 76.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' CD2' ' SG ' ' A' ' 42' ' ' CYS . 23.6 m-85 -81.52 163.87 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.583 0.814 . . . . 0.0 110.038 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' GLY . 3.4 mppt? -86.71 169.14 12.92 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.292 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -31.18 99.82 0.01 OUTLIER Glycine 0 N--CA 1.491 2.34 0 O-C-N 125.647 1.842 . . . . 0.0 110.932 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.41 -165.96 33.6 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.587 ' ND1' ' CD ' ' A' ' 43' ' ' GLU . 32.6 p-80 -164.19 171.98 14.27 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.282 -0.959 . . . . 0.0 109.938 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 20.7 m -101.52 147.44 26.38 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 21.44 -124.16 0.01 OUTLIER Glycine 0 N--CA 1.481 1.697 0 O-C-N 125.664 1.853 . . . . 0.0 112.615 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -158.53 -45.06 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 125.179 1.164 . . . . 0.0 109.218 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 23.0 t80 -172.04 85.46 0.07 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.137 0.898 . . . . 0.0 110.456 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 84.19 53.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.794 1.309 . . . . 0.0 109.289 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.588 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 57.6 t30 -106.9 -154.02 0.51 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 113.492 -1.685 . . . . 0.0 107.971 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' ASN . 8.1 m -165.9 35.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 123.914 0.759 . . . . 0.0 108.991 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -153.22 174.38 14.34 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 123.563 0.539 . . . . 0.0 110.242 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.65 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -122.53 147.3 46.54 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 124.782 1.301 . . . . 0.0 107.997 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.537 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.0 m95 -146.72 160.45 42.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.263 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.535 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 93.0 m -94.21 -173.01 2.96 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 117.224 -1.79 . . . . 0.0 108.673 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.587 ' CD ' ' ND1' ' A' ' 31' ' ' HIS . 5.5 mt-10 -143.88 76.42 1.51 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 122.072 0.939 . . . . 0.0 110.272 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 C--N 1.299 -1.623 0 CA-C-O 115.952 -1.975 . . . . 0.0 109.969 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.422 ' HA ' ' HG1' ' A' ' 44' ' ' THR . 3.1 m-20 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.587 ' HB2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -120.9 109.97 15.74 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.476 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 4' ' ' ILE . 10.5 tt -71.74 163.33 28.0 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.832 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.688 HD13 ' SG ' ' A' ' 22' ' ' CYS . 4.9 pt -136.53 -41.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 125.17 1.544 . . . . 0.0 108.74 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -163.06 24.99 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 m -93.52 163.48 13.55 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.354 -0.923 . . . . 0.0 109.507 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 t -123.06 54.49 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.9 t -126.83 121.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.34 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -77.6 71.12 4.06 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.95 59.35 0.04 OUTLIER Glycine 0 N--CA 1.491 2.301 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.76 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.8 179.71 8.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' C ' ' N ' ' A' ' 14' ' ' TYR . 3.5 t -79.24 170.72 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER 40.5 30.47 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.61 1.194 . . . . 0.0 109.511 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CE2' ' HB2' ' A' ' 16' ' ' SER . 25.0 t80 -52.99 135.16 37.38 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.642 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 16' ' ' SER . 50.6 m -92.29 -74.58 0.51 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.485 1.116 . . . . 0.0 109.695 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 15' ' ' THR . 3.6 t 90.21 -39.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.4 p-10 -136.84 73.93 1.47 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.245 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 6.7 t -43.91 -57.96 3.02 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.54 -36.03 61.36 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -67.01 -70.19 1.18 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.664 ' HG3' ' HB ' ' A' ' 4' ' ' ILE . 46.3 tp10 -45.64 -34.01 3.22 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 122.412 1.101 . . . . 0.0 110.206 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' HD13 ' A' ' 4' ' ' ILE . 4.2 m -73.23 -43.59 60.96 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.697 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.0 mt -64.34 -30.99 72.02 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 mt -64.37 -30.34 71.39 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.986 1.429 . . . . 0.0 109.166 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -98.68 7.73 45.76 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.187 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.72 19.62 69.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.558 ' HD2' ' SG ' ' A' ' 42' ' ' CYS . 15.4 m-30 -84.29 172.0 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.913 -0.643 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -85.03 149.43 25.58 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 113.92 -1.491 . . . . 0.0 108.886 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -30.43 99.46 0.01 OUTLIER Glycine 0 N--CA 1.486 2.021 0 O-C-N 125.744 1.903 . . . . 0.0 110.714 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.568 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -75.42 -174.7 35.78 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.509 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 10.9 p-80 -163.94 174.43 11.45 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.674 -1.263 . . . . 0.0 110.19 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' O ' ' C ' ' A' ' 33' ' ' GLY . 99.3 m -90.94 152.58 20.66 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -19.51 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 O-C-N 126.058 2.099 . . . . 0.0 111.595 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 t -166.7 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 O-C-N 124.556 0.798 . . . . 0.0 108.972 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -125.54 39.61 3.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 123.856 0.722 . . . . 0.0 109.811 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.86 56.13 0.11 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.103 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -37.98 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.226 0.954 . . . . 0.0 109.755 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 36' ' ' ALA . 15.3 m -136.55 -48.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.496 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -125.93 136.29 52.86 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.233 0.958 . . . . 0.0 109.805 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -105.6 140.47 38.62 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 51.1 m95 -129.66 162.67 27.81 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.04 -1.437 . . . . 0.0 107.851 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 80.9 m -95.21 172.25 8.23 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 117.269 -1.772 . . . . 0.0 108.382 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -101.16 61.23 0.94 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 124.754 2.216 . . . . 0.0 112.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 28' ' ' LYS . 36.4 p . . . . . 0 C--N 1.305 -1.364 0 CA-C-O 112.489 -3.624 . . . . 0.0 111.252 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.41 ' HB2' ' CE3' ' A' ' 41' ' ' TRP . 3.5 m-20 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -110.67 98.18 7.41 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.967 -1.469 . . . . 0.0 109.089 -179.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD12 ' CZ2' ' A' ' 41' ' ' TRP . 8.1 tt -56.16 161.47 2.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.077 0.861 . . . . 0.0 109.062 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.524 ' N ' HD23 ' A' ' 3' ' ' LEU . 19.8 pt -136.26 -41.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 124.823 1.327 . . . . 0.0 109.396 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.26 -148.59 9.62 Favored Glycine 0 N--CA 1.487 2.046 0 O-C-N 124.86 1.35 . . . . 0.0 110.156 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.7 m -94.42 -172.45 2.78 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.777 -0.711 . . . . 0.0 109.812 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.42 ' N ' ' O ' ' A' ' 38' ' ' VAL . 24.5 t -152.89 34.91 0.48 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 38' ' ' VAL . 2.0 t -126.97 127.12 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.45 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -78.73 62.15 3.18 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 44.47 0.02 OUTLIER Glycine 0 N--CA 1.487 2.055 0 CA-C-N 114.253 -1.34 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.23 179.06 9.09 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -78.2 167.65 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.634 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.47 29.81 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.988 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 15' ' ' THR . 0.7 OUTLIER -52.1 135.77 30.86 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 124.902 1.376 . . . . 0.0 110.173 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.513 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.5 t -120.65 175.58 5.94 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 125.125 1.516 . . . . 0.0 108.931 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.7 -50.5 0.41 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.126 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 18' ' ' CYS . 7.7 p-10 -109.12 69.26 0.7 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.434 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 4' ' ' ILE . 7.6 t -38.26 -58.58 0.97 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -45.63 -50.28 13.49 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.311 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -61.61 -65.06 3.47 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.572 ' HG3' ' CZ ' ' A' ' 25' ' ' ARG . 6.1 tp10 -41.19 -37.1 0.85 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 124.376 1.071 . . . . 0.0 108.627 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.646 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 1.5 m -75.56 -43.9 46.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.517 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 22.2 mt -62.75 -30.29 71.33 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 mt -64.09 -32.84 74.55 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 124.261 0.975 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.572 ' CZ ' ' HG3' ' A' ' 21' ' ' GLU . 18.6 mtm-85 -92.18 3.79 54.58 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.679 -1.6 . . . . 0.0 110.843 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 12.89 83.54 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 2' ' ' LYS . 21.8 m-85 -89.89 170.04 10.72 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.994 0.902 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 43' ' ' GLU . 34.3 mtpt -84.64 154.86 22.27 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.252 -1.795 . . . . 0.0 108.446 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -34.98 96.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.062 0 O-C-N 125.341 1.65 . . . . 0.0 110.57 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.646 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -69.45 -170.83 7.6 Favored Glycine 0 N--CA 1.48 1.607 0 O-C-N 125.386 1.286 . . . . 0.0 110.893 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -161.94 171.46 17.61 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 113.578 -1.311 . . . . 0.0 110.455 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' C ' ' A' ' 33' ' ' GLY . 87.0 m -92.04 151.45 20.45 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 32' ' ' CYS . . . -20.7 -92.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.415 0 O-C-N 125.667 1.855 . . . . 0.0 112.509 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 p -176.07 -70.3 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 124.949 1.029 . . . . 0.0 110.13 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -119.23 39.21 3.63 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.364 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 38' ' ' VAL . . . -165.61 49.89 0.09 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.191 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -40.82 95.3 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 8' ' ' VAL . 2.5 p -152.28 -45.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 124.777 1.298 . . . . 0.0 109.241 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 35.5 m120 -120.94 137.63 54.51 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 124.156 0.91 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.467 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -107.36 147.28 30.53 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 65.2 m95 -137.06 152.49 50.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' SG ' ' CD2' ' A' ' 27' ' ' TYR . 84.2 m -86.45 -171.59 3.62 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.051 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -142.73 74.46 1.45 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.856 0.836 . . . . 0.0 110.911 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 59.7 p . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 112.973 -3.394 . . . . 0.0 109.573 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' HE2' ' OH ' ' A' ' 27' ' ' TYR . 3.6 tmtm? -97.73 107.18 19.62 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD12 ' CH2' ' A' ' 41' ' ' TRP . 5.7 tt -64.32 162.69 14.36 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.077 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 ' SG ' ' A' ' 18' ' ' CYS . 18.3 pt -135.73 -39.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.392 -1.277 . . . . 0.0 109.117 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.426 ' N ' HG13 ' A' ' 4' ' ' ILE . . . 176.33 -148.1 8.96 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.433 ' O ' ' HB ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -104.34 167.37 9.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.185 -1.008 . . . . 0.0 109.765 -179.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 56.1 m -134.62 43.87 2.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -122.94 123.79 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 124.779 1.299 . . . . 0.0 109.08 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 73.57 4.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.08 52.08 0.02 OUTLIER Glycine 0 N--CA 1.488 2.102 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.152 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.67 176.57 10.82 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 13' ' ' ASN . 3.6 t -80.47 170.64 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.408 ' H ' HG12 ' A' ' 12' ' ' VAL . 35.3 m-20 42.49 30.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.569 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -60.37 134.28 56.91 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.999 1.437 . . . . 0.0 109.965 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 6' ' ' SER . 2.8 m -120.46 173.84 6.91 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 124.807 1.317 . . . . 0.0 109.107 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.0 t -142.36 -50.04 0.37 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.919 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -102.58 66.42 0.96 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.057 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.6 t -43.15 -71.91 0.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.495 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.505 HD22 ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -43.64 -28.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.075 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.48 -60.78 4.51 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' O ' ' NE ' ' A' ' 25' ' ' ARG . 1.1 tt0 -56.26 -31.49 63.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 10.9 m -77.1 -41.91 40.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' CD1' HD22 ' A' ' 19' ' ' ASN . 17.6 mt -64.08 -29.45 70.59 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 24' ' ' LEU . 8.8 mt -65.78 -30.41 71.06 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 124.308 1.005 . . . . 0.0 109.309 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -86.94 0.85 54.38 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.613 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.79 14.93 76.67 Favored Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.321 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 25' ' ' ARG . 18.9 m-85 -79.24 140.7 37.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.082 -1.447 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.495 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -43.39 -50.21 6.87 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 112.932 -1.94 . . . . 0.0 109.334 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.04 169.3 40.83 Favored Glycine 0 N--CA 1.481 1.662 0 O-C-N 125.213 1.571 . . . . 0.0 110.445 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -148.51 154.17 25.68 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -149.85 160.6 43.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' O ' ' C ' ' A' ' 33' ' ' GLY . 21.0 m -85.06 146.54 27.11 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.618 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 21.73 -126.25 0.01 OUTLIER Glycine 0 N--CA 1.484 1.842 0 O-C-N 126.133 2.145 . . . . 0.0 111.95 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -156.07 -45.2 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 125.081 1.106 . . . . 0.0 108.92 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.5 t80 -172.35 85.53 0.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.24 52.18 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 124.863 1.352 . . . . 0.0 109.219 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.618 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 9.9 t-20 -105.53 -152.71 0.47 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.806 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 13.5 m -165.55 33.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' ND2' ' OG ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -153.34 175.67 12.85 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -121.3 144.94 48.36 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.445 ' CH2' HD12 ' A' ' 3' ' ' LEU . 50.1 m95 -146.95 158.03 43.8 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.514 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 89.7 m -88.33 -174.9 4.81 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 117.837 -1.545 . . . . 0.0 108.11 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.271 44.6 tt0 -141.72 73.66 1.42 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 124.083 0.864 . . . . 0.0 110.364 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.495 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 45.3 p . . . . . 0 C--N 1.295 -1.783 0 O-C-N 125.24 1.587 . . . . 0.0 111.675 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 27' ' ' TYR . 11.9 tptt -134.18 100.51 4.73 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.241 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 4' ' ' ILE . 8.8 tt -59.45 161.56 5.67 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.609 HD11 ' SG ' ' A' ' 18' ' ' CYS . 9.0 pt -135.82 -42.58 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.727 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.58 -148.39 9.04 Favored Glycine 0 N--CA 1.482 1.703 0 O-C-N 124.987 1.429 . . . . 0.0 109.983 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.475 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 25.1 t -102.61 171.57 7.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.318 -1.353 . . . . 0.0 108.639 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 44.4 t -144.32 40.99 1.35 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.659 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.5 t -123.38 127.13 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.268 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.58 68.08 3.6 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.95 50.17 0.01 OUTLIER Glycine 0 N--CA 1.487 2.085 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.222 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.23 178.41 10.21 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' C ' ' N ' ' A' ' 14' ' ' TYR . 2.1 t -84.61 168.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 43.31 29.5 0.23 Allowed 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.837 1.336 . . . . 0.0 108.225 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' CE1' ' O ' ' A' ' 15' ' ' THR . 18.6 t80 -57.85 134.24 56.12 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 124.893 1.37 . . . . 0.0 110.073 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.508 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.0 t -117.73 -179.76 3.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 124.741 1.276 . . . . 0.0 109.15 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 15' ' ' THR . 0.7 OUTLIER -142.05 -49.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 113.574 -1.648 . . . . 0.0 110.682 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 18' ' ' CYS . 10.5 p-10 -105.24 66.15 0.74 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.096 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.1 t -37.77 -71.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 59.9 t30 -37.19 -42.85 0.47 Allowed 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.618 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 17' ' ' ASP . . . -64.78 -55.03 24.81 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG2' ' NH2' ' A' ' 25' ' ' ARG . 18.0 tt0 -56.79 -29.94 63.19 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' SG ' HD13 ' A' ' 4' ' ' ILE . 1.9 m -76.08 -45.45 33.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.1 mt -61.11 -32.29 71.97 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.78 -34.75 76.42 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.802 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.605 HH11 ' CA ' ' A' ' 4' ' ' ILE . 4.4 mtm180 -89.5 -0.42 57.49 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.309 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.85 12.6 79.53 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 2' ' ' LYS . 18.2 m-30 -83.98 164.69 19.18 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.303 -0.959 . . . . 0.0 110.251 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -87.92 172.38 9.64 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.369 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.512 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -27.89 106.2 0.01 OUTLIER Glycine 0 N--CA 1.485 1.961 0 O-C-N 125.964 2.04 . . . . 0.0 110.834 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.2 -170.17 33.44 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' ND1' ' OE2' ' A' ' 43' ' ' GLU . 6.6 p-80 -166.08 176.83 7.4 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.961 0.886 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 60.4 m -100.68 147.38 26.07 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.626 ' HA3' ' HB3' ' A' ' 37' ' ' ASN . . . 22.06 -125.87 0.01 OUTLIER Glycine 0 N--CA 1.483 1.768 0 O-C-N 126.126 2.141 . . . . 0.0 112.046 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t -155.59 -45.64 0.08 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 125.239 1.199 . . . . 0.0 108.901 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 22.3 t80 -171.99 85.47 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.389 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 35' ' ' PHE . . . 85.24 52.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 124.817 1.323 . . . . 0.0 109.327 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.626 ' HB3' ' HA3' ' A' ' 33' ' ' GLY . 16.8 t-20 -105.29 -152.57 0.47 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.899 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' H ' ' CG ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -166.52 34.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 123.85 0.719 . . . . 0.0 109.491 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 8.7 m-80 -155.36 176.38 12.66 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.656 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -120.97 147.81 44.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 122.351 1.072 . . . . 0.0 108.319 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' HD12 ' A' ' 3' ' ' LEU . 52.2 m95 -146.16 162.02 38.92 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 113.468 -1.696 . . . . 0.0 108.399 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.5 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 88.2 m -94.61 -173.51 3.04 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 117.038 -1.865 . . . . 0.0 108.868 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' OE2' ' ND1' ' A' ' 31' ' ' HIS . 11.5 tt0 -142.68 75.79 1.5 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 123.959 0.787 . . . . 0.0 109.944 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 115.057 -2.402 . . . . 0.0 110.439 179.926 . . . . . . . . 0 0 . 1 stop_ save_